Louisiana State University

LSU Digital Commons
LSU Doctoral Dissertations

Graduate School

2-18-2019

Understanding Immune-mediated Responses During the
Pathogenesis of Muco-obstructive Airway Disease in Mice
Brandon Wayne Lewis
Louisiana State University and Agricultural and Mechanical College

Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations
Part of the Medicine and Health Sciences Commons

Recommended Citation
Lewis, Brandon Wayne, "Understanding Immune-mediated Responses During the Pathogenesis of Mucoobstructive Airway Disease in Mice" (2019). LSU Doctoral Dissertations. 4810.
https://digitalcommons.lsu.edu/gradschool_dissertations/4810

This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It
has been accepted for inclusion in LSU Doctoral Dissertations by an authorized graduate school editor of LSU
Digital Commons. For more information, please contactgradetd@lsu.edu.

UNDERSTANDING IMMUNE-MEDIATED RESPONSES DURING THE
PATHOGENESIS OF MUCO-OBSTRUCTIVE AIRWAY DISEASE IN MICE

A Dissertation
Submitted to the Graduate Faculty of
Louisiana State University and
Agricultural and Mechanical College
in partial fulfillment of the
requirements for the degree of
Doctor of Philosophy
in
The Interdepartmental Program in
Biomedical and Veterinary Sciences through the
Veterinary Medicine--Interdepartmental Program

by
Brandon Wayne Lewis
B.A., The University of Mississippi, 2009
M.S., Mississippi College, 2010
May 2019

ACKNOWLEDGMENTS
I would like express my sincerest gratitude to my faculty mentor and friend, Dr. Yogesh
Saini, for his guidance and unwavering support throughout my doctoral training. Throughout my
graduate studies, Dr. Saini provided the best possible training for success in academia. Dr.
Saini’s advice on a career in research, and life in general, has helped me reach a level that will
enable me to be successful moving forward. I am truly honored to go forward as a trainee from
the laboratory of Dr. Yogesh Saini.
I would also like to thank my graduate committee, Dr. Arthur Penn, Dr. Joseph Francis,
Dr. Samithamby Jeyaseelan, Dr. Sonika Patial, Dr. Fabio Del Piero, and Dr. Jacob Esselstyn, for
their continued guidance and support throughout my time at Louisiana State University.
Additionally, I would like to thank my fellow laboratory members: Dr. Chandra Bathula,
Thao Vo, Alexandra Walsh, Allison Kidder, and Madi Adams for help throughout my projects and
creating a fun laboratory atmosphere.
I would like to thank my parents, Wayne and Pam Lewis, for their constant emotional and
financial support. This achievement would not be possible without their help. I would like to thank
my brother, Cody Lewis, for being a shining example of hard work. I would like to thank Erin
Monique Narcisse, Esq. for her support throughout my doctoral studies.
Lastly, I would like to thank all of the faculty, staff, and students of the Comparative
Biomedical Sciences at Louisiana State University School of Veterinary Medicine.

ii

TABLE OF CONTENTS
ACKNOWLEDGMENTS................................................................................................................... ii
LIST OF TABLES ............................................................................................................................ iv
LIST OF FIGURES ........................................................................................................................... v
ABSTRACT

............................................................................................................................... xv

CHAPTER I. MOUSE MODEL OF PULMONARY CYSTIC FIBROSIS (CF) AND AIRWAY
SURFACE LIQUID (ASL) DEHYDRATION .............................................................. 1
Introduction ...................................................................................................................................... 1
Physiology of ASL layer ............................................................................................................... 1
ASL dehydration in CF: a result of single ion-channel defect ...................................................... 4
Animal models of ASL dehydration .............................................................................................. 6
Immune Cell Types .................................................................................................................... 14
Spontaneous bacterial infection in CF ....................................................................................... 22
Does infection lead to the airway inflammation? ........................................................................ 23
Does mucous cell metaplasia (MCM) lead to the muco-obstruction? ........................................ 24
Concluding remarks ................................................................................................................... 25
References ................................................................................................................................. 28
CHAPTER II. EARLY POSTNATAL SECONDHAND SMOKE (SHS) ABOLISHES TH2
RESPONSES AND DISRUPTS BACTERIAL CLEARANCE IN A MURINE MODEL
OF MUCO-OBSTRUCTIVE LUNG DISEASE ........................................................ 38
Introduction ................................................................................................................................. 38
Methods ...................................................................................................................................... 40
Results ....................................................................................................................................... 50
Discussion .................................................................................................................................. 82
References ................................................................................................................................. 91
CHAPTER III. AIRWAY MUCOUS CELL METAPLASIA, NOT MUCO-OBSTRUCTION, IS
MEDIATED THROUGH INTERLEUKIN 33 (IL33) ................................................. 96
Introduction ................................................................................................................................. 96
Methods ...................................................................................................................................... 98
Results ..................................................................................................................................... 100
Discussion ................................................................................................................................ 117
References ............................................................................................................................... 122
CHAPTER IV. CONCLUSION ...................................................................................................... 126
CHAPTER V. TRANSLATIONAL APPLICATION AND FUTURE DIRECTIONS ........................ 127
APPENDIX. LETTER OF PERMISSION ..................................................................................... 129
VITA

............................................................................................................................. 130

iii

LIST OF TABLES
Table 1.1. Mouse models of ASL layer dehydration ...................................................................... 10
Table 1.2. Immune cell profiles in the Scnn1b-Tg+ mouse model as compared to profiles in the
WT mice ....................................................................................................................... 27
Table 2.1. Total number of animals ............................................................................................... 45
Table 2.2. Primer sequences for RT-PCR ..................................................................................... 46
Table 2.3. Comparison between FA-Tg+ and FA-WT mice........................................................... 48
Table 2.4. Comparison between FA-Tg+ and SHS-Tg+ mice ....................................................... 49
Table 2.5. SHS supresses Th2/ mucous cell metaplasia-associated responses in Scnn1b-Tg+
mice ............................................................................................................................. 64
Table 2.6. Cessation of SHS restores Th2/ mucous cell metaplasia-associated responses in
Scnn1b-Tg+ mice......................................................................................................... 81
Table 3.1. Cytokine Levels (pg/ml) in BALF................................................................................. 108

iv

LIST OF FIGURES
Figure 1.1. Diagrammatic representation of normal and Cystic Fibrosis airways ............................ 5
Figure 2.1. SHS exposure methodology ........................................................................................ 47
Figure 2.2. SHS exposure alters immune cell composition in lung airspaces ............................... 51
Figure 2.3. Representative photomicrographs BALF cytospins..................................................... 52
Figure 2.4. Altered immune-cell recruitment is associated with altered BALF chemokine levels .. 54
Figure 2.5. SHS exposure is associated with altered BALF IgA levels ......................................... 56
Figure 2.6. SHS exposure results in defective clearance of spontaneous bacterial infection ....... 57
Figure 2.7. SHS exposure alters Scnn1b-Tg+ lung pathology ...................................................... 59
Figure 2.8. SHS exposure alters Scnn1b-Tg+ lung pathology ...................................................... 60
Figure 2.9. SHS exposure alters Scnn1b-Tg+ lung pathology ...................................................... 61
Figure 2.10. SHS exposure suppresses Th2-associated cytokine release into airspaces ............ 63
Figure 2.11 SHS exposure results in downregulation of Th2-associated genes ........................... 66
Figure 2.12. SHS suppresses Il33 gene transcription and protein expression .............................. 67
Figure 2.13 Representative images from sections stained for immunolocalization of
IL-33 protein ................................................................................................................. 69
Figure 2.14 Cessation of SHS exposure........................................................................................ 71
Figure 2.15. Cessation of SHS exposure restores immune-cell recruitment into the
lung airspaces .............................................................................................................. 72
Figure 2.16. Representative photomicrographs BALF cytospins................................................... 73
Figure 2.17. Cessation of SHS exposure restores BALF chemokine levels .................................. 75
Figure 2.18 Early postnatal SHS exposure followed by cessation leads to exaggerated lung
pathology ..................................................................................................................... 76
Figure 2.19. Cessation of SHS exposure restores IgA concentrations in BALF............................ 77
Figure 2.20 Cessation of SHS exposure restores Th2 responses in Scnn1b-Tg+ adults ............. 79
Figure 2.21. Cessation of SHS restores Th2/ mucous cell metaplasia-associated responses in
Scnn1b-Tg+ mice......................................................................................................... 80

v

Figure 2.22. Hypothetical model for SHS exposure-induced suppression of Th2 immune
responses .................................................................................................................... 90
Figure 3.1. IL33 contents are elevated in the Scnn1b-Tg+ lungs ................................................ 101
Figure 3.2. IL33 contents are elevated in the Scnn1b-Tg+ lungs ................................................ 102
Figure 3.3. Generation of IL33-deficient mice .............................................................................. 103
Figure 3.4. Generation of IL33-deficient mice .............................................................................. 104
Figure 3.5. IL33 deficiency alters immune cell recruitment.......................................................... 106
Figure 3.6. IL33 deficiency alters immune cell recruitment. BALF cytokine levels ...................... 107
Figure 3.7. IL33 deficiency does not improve bacterial clearance ............................................... 110
Figure 3.8. IL33 deficiency increases airway inflammation in Scnn1b-Tg+ airways ................... 112
Figure 3.9. IL33 deficiency increases distal airspace enlargement in Scnn1b-Tg+ airways ....... 113
Figure 3.10. IL33 deficiency modulates pulmonary pathology in Scnn1b-Tg+ airways............... 114
Figure 3.11. IL33 is essential for mucous cell metaplasia (MCM) in Scnn1b-Tg+ airways ......... 116
Figure 3.12. Mucus plugs from IL33-deficient mice have reduced mucins .................................. 118

vi

LIST OF ABBREVIATIONS

Ab

Antibody

AB-PAS

Alcian blue-periodic acid-Schiff

Actb

Beta-actin

Ag

Antigen

Agr2

Anterior gradient protein 2

ANOVA

One way analysis of variance

AREG

Amphiregulin

ASL

Airway surface liquid

BALF

Bronchoalveolar lavage fluid

BALT

Bronchus-associated lymphoid tissue

Cacc

Calcium-activated chloride channel

CBA

Columbia blood agar

CCR2

C-C chemokine receptor type 2

cDNA

Complementary DNA

CF

Cystic fibrosis

CFTR

Cystic Fibrosis Transmembrane Conductance
regulator

vii

CFU

Colony forming unit

Chi3l4

Chitinase 3 like 4

ChILP

Common helper ILCX

Cit-H3

Citrullinated- histone H3

Cl-

Chloride

Clca1 (gob5/Clca3)

Calcium activated chloride channel protein 1

CO2

Carbon dioxide

DAB

3’,3’-diaminobenzidine substrate

DAMPs

Damage associated molecular patterns

DTA

Diptheria toxin A

EGFR

Epidermal growth factor receptor

ENaC

Epithelial sodium channel

FA

HEPA-filtered air

Foxa3

Forkhead box protein a 3

g

gravity

G-CSF

Granulocyte-colony stimulating factor

Gata3

Gata binding protein 3

H&E

Hematoxylin and eosin

viii

HCO3-

Bicarbonate

Het

Heterozygous

HMGB1

High-mobility group box 1

i.p.

Intraperitoneal

Id2

Inhibitor of DNA binding 2

IFN-Υ

Interferon-gamma

Ifng

Interferon-gamma

Ig

Immunoglobulins

IgA

Immunoglobulin A

IgG

Immunoglobulin G

IgM

Immunoglobulin M

IL10

Interleukin 10

IL12

Interleukin 12

IL13

Interleukin 13

IL17

Interleukin 17

Il1r

Interleukin 1 receptor

IL1α

Interleukin 1 alpha

IL1β

Interleukin 1-beta

ix

IL2

Interleukin 2

IL22

Interleukin 22

IL25

Interleukin 25

Il2rg

Common cytokine receptor γ

IL33

Interleukin 33

IL33-

IL33 deficient

IL33+

IL33 sufficient

IL33R

IL33 receptor

IL4

Interleukin 4

IL4rα

Interleukin 4 receptor alpha

IL5

Interleukin 5

IL5

Interleukin 5

IL6

Interleukin 6

IL7

Interleukin 7

IL8

Interluekin 8

IL9

Interleukin 9

ILC

Innate lymphoid cell

ILC

Innate lymphoid cell

x

ILC2

Innate lymphoid cell type 2

IP10

Interferon gamma-induced protein 10

KC

Keratinocyte chemoattractant

KDa

Kilodaltons

KO

Knockout

LIX

Lipopolysaccharide-induced CXC chemokine

LPS

Lipopolysaccharide

Lysozyme M

LysM

M1

Classically activated macrophage

M2

Alternatively activated macrophage

m3

Cubic meters

MCC

Mucociliary clearance

MCM

Mucous cell metaplasia

MCP-1

Monocyte chemoattractant protein 1

MFI

Mean fluorescence intensity

mg

milligrams

MIP1α

Macrophage inflammatory protein-1 alpha

MIP1β

Macrophage inflammatory protein-1 beta

xi

MIP2

Macrophage inflammatory protein 2

ml

Milliliters

MLI

Mean linear intercepts

mm

millimeters

MMP12

Matrix metalloproteinase

Muc5ac

Mucin 5ac

Muc5b

Mucin 5b

MyD88

Myeloid differentiation factor

Na+

Sodium

NADPH

Nicotinamide adenine dinucleotide phosphate

ND

Not detected

NE

Neutrophil elastase

NETs

Neutrophil extracellular traps

NF-κB

Nuclear factor-kappa B

NK cells

Natural killer cells

nm

nanometers

NS

Non-significant

O2

Oxygen

xii

PAMPs

Pathogen associated molecular patterns

PBS

Phosphate buffered saline

pg

picograms

PND

Postnatal day

PO2

Partial pressure of oxygen

ppm

Parts per million

RAG1

Recombinase activating gene 1

RAG2

Recombinase activating gene 1

Rantes

Regulated on Activation, Normal T cell
expressed and secreted

RH

Relative humidity

ROR

Rare orphan receptor

Scnn1b

Sodium channel non-voltage-gated 1, beta
subunit

SEM

Standard error of the mean

SHS

Secondhand smoke

SHS

Secondhand smoke

SIga

Secretory immunoglobulin A

SLC26a4

Solute carrier family 26 member 4

xiii

sp.

Species

Spedf

SAM pointed domain containing ETS
transcription factor

ST2

Suppressor of tumorigenecity 2

STAT

Signal transducer and activator of transcription

Tff2

Trefoil factor 2

Tg+

Transgenic

Th

T-helper

Th1

T-helper 1

Th17

T-helper 17

Th2

T-helper 2

TLR

Toll-like receptors

TNF-α

Tumor necrosis factor-alpha

Tregs

Regulatory T cells

TSLP

Thymic stromal lymphopoietin

TSP

Total suspended particulate

WT

Wild type

ΔF508

Deletion of phenylalanine at position 508

μg

micrograms

xiv

μl

Microliter

μm

micrometers

xv

ABSTRACT
The primary purpose of pulmonary ventilation is to supply oxygen for sustained aerobic
respiration. However, a plethora of abiotic insults and airborne pathogens present in the
environment are occasionally introduced into the airspaces during inhalation. Multiple layers of host
defense, termed the mucociliary escalator, act in concert to eliminate unwanted constituents from
the airspaces. Defects in the mucociliary escalator, as exhibited in cystic fibrosis (CF), compromise
the mucociliary clearance (MCC) of inhaled pathogens, which favors microbial lung infection and
progressive decreases in lung function. In CF, a mutation in the Cystic Fibrosis Transmembrane
Conductance Regulator (CFTR) gene results in dehydration of the airway surface liquid (ASL) layer.
The Scnn1b transgenic mouse model overexpressing a transgene encoding Sodium channel nonvoltage-gated 1, beta subunit provides a unique model that recapitulates many pulmonary
pathological manifestations of CF, e.g., early onset of disease, ASL layer dehydration, airway
inflammation/mucus obstruction, and spontaneous pulmonary bacterial infections. Secondhand
smoke (SHS) has been linked to the worsening of ongoing lung diseases. There remains a dearth
of knowledge on the immunological consequences chronic SHS exposure inflicts upon mucoobstructive lung diseases such as CF. The Scnn1b-Tg+ mice were exposed to SHS from PND 321 and lungs phenotypes were compared on PND 22. Compared to filtered-air exposed
counterparts, SHS-exposed Scnn1b-Tg+ mice exhibited a significant decrease in Th2-associated
responses, i.e., mucous cell metaplasia (MCM) and airway mucus obstruction. SHS was found to
suppress Th2-responses by a suppression of Interleukin (IL) 33, a potent Th2 stimulator. To test
our hypothesis that ablation of IL33 would attenuate MCM and airway mucus obstruction, IL33deficient Scnn1b-Tg+ mice were generated and lung phenotypes observed at PND 7 and PND 21
exhibited a reduction in MCM but not mucus obstruction. Our studies revealed a possible protective
role of IL33 against the development of alveolar space enlargement. Taken together, our studies
reveal the importance of IL33 in the pathogenesis of muco-obstructive lung disease.
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CHAPTER I. MOUSE MODEL OF PULMONARY CYSTIC FIBROSIS
(CF) AND AIRW AY SURFACE LIQUID (ASL) DEHYDRATION
Introduction
Aerobic processes within a cell consume oxygen (O 2) and release carbon dioxide (CO2)
during the process of respiration. Pulmonary ventilation is responsible for supplying O2 and
eliminating CO2 from cells undergoing aerobic respiration. In addition to oxygen, aberrant
constituents of ambient air such as abiotic insults and airborne pathogens also are inhaled into the
airspaces (Knowles et al., 2002).

Upon entering the conducting airways, airborne insults are

trapped within the airway surface liquid (ASL) layer, a thin layer of hydrated mucus that lines the
airway epithelium. The airway epithelial cells are specialized to constitute a mucociliary clearance
(MCC) host defense mechanism that facilitates the removal of trapped insults (Knowles et al.,
2002). Ciliated cells move the layer of mucus containing the airborne insults towards the epiglottis,
thus away from airspaces (Knowles et al., 2002).
Defects in the functioning of the mucociliary escalator compromise the MCC of inhaled
pathogens and abiotic insults, which favor airspace infection and lung injury, respectively (Fahy et
al., 2010). Impaired MCC often associated with airway muco-obstruction in muco-obstructive lung
disease patients (Fahy et al., 2010). The cause-effect relationship between these two responses
and their effect on microbial infections is unclear. High morbidity and mortality among mucoobstructive disease patients, high economic and health burdens, and lack of scientific
understanding of the progression of muco-obstruction warrants in-depth investigation of the
pathogenesis of muco-obstruction via use muco-obstructive disease models (Krauth et al., 2003;
Schibler et al., 2001; Zhou et al., 2011). In this chapter, the focus will be upon the mucociliary
clearance defect in Cystic Fibrosis (CF) and its recapitulation in a widely accepted mouse model of
CF, i.e., Scnn1b-Tg+ mouse.
Physiology of ASL layer
The ASL layer, a thin layer of fluid that lines the luminal surface of airway epithelium, is
comprised of two distinct layers: a mucus layer and a periciliary layer (Knowles et al., 2002). The

mucus layer is a luminal (superficial) layer of ASL that is exposed to the air and traps the airborne
insults (Button et al., 2012). Removal of inhaled pathogens and abiotic insults involves
unidirectional movement of the mucus layer towards epiglottis (Knowles et al., 2002). Located
directly underneath the mucus layer, the aqueous periciliary layer bathes the cilia projecting from
airway epithelium and facilitates ciliary beating (Fahy et al., 2010). The force generated by ciliary
beating within the periciliary layer fuels the movement of the mucus layer towards the epiglottis
(Figure 1a) (Knowles et al., 2002).
The two layers work on the Gel-on-Brush model in which the large membrane tethered
mucins and muco-polysaccharides of the periciliary layer form a brush-like network of polymers on
the epithelial surface (Button et al., 2012). Electron microscopic examination of cultured human
bronchial epithelial cells reveals the brush to be a meshwork consisting of large tethered
macromolecules, i.e., MUC1, MUC4, MUC16, MUC20, and heparin sulfate, that are attached to the
ciliary shaft and epithelial cell surface (Button et al., 2012). These large tethered macromolecules
create a semi-permeable gradient mesh that becomes tighter near the epithelial surface and is
seemingly impenetrable to MUC5B, MUC5AC, and inhaled particles (Button et al., 2012). Button
et al. determined that 2 nm dextran particles readily infiltrate the periciliary layer to reach the
epithelial surface while 40 nm particles are excluded from reaching the epithelial surface (Button et
al., 2012). Thus, the brush acts as a size-exclusion barrier for infiltrating entities (Button et al.,
2012).
The periciliary brush also contributes to the regulation of ASL layer hydration by facilitating
water distribution between the two layers (Button et al., 2012). Identical charges among the
membrane tethered macromolecules create intermolecular repulsive forces to create an osmotic
pressure gradient that stabilizes the periciliary layer by opposing the osmotic pressure gradient
created by the overlying mucus layer (Button et al., 2012). In healthy hydrated airways, osmotic
pressure created by the brush keeps the mucus layer above the outstretched cilia and facilitates
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normal MCC (Button et al., 2012). During dehydration of the ASL layer in diseases such as CF,
water is first drawn from the mucus layer, increasing the concentration of mucus and osmotic
pressure (Button et al., 2012). As the pressure generated from the mucus layer increases, water is
drawn from the mucus layer as well as the periciliary layer, resulting in ciliary compression and
impaired MCC (Button et al., 2012).
Contrary to a previous hypothesis that the periciliary layer is stationary (Satir et al., 1990),
a study by Matsui et al. reveals that the periciliary layer is moved along with the mucus layer and
that dextran was cleared at a similar rate by both layers (Matsui et al., 1998). Simple frictional
interaction between the two layers does not account for the similar clearance rates (Matsui et al.,
1998).

Matsui et al. propose that a transfer of momentum takes place in order to facilitate the

efficient movement of the two layers (Matsui et al., 1998). Ciliary beating promotes momentum
transfer from the mucus layer to the periciliary layer, thus facilitating concerted movement of both
layers (Matsui et al., 1998). The transport rate and the contribution of both of these layers towards
efficient MCC is determined by the amount and composition of the ASL.
The amount of ASL, expressed as the height of ASL layer, is a critical factor for normal
functioning of mucociliary escalator. While the height of mucus layer varies depending on the
airway location (7-70 m), the optimal height of the periciliary layer in human airways is
approximately 7 m, approximately the height of outstretched cilia (Fahy et al., 2010; Knowles et
al., 2002; Tarran, 2004). The height of ASL layer is regulated by a concerted action of various ion
channels on the apical surface of airway epithelium (Randell et al., 2006). Major ion channels
responsible for regulating chloride (Cl-)/sodium (Na+) transport are the Cystic Fibrosis
Transmembrane Conductance Regulator (CFTR), Calcium-activated Chloride Channels (CaCCs),
and Epithelial Na+ Channels (ENaC) (Randell et al., 2006). While epithelial excretion of Clis regulated by CFTR and CaCCs, epithelial Na+ absorption is regulated by ENaC (Randell et al.,
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2006). CFTR is also responsible for bicarbonate (HCO3-) transport that regulates the local pH of
the airways (Borowitz, 2015). The outcome of concerted action of these ion channels regulates Cland Na+ transport (Randell et al., 2006) across the apical surface of airway epithelial cells, and thus
regulates hydration status of the airway epithelium.
Another factor determining the efficient functioning of MCC system is the percent of solids
in ASL layer. The constituents of the ASL layer, including secreted mucins, immune cells, ions,
antimicrobial peptides, and cytokines (Knowles et al., 2002), account for approximately 2.5% solids
in healthy airways (Boucher, 2007).
ASL dehydration in CF: a result of single ion-channel defect
CF lung disease exemplifies how a defective functioning of a single ion channel, i.e., CFTR, results
in serious disturbances in ASL physiology (Figure 1b). With the loss of CFTR function in CF
epithelial cells, Cl- is retained within the epithelial cells while Na + absorption by ENaC increases
(Knowles et al., 1983), leading to increased epithelial cytosolic NaCl contents (Tarran, 2004).
Increased cytosolic contents of NaCl in epithelial cells create an osmotic drive that promotes net
movement of water from the ASL layer into the epithelial cells, thus leading to ASL layer dehydration
(Tarran, 2004).
Dehydration of the ASL layer results in increased concentration of solutes (hyperconcentration)
that leads to the compression of the periciliary layer by the overlying mucus layer, resulting in ciliary
collapse and impaired MCC (Button et al., 2012). An increase from 2.5% to 6% solids, e.g., in CF
airways, in the ASL layer compromises ciliary beat frequency and mucus layer transport (Boucher,
2007). Whether the increase in percent solids in muco-obstructive airways is a direct result of ASL
layer dehydrations or excessive accumulation, or poor clearance, of aberrant entities such as
mucus plugs, microbes, inflammatory cells, or cellular debris, or a combination of both outcomes,
remains unclear.
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a

b

Figure 1.1. Diagrammatic representation of normal and Cystic Fibrosis airways. (a) The normal
airways maintain airway surface liquid (ASL) that is regulated by the action of the
ion channels (inset). The normal ASL layer is essential for the continuous ciliary beating and
muco-ciliary clearance. (b) In cystic fibrosis, ion channel defect (Inset) causes ASL dehydration,
which leads to mucus hyperconcentration, muco-obstruction, mucous cell metaplasia, bacterial
infection, and airway inflammation.
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Animal models of ASL dehydration
Although CF affects multiple organs, muco-obstructive lung disease is the major contributor
to the morbidity and mortality associated with CF (Rowe et al., 2005). Various CFTR knockout
animal models including mice, pigs, ferrets, and rats have been generated with the intent of
recapitulating mucociliary clearance impairment of human CF airways. In the following section, the
advantages and limitations of various animal models of impaired CFTR functioning is discussed.
Mice
The availability of strains with genetic alterations related to various inflammatory or
pathological outcomes is an unmatched advantage of employing the mouse as a disease model.
Therefore, to recapitulate human CF-like lung disease, a number of mice models have been
developed over past two decades (summarized in Table 1).
In 1992, Snouwaert et al. generated Cftrtm1UNC mice via targeted disruption of the Cftr gene
(Table 1) (Snouwaert et al., 1992). When compared with wild-type (WT) mice, Cftrtm1UNC mice
exhibited mortality due to intestinal muco-obstruction; however, contrary to many pathological
changes observed in human CF patients, these mice did not exhibit significant pathological
changes in the pancreas, male reproductive system, liver, and gallbladder (Snouwaert et al., 1992).
Although muco-obstruction and bacterial infection were not observed in the airways in Cftrtm1UNC
mice, an increase in goblet cells in the proximal airways and impaired MCC were observed (Cowley
et al., 1997; Snouwaert et al., 1992).

Although the Cftrtm1UNC mouse model exhibited impaired

MCC upon bacterial challenge, it did not recapitulate the spontaneously arising airway mucoobstruction and bacterial infection observed in CF patients.
In 1992, Dorin et al. generated the Cftrtm1HGU mouse model via targeted disruption of exon
10 (Dorin et al., 1992). Similar to Cftrtm1UNC mice, the Cftrtm1HGU mice exhibited no pathological
abnormalities in the pancreas and reproductive system, although one male exhibited increased
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mucus accumulation in the vas deferens (Dorin et al., 1992). Unlike the Cftrtm1UNC mouse model,
however, the Cftrtm1HGU mouse model exhibited only mild intestinal muco-obstruction and all pups
were able to survive past weaning (Dorin et al., 1992).

Although the airway muco-obstructive

phenotype associated with CF was not observed, upon challenge with two types of bacteria
commonly associated with CF, i.e., Staphylococcus aureus and Burkholderia cepacia, Cftrtm1HGU
mice exhibited pathological features of CF lung disease (Davidson et al., 1995). Cftrtm1HGU mice
exhibited difficulty in clearing the bacteria from the airspaces as effectively as wild-type (WT)
littermates (Davidson et al., 1995). The airways of Cftrtm1HGU mice also exhibited a marked increase
in the abundance of goblet cells and muco-obstruction in response to bacterial challenge (Davidson
et al., 1995). Although the Cftrtm1HGU mouse model, similar to Cftrtm1UNC, exhibited impaired MCC in
response to challenge, it also did not exhibit the spontaneously occurring muco-obstructive
phenotype seen in CF airways.
Similar to the previously mentioned models, Ratcliff et al. targeted exon 10 of Cftr to
generate the Cftrtm1CAM mouse model (Ratcliff et al., 1993). Similar to the Cftrtm1UNC, CFTRtm1CAM
pups exhibited increased mortality attributed to intestinal muco-obstruction (Ratcliff et al., 1993).
Similar to human CF patients, Cftrtm1CAM mice exhibited obstruction of the pancreatic ducts, a
phenotype not observed in Cftrtm1UNC and Cftrtm1HGU mice (Ratcliff et al., 1993).

An interesting

phenotype observed in the Cftrtm1CAM model that was previously not reported in Cftr -/- mice was the
susceptibility to ocular infections and lacrimal gland abnormalities (Ratcliff et al., 1993). Although
the Cftrtm1CAM mouse exhibited increased mortality, intestinal mucus obstruction, and pancreatic
abnormalities, this model still did not exhibit mucus accumulation in the airways as seen in CF
(Ratcliff et al., 1993).
In 1993, O’Neal et al. generated the Cftrtm1BAY mouse model by targeted disruption in exon
3 of the Cftr locus (O'Neal et al., 1993). This mouse model also exhibited increased mortality
associated muco-obstruction of the intestines (O'Neal et al., 1993). No pathological abnormalities,
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i.e., mucus obstruction, were observed in the lungs of Cftrtm1BAY (O'Neal et al., 1993).

In 1995,

Hasty et al. targeted exon 2 of the Cftr locus in order to generate the Cftrtm3BAY mouse model (Hasty
et al., 1995). In accordance to the previous mouse models, Cftrtm3BAY mice exhibited high mortality
as a result of severe intestinal muco-obstruction (Hasty et al., 1995). Cftrtm3BAY mice also did not
exhibit an onset of lung disease, liver disease, or obstruction of the pancreatic ducts when
examined at birth, one week of age, or three to four weeks of age (Hasty et al., 1995). A clinical
phenotype that is commonly associated with male CF patients is sterility (Snouwaert et al., 1992).
Contrary to the phenotype observed in male CF patients, Cftrtm3BAY males exhibited no reproductive
abnormalities, whereas most females were sterile (Hasty et al., 1995). In 1996, Rozmahel et al.
generated the Cftrtm1HSC mouse model on a 129/SV background by targeted disruption of exon 1
(Rozmahel et al., 1996). As seen in previously discussed models, the Cftrtm1HSC mouse model
exhibited severe intestinal muco-obstruction that led to high mortality rates (Rozmahel et al., 1996).
In 1995, two mouse models, Cftrtm2CAM and Cftrtm1KTH, incorporating a deletion of
phenylalanine at position 508 (ΔF508) of the Cftr gene locus, the most common genetic mutation
associated with human CF, were generated by two separate groups (Colledge et al., 1995;Zeiher
et al., 1995). Although significant mortality due to intestinal muco-obstruction was observed in both
strains, no abnormalities in the pancreas, male reproductive system, or lungs were evident (Zeiher
et al., 1995; Colledge et al., 1995). In 1995, a third mouse, Cftrtm1EUR, with ΔF508 mutation was
generated on an FVB background (van Doorninck et al., 1995). As seen in Cftrtm2CAM and Cftrtm1KTH,
pathological abnormalities, i.e., mucus retention, were not observed in the lungs, pancreas, liver,
or vas deferens in these mice. However, these mice did not exhibit mortality due to intestinal mucus
obstruction but did exhibit hypertrophy of goblet cells in the intestines (van Doorninck et al., 1995).
The observed difference in the rate of mortality may be attributed to the strain background.
Also in 1996, Delaney et al. generated a mouse model possessing another mutation
associated with human CF, the G551D mutation (CftrG551D) that occurs in approximately 3% of CF
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patients (Delaney et al., 1996). The CftrG551D also exhibited increased mortality due to intestinal
muco-obstruction (Delaney et al., 1996). No pathological differences in the lung, pancreas, and
reproductive system were observed in CftrG551D mice (Delaney et al., 1996). In 2002, Dickinson et
al. generated the Cftrtm2HGU targeted integration of the G480C mutation, a mutation associated with
human CF (Dickinson et al., 2002). The Cftrtm2HGU exhibited comparable survival to WT littermates
and intestinal muco-obstruction was observed (Dickinson et al., 2002). Mild goblet cell hypertrophy
was observed in the intestines of the Cftrtm2HGU mice (Dickinson et al., 2002). There were no
abnormalities reported in the lungs and reproductive systems (Dickinson et al., 2002).

The

Cftrtm2UTH model was generated by integration of the R117H mutation, a mutation characterized by
CFTR reaching the apical surface of the epithelium but improper functioning (van Heeckeren et al.,
2004). Upon challenge with Psuedomonas aeruginosa, the Cftrtm2UTH mouse model exhibited
significantly lower neutrophil counts as compared to similar inflammatory responses to a previous
Cftr-/- mouse model, i.e., Cftrtm1UNC, but presented no significant differences in inflammatory cytokine
levels (van Heeckeren et al., 2004). The Cftrtm3UTH mouse model was generated by integrating the
Y122X mutation (van Heeckeren et al., 2004). The Cftrtm3UTH mouse model exhibited lower levels
of TNF- and IL-1 when compared to the Cftrtm1UNC mouse model in response to Psuedomonas
aeruginosa (van Heeckeren et al., 2004). Taken together, there were no substantial differences
between the tested Cftr-/- mouse models in response to Psuedomonas aeruginosa challenge (van
Heeckeren et al., 2004). Although mouse models of CFTR knockdown or various functional
mutations recapitulated the intestinal muco-obstruction, none of these models produced the
spontaneous onset of airway muco-obstruction and airway bacterial infection exhibited in CF,
warranting a need for an animal model that recapitulates human CF.
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Pig
In order to address the limitations observed in CF mouse models, Rogers et al. generated
CFTR-/- pigs that exhibited gastrointestinal, pancreatic, and reproductive abnormalities commonly
associated with CF (Rogers et al., 2008). All CFTR-/- piglets exhibited meconium ileus, a phenotype
seen in ~15% of human CF patients (Rogers et al., 2008). The pancreas of CFTR-/- piglets was
morphologically smaller when compared with WT littermates and exhibited ductal obstruction
(Rogers et al., 2008). Male CFTR-/- pigs were also infertile; a phenotype commonly associated with
human male CF patients (Rogers et al., 2008). Pertaining to lung disease manifestation, no lung
inflammation, mucus obstruction, or infection was observed at 6-12 hours after birth (Rogers et al.,
2008; Stoltz et al., 2010). However, CFTR-/- newborn pigs exhibited difficulty in clearing bacteria
upon challenge, i.e., Staphylococcus aureus (Stoltz et al., 2010). CFTR-/- pigs that survived more
than two months exhibited delayed onset of lung disease characterized by airway inflammation and
muco-obstruction (Stoltz et al., 2010). Although the CFTR-/- pig phenotypically expressed common
hallmarks of CF, the muco-obstructive airway phenotypes in this model have been described as
variable, ranging from none to severe manifestation (Stoltz et al., 2010).
Ferret
In 2010, Sun et al. generated the CFTR-/- ferret by targeted disruption that exhibited
meconium ileus, pancreatic lesions, degenerate or absent vas deferens, dehydration of the ASL
layer, severe airway inflammation, and a predisposition to lung infections (Sun et al., 2010). Due
to the susceptibility to lung infections, antibiotic treatment was necessary for the survival of the
CFTR-/- ferret (Sun et al., 2014).

The CFTR-/- ferret exhibited mortality by the age of six months

with antibiotic treatment, with 3 of 11 CFTR-/- ferrets surviving (Sun et al., 2014). In order to
investigate the progression of lung disease, Sun et al. removed the CFTR-/- ferret from antibiotics
at three months of age (Sun et al., 2014). Upon cessation of antibiotic treatment, progressive lung
disease that resembled human CF, i.e., muco-obstruction and bacterial colonization, was observed
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in the major and small airways (Sun et al., 2014).

Thus, antibiotic intervention was needed to

enhance survival to induce a more applicable CF lung phenotype in the CFTR-/- ferret.
Rat
In 2014, Tuggle et al. generated the Cftr-/- rat model by targeted disruption (Tuggle et al.,
2014).

There was no significant difference in survival between Cftr-/- and WT littermates until

weaning and survival was drastically decreased in the Cftr-/- rat by the age of six weeks (Tuggle et
al., 2014).

Decreased survival was a result of intestinal muco-obstruction and complications

(Tuggle et al., 2014). There were no pancreatic abnormalities observed in the Cftr-/- rat (Tuggle et
al., 2014). Although the ASL layer in Cftr-/- rat model was dehydrated, no pathological abnormalities
were observed in the lungs at the age of 22 to 42 days (Tuggle et al., 2014).

Abnormal lung

pathology developed as the Cftr-/- rats aged due to the development of sub-mucosal gland
hypertrophy (Birket et al., 2018). At six months of age, the small airways of the Cftr-/- rat exhibited
increased mucus secretion and accumulation leading to delayed mucus transport (Birket et al.,
2018).

The Cftr-/- rat model did not exhibit airway obstruction or spontaneously arising bacterial

infection (Birket et al., 2018).
While non-murine CFTR-/- models have been somewhat successful in recapitulating the
human CF-like spontaneous muco-obstruction and bacterial infection, unlike mice models, it
remains challenging to introduce genetic changes into their genomes. The Scnn1b-Tg+ mouse
model, although with intact Cftr gene, exhibits CF-like lung pathology. In next section,
characteristics of this strain and modulation of Scnn1b-Tg+ lung disease upon various genetic
modulations are discussed.
Scnn1b-Tg+ mouse model
None of the Cftr-/- mice models recapitulate human CF-like disease, most likely due to the
functional compensation by CaCCs (Grubb et al., 1994).
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To circumvent this issue, the Scnn1b-

Tg+ mouse was generated to facilitate increased Na+ absorption into the airway epithelial cells
(Mall et al., 2004). The increased Na+ absorption in Scnn1b-Tg+ mice was achieved via
overexpressing a transgene encoding Sodium channel non-voltage-gated 1, beta subunit (Scnn1b)
in club cells (Mall et al., 2004). In these mice, while Na+ absorption in tracheal tissues of adult and
neonatal Scnn1b-Tg+ mice is enhanced, the Cl- secretion remains unaffected (Mall et al., 2004).
These mice exhibit various features of muco-obstructive airway diseases. The increased
Na+ absorption into the airway epithelium of Scnn1b-Tg+ mice is evident as early as postnatal day
(PND) 3 and results in the dehydration of the ASL layer leading to muco-obstruction and impaired
MCC (Mall et al., 2004; Mall et al., 2008). A longitudinal study revealed that high mortality (~50%
in the first two weeks of life) is a result of asphyxiation related to airway muco-obstruction (Mall et
al., 2008). The Scnn1b-Tg+ mice exhibited difficulty in clearing bacteria upon challenge with
Haemophilus influenza and Pseudomonas aeruginosa (Mall et al., 2004).
The initial microbiological studies on BALF from Scnn1b-Tg+ adult mice failed to detect
spontaneous bacterial infection (Mall et al., 2004). The initial microbiological studies were
conducted only in adult mice. Speculating that muco-obstruction creates a microaerophilic
environment, Livraghi-Butrico et al. hypothesized that Scnn1b-Tg+ mice would be more susceptible
to pulmonary infections by microaerophilic bacteria in neonates when the immune system is
underdeveloped as compared to adult Scnn1b-Tg+ mice (Livraghi-Butrico et al., 2012).

Under

microaerophilic conditions, BALF from Scnn1b-Tg+ neonates show poly-microbial bacterial
infection that is almost cleared at adult age (Livraghi-Butrico et al., 2012).
The Scnn1b-Tg+ mouse model also exhibited necrosis of epithelial cells in the airways at
newborn (PND 0.5) and neonatal (PND 3.5) stage (Mall et al., 2008). Interestingly, epithelial cell
hypoxia was observed in the muco-obstructive airways of Scnn1b-Tg+ mice (Mall et al., 2008). It is
likely that the hypoxic stress to the airway epithelial cells caused by muco-obstruction leads to
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epithelial necrosis (Mall et al., 2008). The blood gas analyses on neonatal (PND 3.5-5.5) Scnn1bTg+ mice revealed significant reduction in the partial pressure of oxygen (P O2) and oxygen
saturation, indicative of a systemic hypoxic environment (Mall et al., 2008). This is most likely a
result of broncho-pulmonary dysplasia or emphysematous changes that are evident in Scnn1b-Tg+
mice.

The Scnn1b-Tg+ mice manifest airway inflammation accompanied by granulocyte

(neutrophil and eosinophil) infiltration and macrophage activation (Mall et al., 2008).
In the remaining review, the roles various immune cells in the context of disease evolution
in Scnn1b-Tg+ mice are discussed.
Immune Cell Types
Macrophages
Macrophages are key sentinel cells that express pro- or anti-inflammatory functions based
on external cytokine milieu, broadly classified as M1 and M2 activation, respectively. M1
macrophages are associated with the elimination of pathogens and secretion of pro-inflammatory
cytokines, e.g., IL1, IL6, and IL23 (Mosser et al., 2008). M1 macrophages also facilitate the
expansion of Th17 lymphocytes that recruit neutrophils through the secretion of IL-17 (Mosser et
al., 2008).

Stimulation of M1 macrophages is facilitated by IFN-

(Nathan et al., 1983), LPS

(Means et al., 2001), and other activators of Toll-like Receptors (TLRs) (Jones et al., 2001). Most
of the TLRs require an adaptor molecule, myeloid differentiation factor 88 (MyD88), to initiate
downstream intracellular signaling cascade (Medzhitov et al., 1998). The MyD88 pathway leads
to the activation of Nuclear factor-kappa B (NF- B), a key transcription factor in M1 activation, that
regulates the expression of a variety of inflammatory genes, e.g., Tumor Necrosis Factor alpha
(TNFα), Interleukin 1 beta (IL1β), and Interleukin6 (IL6) (Wang et al., 2014).
M2 macrophages are associated with parasitic infection, tissue remodeling, and promotion
of Th2 responses (Wang et al., 2014). Stimulation of M2 macrophages is facilitated through IL4
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(Stein et al., 1992), IL13 (Doherty et al., 1993), and IL10 (Lang et al., 2002). IL4 and IL13 facilitate
the polarization of M2 macrophages through Signal transducer and activator of transcription (STAT)
6 (Terabe et al., 2000), whereas IL10 acts through STAT3 (O'Farrell et al., 1998) .
Mall et al. initially observed morphological activation of pulmonary macrophages at two
weeks of age, a phenotype that was found to persist into adulthood (Mall et al., 2008). To profile
molecular signatures of macrophages as they relate to the development of muco-obstructive lung
disease, we performed gene expression analyses on purified Scnn1b-Tg+ macrophages at four
disease-relevant time-points, i.e., PNDs 0 (less than 24 hours of age), 3, 10, and 42 (Saini et al.,
2014). There was evidence of both M1 and M2 macrophages in the BALF of Scnn1b-Tg+ mice at
PND 3, with M1 as the more robust polarization state (Saini et al., 2014). The predominance of M1
macrophages at PND 3 was found to be consistent with the presence of pulmonary bacterial
infection typical of Scnn1b-Tg+ neonates (Saini et al., 2014). The macrophage activation status
experienced a shift to the M2 state at PND 10, and M2 was found to be more robust at PND 42
(Saini et al., 2014). The robust molecular signatures exhibited by pulmonary macrophages during
the progression of muco-obstructive lung disease in Scnn1b-Tg+ mice indicated their critical role
in disease pathogenesis (Saini et al., 2014).
To elucidate the role of pulmonary macrophages in neonatal (PND 5-7) Scnn1b-Tg+ mice,
we generated Scnn1b-Tg+ mice with a macrophage deficiency (Saini et al., 2016).

In this strain,

the expression of apoptosis-inducing diphtheria toxin A (DTA) was targeted to pulmonary
macrophages via myeloid cell-specific Lysozyme M (LysM) promoter (Kreisel et al., 2010; Saini et
al., 2016). The superimposition of impaired MCC on macrophage depletion (DTA+/Scnn1b-Tg+)
resulted in ~51% mortality due to an emaciated phenotype characterized by reduced weight gain,
“flaky discoloration”, lethargy, and mortality (Saini et al., 2016). Macrophage depletion affected
various inflammatory characteristics, i.e., alveolar space consolidation, airway inflammation, mucoobstruction, immune cell infiltration, and bacterial infection in Scnn1b-Tg+ (Saini et al., 2016). The
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macrophage-depleted Scnn1b-Tg+ mice exhibited a significantly higher bacterial burden (Saini et
al., 2016). Although there was a presence of additional bacterial species, Pasteurella
pneumotropica remained the predominant microbial inhabitant in the airways of macrophagedepleted mice.
To elucidate the contribution of pulmonary macrophages to muco-obstructive lung disease
in adulthood, we compared the lung pathology of surviving macrophage-deleted adult mice (Saini
et al., 2018). Adult mice with macrophage-deficiency exhibited a significantly higher degree of
alveolar space consolidation (Saini et al., 2018). DTA+/Scnn1b-Tg+ adult mice exhibited a
significantly higher degree of muco-obstruction in airways and increased number of mucus
producing cells compared to DTA+/Scnn1b-Tg+ littermates (Saini et al., 2018). Taken together,
these mechanistic reports that focused on numerical deletion of macrophage highlight critical roles
of these cells in the pathogenesis of lung disease in Scnn1b-Tg+ mice.
Matrix metalloproteinase (MMP) 12, a candidate genetic contributor to the development of
emphysema, was found to be upregulated in the lungs of Scnn1b-Tg+ mice (Trojanek et al., 2014),
(Saini et al., 2014). MMP12 was also found to be significantly upregulated in BALF macrophages
of CF patients (Trojanek et al., 2014). Trojanek et al. determined that MMP12 proteolytic activity
was significantly higher on the surface of activated BALF macrophages of Scnn1b-Tg+ mice
(Trojanek et al., 2014). The administration of pharmacological inhibitors as well as genetic deletion
of MMP12 in Scnn1b-Tg+ mice significantly reduced both mean linear intercept and destructive
index values as compared to MMP-12 sufficient Scnn1b-Tg+ mice (Trojanek et al., 2014). Since
MMP12 is expressed in non-macrophage cells as well, it remains to be determined whether
inactivation or deletion of macrophage-originated MMP12 accounts for the amelioration of alveolar
space pathology in Scnn1b-Tg+ mice. Further investigation employing macrophage-specific
deletion of various functionally-relevant genes is necessary to determine the effect of functionally
compromised macrophages on various pathological features of Scnn1b-Tg+ mice.
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Neutrophils
Neutrophils are cells of the innate immune system that are typically the first cells to be
recruited during inflammation and serve to eliminate invading pathogens (Kolaczkowska et al.,
2013). Neutrophils employ a variety of mechanisms for bacterial killing, e.g., phagocytosis,
degranulation, or release of neutrophil extracellular traps (NETs) (Brinkmann et al., 2004). In the
process of phagocytosis, neutrophils engulf pathogens that are subsequently encapsulated in
phagosomes (Kolaczkowska et al., 2013). Encapsulated pathogens are killed by the use of NADPH
oxygenase-dependent mechanisms (reactive oxygen species) or antibacterial proteins contained
within the neutrophilic granules (Kolaczkowska et al., 2013). These neutrophilic granules can also
be released extracellularly through the process of degranulation in order to act upon extracellular
pathogens (Kolaczkowska et al., 2013).

Highly activated neutrophils produce NETs that can

immobilize the pathogens for subsequent phagocytosis or directly kill the entrapped pathogens
(Brinkmann et al., 2004). NETs are also composed of antimicrobial proteins and enzymes, e.g.,
lactoferrin, cathepsin, and neutrophil elastase (NE), responsible for the elimination of invading
pathogens (Brinkmann et al., 2004). NE has been linked to both beneficial and detrimental roles in
the pathogenesis of CF (Gehrig et al., 2014).
The Scnn1b-Tg+ mice exhibited neutrophilic airspace infiltration accompanied by
increased expression of neutrophil chemoattractants, i.e., keratinocyte chemoattractant (KC),
lipopolysaccharide-induced CXC chemokine (LIX), macrophage inflammatory protein 2 (MIP-2),
and granulocyte-colony stimulating factor (G-CSF), beginning in the neonatal stages and persisting
into adulthood (Livraghi-Butrico et al., 2012; Mall et al., 2008).

NE has been implicated in the

induction of emphysema (Shapiro et al., 2003), MCM and mucus hypersecretion (Voynow et al.,
2004; Voynow et al., 1999). Ablation of NE in Scnn1b-Tg+ mice resulted in a significant decrease
in lung volume, mean linear intercept, and destructive index values as compared to Scnn1b-Tg+
littermates (Gehrig et al., 2014). The NE deficient Scnn1b-Tg+ mice also had reduced MCM and
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expression levels of genes associated with goblet cells and mucus secretion, i.e., Gob5, Muc5ac,
and Muc5b, involved in this response (Gehrig et al., 2014). These results suggested that
compromised neutrophil function via NE deletion ameliorate lung pathology in Scnn1b-Tg+ mice
(Gehrig et al., 2014).
Myeloid differentiation primary response 88 (MyD88) is a cytosolic adaptor molecule that
is required for the downstream signaling upon TLR ligation. The ablation of the MyD88 gene in
Scnn1b-Tg+ mice resulted in significantly increased mortality when compared to MyD88+/--Scnn1bMyD88-/--Scnn1b-Tg+ mice also exhibited

Tg+ littermates (Livraghi-Butrico et al., 2012).

significantly increased bacterial burden by a greater diversity of bacterial species (Livraghi-Butrico
et al., 2012). As compared to MyD88+/--Scnn1b-Tg+ mice, the MyD88-/--Scnn1b-Tg+ mice exhibited
a significant reduction in neutrophils and BALF levels of neutrophil chemokines, i.e., KC, LIX, MIP2, and G-CSF (Livraghi-Butrico et al., 2012). These data suggested that the ablation of TLR
signaling in Scnn1b-Tg+ mice leads to reduced production of neutrophil chemoattractants and poor
neutrophil recruitment, thus poor bacterial clearance.
Eosinophils
Eosinophils are granulated cells of the innate immune system that respond to helminthes
and allergies (Weller et al., 2017). The eosinophilic granules contain IL-4, IL-6, IL-10, and TNF
(Chu et al., 2012).

As compared to WT mice, the Scnn1b-Tg+ mice exhibited significantly

increased eosinophilia that, unlike neutrophilia that persisted into adulthood, peaked during the
juvenile (2-3 weeks) stages and subsided during the adult stages (Mall et al., 2008). The eosinophil
chemoattractant, Eotaxin 1, was found to be overexpressed in the Scnn1b-Tg+ mouse as
compared to WT littermates (Mall et al., 2008).

The ablation of Interleukin (IL)-4 receptor alpha

(Il4rα), the receptor for IL-4 and IL-13 (Nelms et al., 1999), significantly reduced eosinophilic
infiltration in 10-day old Scnn1b-Tg+ mice, suggesting the involvement of IL4R ligands in
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eosinophilic recruitment (Livraghi et al., 2009). The exact role, however, of eosinophils in the lung
disease pathogenesis is not yet clear.
Natural killer cells
Natural-killer (NK) cells are cells of the innate immune system that are responsible for
eliminating tumor cells (Kiessling et al., 1975) and virally infected cells (Welsh et al., 1991).
Johannson et al. found that NK cells determine “self” from “non-self” through the recognition of
Major Histocompatibility Complex Class I (MHC-I) (Johansson et al., 1997).
possess the ability to kill target cells but also produce IFN-

NK cells not only

and TNF- (Wolfe et al., 1976).

Through the production of IFN- , NK cells have also been shown to be involved in the
differentiation of Th1 lymphocytes (Martin-Fontecha et al., 2004). While the levels of IFN-

and

TNF- are found to be elevated in the BALF from Scnn1b-Tg+ mice, whether NK cells are involved
in the pathogenesis of Scnn1b-Tg+ mice remain unexplored.
T-lymphocytes
The cells of the adaptive immune system, i.e., T- and B-lymphocytes, possess antigenspecific surface receptors that undergo recombination in order to mature (Alt et al., 1984).

The

recombination is facilitated through Recombinase activating gene (RAG)-1 and RAG-2 (Oettinger
et al., 1990). T-lymphocytes are cells of the adaptive immune system and can functionally be
divided into subsets, e.g., Th1, Th2, Th17, and T regulatory lymphocytes (Tregs) (Constant et al.,
1997).
Th1 lymphocytes are responsible for controlling intracellular pathogens and are associated
with the production of TNF- and Interferon-gamma (IFN- ) (Constant et al., 1997).

Th2

lymphocytes are associated with the production of IL4, IL5, and IL13 (Constant et al., 1997;
McKenzie et al., 1993). As discussed previously, IL4 and IL13 have been linked to MCM and
increased mucus production (Dabbagh et al., 1999; Zhu et al., 1999). Th17 lymphocytes secrete
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IL17, a key pro-inflammatory cytokine associated with neutrophil recruitment (Aujla et al., 2007).
Th17 lymphocytes are present during the early stages of CF and a significant correlation exists
between IL-7 and total number of neutrophils (Tan et al., 2011). Pseudomonas aeruginosa infection
in BALF from CF patients is associated with significantly higher Th17-associated cytokines (IL17,
IL6, IL1, IL8) (Tiringer et al., 2013). Tregs are associated with the suppression of exacerbated
Th2/Th17 inflammation (Josefowicz et al., 2012). CF patients exhibiting chronic Pseudomonas
aeruginosa infection exhibited lower Treg counts as well as percentages when compared to CF
patients that had never presented Pseudomonas aeruginosa infection (Hector et al., 2015).
Lymphocyte counts tend to be higher in BALF from Scnn1b-Tg+ mice as compared to WT
littermates, but a significant increase is evident only in adult Scnn1b-Tg+ mice (Mall et al., 2008).
While IFN-γ remains comparable between WT and Scnn1b-Tg+ littermates, BALF levels of TNF, a Th1-associated cytokine, are elevated in the BALF of Scnn1b-Tg+ neonates (Mall et al., 2008).
Mall et al. found significantly higher levels of IL13 starting at one week of age and waning after
three weeks of age (Mall et al., 2008). During this time, the Scnn1b-Tg+ mouse model exhibited
significantly increased MCM and muco-obstruction (Mall et al., 2008). A detailed analysis of lungs
for the presence of various subtypes of Th cells is warranted to more completely understand the
Th-associated responses in the Scnn1b-Tg+ mice.
B-lymphocytes
B-lymphocytes (B-cells) secrete antigen specific immunoglobulins (Ig) that constitute
anitigen-specific humoral immunity. In addition to bone marrow, spleen, and lymph nodes, B-cells
get localized in the tertiary lymphoid structures such as bronchus-associated lymphoid tissue
(BALT) that surrounds bronchi in lungs. BALTs are found frequently in CF patients (Lammertyn et
al., 2017) and Scnn1b-Tg+ adult mice (Livraghi-Butrico et al., 2012); (Saini et al., 2018).
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CF patients exhibit significantly higher levels of Pseudomonas-specific IgG antibodies
compared to non-CF patients (Pressler et al., 2006). Secretory IgA levels also are significantly
upregulated in the nasal secretions of CF patients infected with Pseudomonas aeruginosa (Aanaes
et al., 2013).

Livraghi-Butrico et al. found that MyD88-/--Scnn1b-Tg+ mice exhibited significantly

more lymphoid aggregates at eight weeks of age than MyD88+/--Scnn1b-Tg+ littermates (LivraghiButrico et al., 2012). In our recent publication, a significant increase in the presence of BALTs in
the lung parenchyma of macrophage-deficient Scnn1b-Tg+ adults was reserved (Saini et al., 2018).
The presence of these lymphoid aggregates was associated with higher levels of immunoglobulin
(Ig) subtypes, i.e., IgA, IgM, IgG1, IgG2b, and IgG3, in BALF from macrophage-deficient Scnn1bTg+ adults (Saini et al., 2018). While the antigen-specificity of these immunoglobulin remain to be
investigated, their increased levels in mice with BALTs likely reflect local adaptive response to
bacterial infections.
Innate lymphoid cells (ILCs)
Innate lymphoid cells (ILCs) are innate immune cells that secrete Th effector cytokines, but
lack antigen-specific receptors that require recombination (Eberl et al., 2015).

In simpler

description, the ILCs (ILC1, 2, 3) are the amnestic equivalent of Th subtypes (Th1, Th2, Th17)
(Eberl et al., 2015). ILCs differentiate separately from T lymphocytes based on the expression of
transcription factor Inhibitor of DNA binding 2 (Id2) (Klose et al., 2014). ILCs also require the
common cytokine receptor -chain (also known as Il2rg) (Spits et al., 2013). ILCs have been
classified based on their expression of transcription factors and cytokines (Spits et al., 2013).
ILC1s differentiate independently from NK cells from Id2 expressing common helper ILC
precursors (ChILPs) (Klose et al., 2014). Moro et al. identified ILC2s in mouse mesentery that
produce high levels of Th2-associated cytokines, i.e., IL5 and IL13, in response to IL-33 (Moro et
al., 2010).

Subsequent studies revealed that ILC2s could also produce the Th2-associated

cytokine IL4 and rely on GATA-3 for differentiation and maintenance (Hoyler et al., 2012; Mjosberg
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et al., 2012). Takatori et al. identified ILC3s that produce Th17 associated cytokines, i.e., IL17 and
IL22, in response to IL1β as well as IL23, and produce IL17 and IL22 (Takatori et al., 2009). ILC3s
rely on the expression of rare orphan receptor (ROR)-t for differentiation (Spits et al., 2013) The
role of ILCs in the pathogenesis and progression of lung disease in the Scnn1b-Tg+ mouse model
remains unclear and warrants extensive investigation.
Given the predominance of Th-mediated responses in Scnn1b-Tg+ mice of different ages,
it is critically important to characterize ILCs as well as Th populations in the Scnn1b-Tg+ mice.
These studies when followed by ILCs and Th subtype depletion studies will dissect cell-specific
roles in muco-obstructive lung disease in Scnn1b-Tg+ mice.
Spontaneous bacterial infection in CF
CF is characterized by early bacterial colonization by microbes originating from the oral
cavity, and progressively shifts to a pathogen dominated environment (Muhlebach et al., 2018).
Muhlebach et al. conducted longitudinal studies to characterize the microbiome in young CF
patients (Muhlebach et al., 2018). The lower airways of CF infants were determined to be relatively
sterile, but microbes commonly associated with the oral cavity, e.g., Streptococcus and Prevotella,
were predominant in the airways by the age of two years (Muhlebach et al., 2018). Of note, the
origin of spontaneous bacterial colonization in Scnn1b-Tg+ neonates was also determined to be
oro-pharyngeal (Livraghi-Butrico et al., 2012). At four years of age, the microbiome analyses from
CF patients revealed presence of pathogenic bacteria, e.g., Staphylococcus aureus, Haemophilus
influenzae, and Pseudomonas aeruginosa (Muhlebach et al., 2018). The presence of pathogenic
bacteria was associated with significantly increased inflammation and structural damage in the lung
(Muhlebach et al., 2018). Coburn et al. found that CF patients over the age of 25 exhibited a
prevalence of Pseudomonas aeruginosa that was associated with declining lung function (Coburn
et al., 2015). The progressively declining lung function associated with Pseudomonas aeruginosa
infection leads to respiratory failure and death in CF patients (Hoiby, 2011).

22

Does infection lead to the airway inflammation?
Whether inflammatory responses in muco-obstructive airways originate from infectious
agents remained unclear until recently. To determine whether the bacterial infection is essential for
airway inflammation in Scnn1b-Tg+ mice, Livraghi-Butrico et al. re-derived Scnn1b-Tg+ mice in a
germ-free environment (Livraghi-Butrico et al., 2012). While, as expected, the germ-free Scnn1bTg+ mice did not exhibit airway bacterial colonization, other phenotypes including airway
inflammation, macrophage activation, MCM, and airway muco-obstruction were still present
(Livraghi-Butrico et al., 2012). Indeed, the macrophage activation was found to be more
exaggerated in germ-free Scnn1b-Tg+ mice as compared to specific-pathogen free Scnn1b-Tg+
mice (Saini et al., 2014). These results suggested that the inflammatory responses observed in
germ-free Scnn1b-Tg+ mice were not dependent on the presence of microbes or pathogenassociated molecular patterns (PAMPs). Along the same lines, antibiotic treatment of
spontaneously infected CFTR-/- ferret failed to mitigate airway inflammation (Rosen et al., 2018). It
is, therefore, likely that the ASL dehydration-induced stress to the airway cells, i.e., epithelium and
immune cells, induces the release of pro-inflammatory damage associated molecular patterns
(DAMPs) that, in turn, mediates inflammatory responses in the airways.
Various DAMPs have been implicated in the pathogenesis of muco-inflammatory outcomes
including airway inflammation, mucin hypersecretion, and MCM.

IL1, a potent inducer of

neutrophilic recruitment (Rider et al., 2011), is present at significantly higher levels in BALF from 5
days old Scnn1b-Tg+ pups (Fritzsching et al., 2015). Genetic deletion of IL1r1, a gene encoding a
receptor for IL-1 and IL-1 , abolishes airway neutrophilia and significantly reduces mortality,
muco-obstruction and emphysema in Scnn1b-Tg+ pups (Fritzsching et al., 2015). Another DAMP,
high-mobility group box 1 (HMGB1) is elevated in the sputum from CF patients (Rowe et al., 2008).
HMGB1 levels are also elevated in the BALF from Scnn1b-Tg+ mice (Rowe et al., 2008). Since
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HMGB1 acts as a ligand for TLR2 and TLR4, its effect is expected to produce responses similar to
PAMPs (LPS and lipoteichoic acid).
IL33, a potent stimulator of Th2-associated responses, acts as a DAMP upon release into
the airspaces (Cayrol et al., 2014). IL33 binds to the ST2 receptor that is present on mast cells,
macrophages, Th2 cells, and type 2 innate lymphoid cells (ILC2s) (Chen et al., 2017).
Administration of IL33 induces production of cytokines by Th2 lymphocytes in vivo (Schmitz et al.,
2005). IL33 has also been linked to the activation of ILC2s that also release Th2-associated
cytokines (Bartemes et al., 2012). IL33 levels are elevated in the juvenile Scnn1b-Tg+ mice (Lewis
et al., 2017). Secondhand-smoke exposure to Scnn1b-Tg+ mice results in diminished IL33
expression and BALF levels, which are strongly associated with diminished MCM and reduced
expression of MCM-associated genes. Further investigation on the mice with genetic deletion of IL33 on Scnn1b-Tg+ background will confirm the role of IL33 in the manifestation of muco-obstructive
responses.
Does mucous cell metaplasia (MCM) lead to the muco-obstruction?
MCM refers to an adaptive epithelial remodeling response that increases the number of
mucous cells in the airway epithelium and upregulates expression of genes involved in mucin
expression and secretion. Scnn1b-Tg+ mice exhibit a significantly higher number of mucous cells
in proximal and distal airways as compared to WT littermates (Mall et al., 2008). The neonatal (PND
3.5) Scnn1b-Tg+ pups exhibit muco-obstruction in the trachea, but in the absence of MCM,
suggesting that mucus accumulation, rather than mucus overproduction, contributes to mucus
plugging at this early age (Mall et al., 2008). In 2-3 week-old Scnn1b-Tg+ mice, however, mucoobstruction along with MCM is found to be most prominent in the large airways and distal
conducting airways, a feature that persists into adult Scnn1b-Tg+ mice (Mall et al., 2008), (Lewis
et al., 2017).

24

MCM is commonly associated with Th2-associated cytokines, i.e., IL4 and IL13 (Dabbagh
et al., 1999; Zhu et al., 1999). As discussed before, ablation of Il4rα, a common receptor for IL4
and IL13, significantly decreases neonatal mortality, MCM, and eosinophilic inflammation in the 10
days old Scnn1b-Tg+ mice (Livraghi et al., 2009). Ablation of Il4rα does not alter the severity of
mucus plugging (Livraghi et al., 2009). It appears that normal production rate of mucus in the ASLdehydrated is capable of producing muco-obstruction; however, further experiments are required
to ascertain this possibility.
Concluding remarks
Due to the morbidity and mortality associated with the CF muco-obstructive lung
phenotype, in-depth investigation of immunological responses initiated as a result of ASL
dehydration and muco-obstruction is warranted.

Although several mouse models incorporating

different Cftr mutations are available, none of the mouse models effectively recapitulates the CF
muco-obstructive lung phenotype. Although not modulating the functioning of CFTR channels, the
Scnn1b-Tg+ mouse model effectively demonstrates how a single ion channel defect leads to the
imbalance in ion transport which ultimately leads to ASL dehydration and associated lung disease.
Earliest manifestations of lung disease, i.e., ASL layer dehydration, muco-obstruction,
immune cell infiltration, and spontaneously arising bacterial infections, exhibited in the Scnn1b-Tg+
mouse model provide a most-representative model for investigation of the pathogenesis and
progression of human CF-like lung disease. The Scnn1b-Tg+ mouse also presents an outstanding
tool for investigation the impact of various environmental insults, e.g., cigarette smoke (Lewis et
al., 2017), nanoparticles (Geiser et al., 2013), and fungal spores (Geiser et al., 2014), may have
on the development and progression of muco-obstructive lung disease.
A complete understanding of the evolution of various pathological manifestations in the
Scnn1b-Tg+ strain is still unclear. Availability of numerous genetic strains on a congenic C57Bl/6
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background presents an opportunity for investigating the development of complex mucoobstructive lung disease which otherwise is challenging to pursue. A list of studies employing
various genetic alterations has been summarized in Table 1.2. Selection of additional genetic
alterations into the Scnn1b-Tg+ strain has already begun to dissect the pathway-specific roles of
various genes in the pathogenesis of muco-obstructive lung disease.
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Table 1.2. Immune cell profiles in the Scnn1b-Tg+ mouse model as compared to profiles in the
WT mice
S.
No.
1
2
3

Genotype

Description

Reference

TNF-/-Scnn1b-Tg+
TNFR1-/-Scnn1b-Tg+
Il4r-/-Scnn1b-Tg+

No significant effect on airway pathology

(Livraghi et
al., 2009)
(Livraghi et
al., 2009)
(Livraghi et
al., 2009)

4

MyD88-/-Scnn1b-Tg+

5

Ne-/--Scnn1bTg+

6

Il1r-/-Scnn1b-Tg+

7

DTA+Scnn1b-Tg+

8

Muc5b-/-Scnn1b-Tg+

9

Muc5ac-/-Scnn1b-Tg+

10

Spedf-/-Scnn1b-Tg+

No significant effect on airway pathology
Eosinophil infiltration significantly reduced at 10
days and 5 weeks; significantly reduced mucous
cell metaplasia (MCM) at 10 days; no significant
differences in neutrophil, macrophage,
lymphocyte infiltration; no significant differences
in airway inflammation, airway mucus
obstruction, and distal airspace enlargement
Neutrophilic airway infiltration significantly
reduced; significantly higher bacterial burden;
significantly lower MCM at PND 5-7, but not at
other observed time-points; airway mucus
obstruction significantly reduced at PND 5-7, but
not at other observed time-points
Neutrophilic airway infiltration significantly
reduces; significantly reduced distal airspace
enlargement; significantly reduced MCM; no
significant difference in airway mucus obstruction
Neutrophilic airway infiltration significantly
reduced airway mucus obstruction significantly
reduced; significantly reduced distal airspace
enlargement
Emaciated phenotype in neonates; neutrophilic
and lymphocytic infiltration significantly higher;
significantly higher bacterial burden in emaciated
pups; significantly reduced MCM and airway
mucus obstruction in emaciated pups; increased
occurrence of lymphoid aggregates in adult mice
Airway mucus obstruction significantly reduced;
no significant reduction in airway inflammation,
distal airspace enlargement, and bacterial
burden
No significant effect on airway pathology

Neutrophilic infiltration significantly increased in
neonates; no significant effect on airway mucus
obstruction
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(LivraghiButrico et al.,
2012)

(Gehrig et al.,
2014)

(Fritzsching et
al., 2015)

(Saini et al.,
2016)

(Saini et al.,
2018)
(LivraghiButrico et al.,
2017)
(LivraghiButrico et al.,
2017)
(Chen et al.,
2018)

References
Aanaes, K., Johansen, H. K., Poulsen, S. S., Pressler, T., Buchwald, C., & Hoiby, N. (2013).
Secretory IgA as a diagnostic tool for Pseudomonas aeruginosa respiratory colonization.
J Cyst Fibros, 12(1), 81-87. doi:10.1016/j.jcf.2012.07.001
Alt, F. W., Yancopoulos, G. D., Blackwell, T. K., Wood, C., Thomas, E., Boss, M., Coffman, R.,
Rosenberg, N., Tonegawa, S., & Baltimore, D. (1984). Ordered rearrangement of
immunoglobulin heavy chain variable region segments. EMBO J, 3(6), 1209-1219.
Aujla, S. J., Dubin, P. J., & Kolls, J. K. (2007). Th17 cells and mucosal host defense. Semin
Immunol, 19(6), 377-382. doi:10.1016/j.smim.2007.10.009
Bartemes, K. R., Iijima, K., Kobayashi, T., Kephart, G. M., McKenzie, A. N., & Kita, H. (2012). IL33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity
and allergic inflammation in the lungs. J Immunol, 188(3), 1503-1513.
doi:10.4049/jimmunol.1102832
Birket, S. E., Davis, J. M., Fernandez, C. M., Tuggle, K. L., Oden, A. M., Chu, K. K., Tearney, G.
J., Fanucchi, M. V., Sorscher, E. J., & Rowe, S. M. (2018). Development of an airway
mucus defect in the cystic fibrosis rat. JCI Insight, 3(1). doi:10.1172/jci.insight.97199
Borowitz, D. (2015). CFTR, bicarbonate, and the pathophysiology of cystic fibrosis. Pediatr
Pulmonol, 50 Suppl 40, S24-S30. doi:10.1002/ppul.23247
Boucher, R. C. (2007). Evidence for airway surface dehydration as the initiating event in CF
airway disease. J Intern Med, 261(1), 5-16. doi:10.1111/j.1365-2796.2006.01744.x
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch,
Y., & Zychlinsky, A. (2004). Neutrophil extracellular traps kill bacteria. Science,
303(5663), 1532-1535. doi:10.1126/science.1092385
Button, B., Cai, L. H., Ehre, C., Kesimer, M., Hill, D. B., Sheehan, J. K., Boucher, R. C., &
Rubinstein, M. (2012). A periciliary brush promotes the lung health by separating the
mucus layer from airway epithelia. Science, 337(6097), 937-941.
doi:10.1126/science.1223012
Cayrol, C., & Girard, J. P. (2014). IL-33: an alarmin cytokine with crucial roles in innate immunity,
inflammation and allergy. Curr Opin Immunol, 31, 31-37. doi:10.1016/j.coi.2014.09.004
Chen, S., Chen, B., Wen, Z., Huang, Z., & Ye, L. (2017). IL-33/ST2-mediated inflammation in
macrophages is directly abrogated by IL-10 during rheumatoid arthritis. Oncotarget,
8(20), 32407-32418. doi:10.18632/oncotarget.16299
Chu, V. T., & Berek, C. (2012). Immunization induces activation of bone marrow eosinophils
required for plasma cell survival. Eur J Immunol, 42(1), 130-137.
doi:10.1002/eji.201141953
Coburn, B., Wang, P. W., Diaz Caballero, J., Clark, S. T., Brahma, V., Donaldson, S., Zhang, Y.,
Surendra, A., Gong, Y., Elizabeth Tullis, D., Yau, Y. C., Waters, V. J., Hwang, D. M., &

28

Guttman, D. S. (2015). Lung microbiota across age and disease stage in cystic fibrosis.
Sci Rep, 5, 10241. doi:10.1038/srep10241
Colledge, W. H., Abella, B. S., Southern, K. W., Ratcliff, R., Jiang, C., Cheng, S. H., MacVinish, L.
J., Anderson, J. R., Cuthbert, A. W., & Evans, M. J. (1995). Generation and
characterization of a delta F508 cystic fibrosis mouse model. Nat Genet, 10(4), 445-452.
doi:10.1038/ng0895-445
Constant, S. L., & Bottomly, K. (1997). Induction of Th1 and Th2 CD4+ T cell responses: the
alternative approaches. Annu Rev Immunol, 15, 297-322.
doi:10.1146/annurev.immunol.15.1.297
Cowley, E. A., Wang, C. G., Gosselin, D., Radzioch, D., & Eidelman, D. H. (1997). Mucociliary
clearance in cystic fibrosis knockout mice infected with Pseudomonas aeruginosa. Eur
Respir J, 10(10), 2312-2318.
Dabbagh, K., Takeyama, K., Lee, H. M., Ueki, I. F., Lausier, J. A., & Nadel, J. A. (1999). IL-4
induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J Immunol,
162(10), 6233-6237.
Davidson, D. J., Dorin, J. R., McLachlan, G., Ranaldi, V., Lamb, D., Doherty, C., Govan, J., &
Porteous, D. J. (1995). Lung disease in the cystic fibrosis mouse exposed to bacterial
pathogens. Nat Genet, 9(4), 351-357. doi:10.1038/ng0495-351
Delaney, S. J., Alton, E. W., Smith, S. N., Lunn, D. P., Farley, R., Lovelock, P. K., Thomson, S.
A., Hume, D. A., Lamb, D., Porteous, D. J., Dorin, J. R., & Wainwright, B. J. (1996).
Cystic fibrosis mice carrying the missense mutation G551D replicate human genotypephenotype correlations. EMBO J, 15(5), 955-963.
Dickinson, P., Smith, S. N., Webb, S., Kilanowski, F. M., Campbell, I. J., Taylor, M. S., Porteous,
D. J., Willemsen, R., de Jonge, H. R., Farley, R., Alton, E. W., & Dorin, J. R. (2002). The
severe G480C cystic fibrosis mutation, when replicated in the mouse, demonstrates
mistrafficking, normal survival and organ-specific bioelectrics. Hum Mol Genet, 11(3),
243-251.
Doherty, T. M., Kastelein, R., Menon, S., Andrade, S., & Coffman, R. L. (1993). Modulation of
murine macrophage function by IL-13. J Immunol, 151(12), 7151-7160.
Dorin, J. R., Dickinson, P., Alton, E. W., Smith, S. N., Geddes, D. M., Stevenson, B. J., Kimber,
W. L., Fleming, S., Clarke, A. R., Hooper, M. L., & et al. (1992). Cystic fibrosis in the
mouse by targeted insertional mutagenesis. Nature, 359(6392), 211-215.
doi:10.1038/359211a0
Eberl, G., Colonna, M., Di Santo, J. P., & McKenzie, A. N. (2015). Innate lymphoid cells. Innate
lymphoid cells: a new paradigm in immunology. Science, 348(6237), aaa6566.
doi:10.1126/science.aaa6566
Fahy, J. V., & Dickey, B. F. (2010). Airway mucus function and dysfunction. N Engl J Med,
363(23), 2233-2247. doi:10.1056/NEJMra0910061

29

Fritzsching, B., Zhou-Suckow, Z., Trojanek, J. B., Schubert, S. C., Schatterny, J., Hirtz, S.,
Agrawal, R., Muley, T., Kahn, N., Sticht, C., Gunkel, N., Welte, T., Randell, S. H., Langer,
F., Schnabel, P., Herth, F. J., & Mall, M. A. (2015). Hypoxic epithelial necrosis triggers
neutrophilic inflammation via IL-1 receptor signaling in cystic fibrosis lung disease. Am J
Respir Crit Care Med, 191(8), 902-913. doi:10.1164/rccm.201409-1610OC
Gehrig, S., Duerr, J., Weitnauer, M., Wagner, C. J., Graeber, S. Y., Schatterny, J., Hirtz, S.,
Belaaouaj, A., Dalpke, A. H., Schultz, C., & Mall, M. A. (2014). Lack of neutrophil
elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus
obstruction, in mice with cystic fibrosis-like lung disease. Am J Respir Crit Care Med,
189(9), 1082-1092. doi:10.1164/rccm.201311-1932OC
Geiser, M., Quaile, O., Wenk, A., Wigge, C., Eigeldinger-Berthou, S., Hirn, S., Schaffler, M.,
Schleh, C., Moller, W., Mall, M. A., & Kreyling, W. G. (2013). Cellular uptake and
localization of inhaled gold nanoparticles in lungs of mice with chronic obstructive
pulmonary disease. Part Fibre Toxicol, 10, 19. doi:10.1186/1743-8977-10-19
Geiser, M., Wigge, C., Conrad, M. L., Eigeldinger-Berthou, S., Kunzi, L., Garn, H., Renz, H., &
Mall, M. A. (2014). Nanoparticle uptake by airway phagocytes after fungal spore
challenge in murine allergic asthma and chronic bronchitis. BMC Pulm Med, 14, 116.
doi:10.1186/1471-2466-14-116
Grubb, B. R., Paradiso, A. M., & Boucher, R. C. (1994). Anomalies in ion transport in CF mouse
tracheal epithelium. Am J Physiol, 267(1 Pt 1), C293-300.
doi:10.1152/ajpcell.1994.267.1.C293
Hasty, P., O'Neal, W. K., Liu, K. Q., Morris, A. P., Bebok, Z., Shumyatsky, G. B., Jilling, T.,
Sorscher, E. J., Bradley, A., & Beaudet, A. L. (1995). Severe phenotype in mice with
termination mutation in exon 2 of cystic fibrosis gene. Somat Cell Mol Genet, 21(3), 177187.
Hector, A., Schafer, H., Poschel, S., Fischer, A., Fritzsching, B., Ralhan, A., Carevic, M., Oz, H.,
Zundel, S., Hogardt, M., Bakele, M., Rieber, N., Riethmueller, J., Graepler-Mainka, U.,
Stahl, M., Bender, A., Frick, J. S., Mall, M., & Hartl, D. (2015). Regulatory T-cell
impairment in cystic fibrosis patients with chronic pseudomonas infection. Am J Respir
Crit Care Med, 191(8), 914-923. doi:10.1164/rccm.201407-1381OC
Hoiby, N. (2011). Recent advances in the treatment of Pseudomonas aeruginosa infections in
cystic fibrosis. BMC Med, 9, 32. doi:10.1186/1741-7015-9-32
Hoyler, T., Klose, C. S., Souabni, A., Turqueti-Neves, A., Pfeifer, D., Rawlins, E. L., Voehringer,
D., Busslinger, M., & Diefenbach, A. (2012). The transcription factor GATA-3 controls cell
fate and maintenance of type 2 innate lymphoid cells. Immunity, 37(4), 634-648.
doi:10.1016/j.immuni.2012.06.020
Johansson, M. H., Bieberich, C., Jay, G., Karre, K., & Hoglund, P. (1997). Natural killer cell
tolerance in mice with mosaic expression of major histocompatibility complex class I
transgene. J Exp Med, 186(3), 353-364.

30

Jones, B. W., Means, T. K., Heldwein, K. A., Keen, M. A., Hill, P. J., Belisle, J. T., & Fenton, M. J.
(2001). Different Toll-like receptor agonists induce distinct macrophage responses. J
Leukoc Biol, 69(6), 1036-1044.
Josefowicz, S. Z., Lu, L. F., & Rudensky, A. Y. (2012). Regulatory T cells: mechanisms of
differentiation and function. Annu Rev Immunol, 30, 531-564.
doi:10.1146/annurev.immunol.25.022106.141623
Kiessling, R., Klein, E., & Wigzell, H. (1975). "Natural" killer cells in the mouse. I. Cytotoxic cells
with specificity for mouse Moloney leukemia cells. Specificity and distribution according to
genotype. Eur J Immunol, 5(2), 112-117. doi:10.1002/eji.1830050208
Klose, C. S. N., Flach, M., Mohle, L., Rogell, L., Hoyler, T., Ebert, K., Fabiunke, C., Pfeifer, D.,
Sexl, V., Fonseca-Pereira, D., Domingues, R. G., Veiga-Fernandes, H., Arnold, S. J.,
Busslinger, M., Dunay, I. R., Tanriver, Y., & Diefenbach, A. (2014). Differentiation of type
1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell,
157(2), 340-356. doi:10.1016/j.cell.2014.03.030
Knowles, M. R., & Boucher, R. C. (2002). Mucus clearance as a primary innate defense
mechanism for mammalian airways. J Clin Invest, 109(5), 571-577.
doi:10.1172/JCI15217
Knowles, M. R., Stutts, M. J., Spock, A., Fischer, N., Gatzy, J. T., & Boucher, R. C. (1983).
Abnormal ion permeation through cystic fibrosis respiratory epithelium. Science,
221(4615), 1067-1070.
Kolaczkowska, E., & Kubes, P. (2013). Neutrophil recruitment and function in health and
inflammation. Nat Rev Immunol, 13(3), 159-175. doi:10.1038/nri3399
Krauth, C., Jalilvand, N., Welte, T., & Busse, R. (2003). Cystic fibrosis: cost of illness and
considerations for the economic evaluation of potential therapies. Pharmacoeconomics,
21(14), 1001-1024.
Kreisel, D., Nava, R. G., Li, W., Zinselmeyer, B. H., Wang, B., Lai, J., Pless, R., Gelman, A. E.,
Krupnick, A. S., & Miller, M. J. (2010). In vivo two-photon imaging reveals monocytedependent neutrophil extravasation during pulmonary inflammation. Proc Natl Acad Sci U
S A, 107(42), 18073-18078. doi:10.1073/pnas.1008737107
Lammertyn, E. J., Vandermeulen, E., Bellon, H., Everaerts, S., Verleden, S. E., Van Den Eynde,
K., Bracke, K. R., Brusselle, G. G., Goeminne, P. C., Verbeken, E. K., Vanaudenaerde,
B. M., & Dupont, L. J. (2017). End-stage cystic fibrosis lung disease is characterised by a
diverse inflammatory pattern: an immunohistochemical analysis. Respir Res, 18(1), 10.
doi:10.1186/s12931-016-0489-2
Lang, R., Patel, D., Morris, J. J., Rutschman, R. L., & Murray, P. J. (2002). Shaping gene
expression in activated and resting primary macrophages by IL-10. J Immunol, 169(5),
2253-2263.
Lewis, B. W., Sultana, R., Sharma, R., Noel, A., Langohr, I., Patial, S., Penn, A. L., & Saini, Y.
(2017). Early Postnatal Secondhand Smoke Exposure Disrupts Bacterial Clearance and

31

Abolishes Immune Responses in Muco-Obstructive Lung Disease. J Immunol, 199(3),
1170-1183. doi:10.4049/jimmunol.1700144
Livraghi, A., Grubb, B. R., Hudson, E. J., Wilkinson, K. J., Sheehan, J. K., Mall, M. A., O'Neal, W.
K., Boucher, R. C., & Randell, S. H. (2009). Airway and lung pathology due to mucosal
surface dehydration in {beta}-epithelial Na+ channel-overexpressing mice: role of TNF{alpha} and IL-4R{alpha} signaling, influence of neonatal development, and limited
efficacy of glucocorticoid treatment. J Immunol, 182(7), 4357-4367.
doi:10.4049/jimmunol.0802557
Livraghi-Butrico, A., Grubb, B. R., Kelly, E. J., Wilkinson, K. J., Yang, H., Geiser, M., Randell, S.
H., Boucher, R. C., & O'Neal, W. K. (2012). Genetically determined heterogeneity of lung
disease in a mouse model of airway mucus obstruction. Physiol Genomics, 44(8), 470484. doi:10.1152/physiolgenomics.00185.2011
Livraghi-Butrico, A., Kelly, E. J., Klem, E. R., Dang, H., Wolfgang, M. C., Boucher, R. C., Randell,
S. H., & O'Neal, W. K. (2012). Mucus clearance, MyD88-dependent and MyD88independent immunity modulate lung susceptibility to spontaneous bacterial infection and
inflammation. Mucosal Immunol, 5(4), 397-408. doi:10.1038/mi.2012.17
Mall, M., Grubb, B. R., Harkema, J. R., O'Neal, W. K., & Boucher, R. C. (2004). Increased airway
epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nat Med,
10(5), 487-493. doi:10.1038/nm1028
Mall, M. A., Harkema, J. R., Trojanek, J. B., Treis, D., Livraghi, A., Schubert, S., Zhou, Z., Kreda,
S. M., Tilley, S. L., Hudson, E. J., O'Neal, W. K., & Boucher, R. C. (2008). Development
of chronic bronchitis and emphysema in beta-epithelial Na+ channel-overexpressing
mice. Am J Respir Crit Care Med, 177(7), 730-742. doi:10.1164/rccm.200708-1233OC
Martin-Fontecha, A., Thomsen, L. L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A., & Sallusto,
F. (2004). Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1
priming. Nat Immunol, 5(12), 1260-1265. doi:10.1038/ni1138
Matsui, H., Randell, S. H., Peretti, S. W., Davis, C. W., & Boucher, R. C. (1998). Coordinated
clearance of periciliary liquid and mucus from airway surfaces. J Clin Invest, 102(6),
1125-1131. doi:10.1172/JCI2687
McKenzie, A. N., Culpepper, J. A., de Waal Malefyt, R., Briere, F., Punnonen, J., Aversa, G.,
Sato, A., Dang, W., Cocks, B. G., Menon, S., & et al. (1993). Interleukin 13, a T-cellderived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci
U S A, 90(8), 3735-3739.
Means, T. K., Jones, B. W., Schromm, A. B., Shurtleff, B. A., Smith, J. A., Keane, J., Golenbock,
D. T., Vogel, S. N., & Fenton, M. J. (2001). Differential effects of a Toll-like receptor
antagonist on Mycobacterium tuberculosis-induced macrophage responses. J Immunol,
166(6), 4074-4082.
Medzhitov, R., Preston-Hurlburt, P., Kopp, E., Stadlen, A., Chen, C., Ghosh, S., & Janeway, C.
A., Jr. (1998). MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling
pathways. Mol Cell, 2(2), 253-258.

32

Mjosberg, J., Bernink, J., Golebski, K., Karrich, J. J., Peters, C. P., Blom, B., te Velde, A. A.,
Fokkens, W. J., van Drunen, C. M., & Spits, H. (2012). The transcription factor GATA3 is
essential for the function of human type 2 innate lymphoid cells. Immunity, 37(4), 649659. doi:10.1016/j.immuni.2012.08.015
Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., Furusawa, J., Ohtani,
M., Fujii, H., & Koyasu, S. (2010). Innate production of T(H)2 cytokines by adipose tissueassociated c-Kit(+)Sca-1(+) lymphoid cells. Nature, 463(7280), 540-544.
doi:10.1038/nature08636
Mosser, D. M., & Edwards, J. P. (2008). Exploring the full spectrum of macrophage activation.
Nat Rev Immunol, 8(12), 958-969. doi:10.1038/nri2448
Muhlebach, M. S., Zorn, B. T., Esther, C. R., Hatch, J. E., Murray, C. P., Turkovic, L.,
Ranganathan, S. C., Boucher, R. C., Stick, S. M., & Wolfgang, M. C. (2018). Initial
acquisition and succession of the cystic fibrosis lung microbiome is associated with
disease progression in infants and preschool children. PLoS Pathog, 14(1), e1006798.
doi:10.1371/journal.ppat.1006798
Nathan, C. F., Murray, H. W., Wiebe, M. E., & Rubin, B. Y. (1983). Identification of interferongamma as the lymphokine that activates human macrophage oxidative metabolism and
antimicrobial activity. J Exp Med, 158(3), 670-689.
Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J., & Paul, W. E. (1999). The IL-4 receptor:
signaling mechanisms and biologic functions. Annu Rev Immunol, 17, 701-738.
doi:10.1146/annurev.immunol.17.1.701
O'Farrell, A. M., Liu, Y., Moore, K. W., & Mui, A. L. (1998). IL-10 inhibits macrophage activation
and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and independent pathways. EMBO J, 17(4), 1006-1018. doi:10.1093/emboj/17.4.1006
O'Neal, W. K., Hasty, P., McCray, P. B., Jr., Casey, B., Rivera-Perez, J., Welsh, M. J., Beaudet,
A. L., & Bradley, A. (1993). A severe phenotype in mice with a duplication of exon 3 in the
cystic fibrosis locus. Hum Mol Genet, 2(10), 1561-1569.
Oettinger, M. A., Schatz, D. G., Gorka, C., & Baltimore, D. (1990). RAG-1 and RAG-2, adjacent
genes that synergistically activate V(D)J recombination. Science, 248(4962), 1517-1523.
Pressler, T., Frederiksen, B., Skov, M., Garred, P., Koch, C., & Hoiby, N. (2006). Early rise of
anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are
risk factors for development of chronic lung infection--a case control study. J Cyst Fibros,
5(1), 9-15. doi:10.1016/j.jcf.2005.11.002
Randell, S. H., Boucher, R. C., & University of North Carolina Virtual Lung, G. (2006). Effective
mucus clearance is essential for respiratory health. Am J Respir Cell Mol Biol, 35(1), 2028. doi:10.1165/rcmb.2006-0082SF
Ratcliff, R., Evans, M. J., Cuthbert, A. W., MacVinish, L. J., Foster, D., Anderson, J. R., &
Colledge, W. H. (1993). Production of a severe cystic fibrosis mutation in mice by gene
targeting. Nat Genet, 4(1), 35-41. doi:10.1038/ng0593-35

33

Rider, P., Carmi, Y., Guttman, O., Braiman, A., Cohen, I., Voronov, E., White, M. R., Dinarello, C.
A., & Apte, R. N. (2011). IL-1alpha and IL-1beta recruit different myeloid cells and
promote different stages of sterile inflammation. J Immunol, 187(9), 4835-4843.
doi:10.4049/jimmunol.1102048
Rogers, C. S., Stoltz, D. A., Meyerholz, D. K., Ostedgaard, L. S., Rokhlina, T., Taft, P. J., Rogan,
M. P., Pezzulo, A. A., Karp, P. H., Itani, O. A., Kabel, A. C., Wohlford-Lenane, C. L.,
Davis, G. J., Hanfland, R. A., Smith, T. L., Samuel, M., Wax, D., Murphy, C. N., Rieke, A.,
Whitworth, K., Uc, A., Starner, T. D., Brogden, K. A., Shilyansky, J., McCray, P. B., Jr.,
Zabner, J., Prather, R. S., & Welsh, M. J. (2008). Disruption of the CFTR gene produces
a model of cystic fibrosis in newborn pigs. Science, 321(5897), 1837-1841.
doi:10.1126/science.1163600
Rosen, B. H., Evans, T. I. A., Moll, S. R., Gray, J. S., Liang, B., Sun, X., Zhang, Y., Jensen-Cody,
C. W., Swatek, A. M., Zhou, W., He, N., Rotti, P. G., Tyler, S. R., Keiser, N. W.,
Anderson, P. J., Brooks, L., Li, Y., Pope, R. M., Rajput, M., Hoffman, E. A., Wang, K.,
Harris, J. K., Parekh, K. R., Gibson-Corley, K. N., & Engelhardt, J. F. (2018). Infection Is
Not Required for Mucoinflammatory Lung Disease in CFTR-Knockout Ferrets. Am J
Respir Crit Care Med, 197(10), 1308-1318. doi:10.1164/rccm.201708-1616OC
Rowe, S. M., Jackson, P. L., Liu, G., Hardison, M., Livraghi, A., Solomon, G. M., McQuaid, D. B.,
Noerager, B. D., Gaggar, A., Clancy, J. P., O'Neal, W., Sorscher, E. J., Abraham, E., &
Blalock, J. E. (2008). Potential role of high-mobility group box 1 in cystic fibrosis airway
disease. Am J Respir Crit Care Med, 178(8), 822-831. doi:10.1164/rccm.200712-1894OC
Rowe, S. M., Miller, S., & Sorscher, E. J. (2005). Cystic fibrosis. N Engl J Med, 352(19), 19922001. doi:10.1056/NEJMra043184
Rozmahel, R., Wilschanski, M., Matin, A., Plyte, S., Oliver, M., Auerbach, W., Moore, A.,
Forstner, J., Durie, P., Nadeau, J., Bear, C., & Tsui, L. C. (1996). Modulation of disease
severity in cystic fibrosis transmembrane conductance regulator deficient mice by a
secondary genetic factor. Nat Genet, 12(3), 280-287. doi:10.1038/ng0396-280
Saini, Y., Dang, H., Livraghi-Butrico, A., Kelly, E. J., Jones, L. C., O'Neal, W. K., & Boucher, R. C.
(2014). Gene expression in whole lung and pulmonary macrophages reflects the dynamic
pathology associated with airway surface dehydration. BMC Genomics, 15, 726.
doi:10.1186/1471-2164-15-726
Saini, Y., Lewis, B. W., Yu, D., Dang, H., Livraghi-Butrico, A., Del Piero, F., O'Neal, W. K., &
Boucher, R. C. (2018). Effect of LysM+ macrophage depletion on lung pathology in mice
with chronic bronchitis. Physiol Rep, 6(8), e13677. doi:10.14814/phy2.13677
Saini, Y., Wilkinson, K. J., Terrell, K. A., Burns, K. A., Livraghi-Butrico, A., Doerschuk, C. M.,
O'Neal, W. K., & Boucher, R. C. (2016). Neonatal Pulmonary Macrophage Depletion
Coupled to Defective Mucus Clearance Increases Susceptibility to Pneumonia and Alters
Pulmonary Immune Responses. Am J Respir Cell Mol Biol, 54(2), 210-221.
doi:10.1165/rcmb.2014-0111OC
Satir, P., & Sleigh, M. A. (1990). The physiology of cilia and mucociliary interactions. Annu Rev
Physiol, 52, 137-155. doi:10.1146/annurev.ph.52.030190.001033

34

Schibler, A., Bolt, I., Gallati, S., Schoni, M. H., & Kraemer, R. (2001). High morbidity and mortality
in cystic fibrosis patients compound heterozygous for 3905insT and deltaF508. Eur
Respir J, 17(6), 1181-1186.
Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G.,
Moshrefi, M., Qin, J., Li, X., Gorman, D. M., Bazan, J. F., & Kastelein, R. A. (2005). IL-33,
an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and
induces T helper type 2-associated cytokines. Immunity, 23(5), 479-490.
doi:10.1016/j.immuni.2005.09.015
Shapiro, S. D., Goldstein, N. M., Houghton, A. M., Kobayashi, D. K., Kelley, D., & Belaaouaj, A.
(2003). Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice.
Am J Pathol, 163(6), 2329-2335. doi:10.1016/S0002-9440(10)63589-4
Snouwaert, J. N., Brigman, K. K., Latour, A. M., Malouf, N. N., Boucher, R. C., Smithies, O., &
Koller, B. H. (1992). An animal model for cystic fibrosis made by gene targeting. Science,
257(5073), 1083-1088.
Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G., Koyasu, S., Locksley,
R. M., McKenzie, A. N., Mebius, R. E., Powrie, F., & Vivier, E. (2013). Innate lymphoid
cells--a proposal for uniform nomenclature. Nat Rev Immunol, 13(2), 145-149.
doi:10.1038/nri3365
Stein, M., Keshav, S., Harris, N., & Gordon, S. (1992). Interleukin 4 potently enhances murine
macrophage mannose receptor activity: a marker of alternative immunologic macrophage
activation. J Exp Med, 176(1), 287-292.
Stoltz, D. A., Meyerholz, D. K., Pezzulo, A. A., Ramachandran, S., Rogan, M. P., Davis, G. J.,
Hanfland, R. A., Wohlford-Lenane, C., Dohrn, C. L., Bartlett, J. A., Nelson, G. A. t.,
Chang, E. H., Taft, P. J., Ludwig, P. S., Estin, M., Hornick, E. E., Launspach, J. L.,
Samuel, M., Rokhlina, T., Karp, P. H., Ostedgaard, L. S., Uc, A., Starner, T. D., Horswill,
A. R., Brogden, K. A., Prather, R. S., Richter, S. S., Shilyansky, J., McCray, P. B., Jr.,
Zabner, J., & Welsh, M. J. (2010). Cystic fibrosis pigs develop lung disease and exhibit
defective bacterial eradication at birth. Sci Transl Med, 2(29), 29ra31.
doi:10.1126/scitranslmed.3000928
Sun, X., Olivier, A. K., Liang, B., Yi, Y., Sui, H., Evans, T. I., Zhang, Y., Zhou, W., Tyler, S. R.,
Fisher, J. T., Keiser, N. W., Liu, X., Yan, Z., Song, Y., Goeken, J. A., Kinyon, J. M., Fligg,
D., Wang, X., Xie, W., Lynch, T. J., Kaminsky, P. M., Stewart, Z. A., Pope, R. M., Frana,
T., Meyerholz, D. K., Parekh, K., & Engelhardt, J. F. (2014). Lung phenotype of juvenile
and adult cystic fibrosis transmembrane conductance regulator-knockout ferrets. Am J
Respir Cell Mol Biol, 50(3), 502-512. doi:10.1165/rcmb.2013-0261OC
Sun, X., Sui, H., Fisher, J. T., Yan, Z., Liu, X., Cho, H. J., Joo, N. S., Zhang, Y., Zhou, W., Yi, Y.,
Kinyon, J. M., Lei-Butters, D. C., Griffin, M. A., Naumann, P., Luo, M., Ascher, J., Wang,
K., Frana, T., Wine, J. J., Meyerholz, D. K., & Engelhardt, J. F. (2010). Disease
phenotype of a ferret CFTR-knockout model of cystic fibrosis. J Clin Invest, 120(9), 31493160. doi:10.1172/JCI43052

35

Takatori, H., Kanno, Y., Watford, W. T., Tato, C. M., Weiss, G., Ivanov, II, Littman, D. R., &
O'Shea, J. J. (2009). Lymphoid tissue inducer-like cells are an innate source of IL-17 and
IL-22. J Exp Med, 206(1), 35-41. doi:10.1084/jem.20072713
Tan, H. L., Regamey, N., Brown, S., Bush, A., Lloyd, C. M., & Davies, J. C. (2011). The Th17
pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med, 184(2), 252-258.
doi:10.1164/rccm.201102-0236OC
Tarran, R. (2004). Regulation of airway surface liquid volume and mucus transport by active ion
transport. Proc Am Thorac Soc, 1(1), 42-46. doi:10.1513/pats.2306014
Terabe, M., Matsui, S., Noben-Trauth, N., Chen, H., Watson, C., Donaldson, D. D., Carbone, D.
P., Paul, W. E., & Berzofsky, J. A. (2000). NKT cell-mediated repression of tumor
immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol, 1(6), 515-520.
doi:10.1038/82771
Tiringer, K., Treis, A., Fucik, P., Gona, M., Gruber, S., Renner, S., Dehlink, E., Nachbaur, E.,
Horak, F., Jaksch, P., Doring, G., Crameri, R., Jung, A., Rochat, M. K., Hormann, M.,
Spittler, A., Klepetko, W., Akdis, C. A., Szepfalusi, Z., Frischer, T., & Eiwegger, T. (2013).
A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential
risk factor for Pseudomonas aeruginosa infection. Am J Respir Crit Care Med, 187(6),
621-629. doi:10.1164/rccm.201206-1150OC
Trojanek, J. B., Cobos-Correa, A., Diemer, S., Kormann, M., Schubert, S. C., Zhou-Suckow, Z.,
Agrawal, R., Duerr, J., Wagner, C. J., Schatterny, J., Hirtz, S., Sommerburg, O., Hartl, D.,
Schultz, C., & Mall, M. A. (2014). Airway mucus obstruction triggers macrophage
activation and matrix metalloproteinase 12-dependent emphysema. Am J Respir Cell Mol
Biol, 51(5), 709-720. doi:10.1165/rcmb.2013-0407OC
Tuggle, K. L., Birket, S. E., Cui, X., Hong, J., Warren, J., Reid, L., Chambers, A., Ji, D., Gamber,
K., Chu, K. K., Tearney, G., Tang, L. P., Fortenberry, J. A., Du, M., Cadillac, J. M.,
Bedwell, D. M., Rowe, S. M., Sorscher, E. J., & Fanucchi, M. V. (2014). Characterization
of defects in ion transport and tissue development in cystic fibrosis transmembrane
conductance regulator (CFTR)-knockout rats. PLoS One, 9(3), e91253.
doi:10.1371/journal.pone.0091253
van Doorninck, J. H., French, P. J., Verbeek, E., Peters, R. H., Morreau, H., Bijman, J., & Scholte,
B. J. (1995). A mouse model for the cystic fibrosis delta F508 mutation. EMBO J, 14(18),
4403-4411.
van Heeckeren, A. M., Schluchter, M. D., Drumm, M. L., & Davis, P. B. (2004). Role of Cftr
genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice. Am
J Physiol Lung Cell Mol Physiol, 287(5), L944-952. doi:10.1152/ajplung.00387.2003
Voynow, J. A., Fischer, B. M., Malarkey, D. E., Burch, L. H., Wong, T., Longphre, M., Ho, S. B., &
Foster, W. M. (2004). Neutrophil elastase induces mucus cell metaplasia in mouse lung.
Am J Physiol Lung Cell Mol Physiol, 287(6), L1293-1302.
doi:10.1152/ajplung.00140.2004

36

Voynow, J. A., Young, L. R., Wang, Y., Horger, T., Rose, M. C., & Fischer, B. M. (1999).
Neutrophil elastase increases MUC5AC mRNA and protein expression in respiratory
epithelial cells. Am J Physiol, 276(5 Pt 1), L835-843.
Wang, N., Liang, H., & Zen, K. (2014). Molecular mechanisms that influence the macrophage m1m2 polarization balance. Front Immunol, 5, 614. doi:10.3389/fimmu.2014.00614
Weller, P. F., & Spencer, L. A. (2017). Functions of tissue-resident eosinophils. Nat Rev Immunol,
17(12), 746-760. doi:10.1038/nri.2017.95
Welsh, R. M., Brubaker, J. O., Vargas-Cortes, M., & O'Donnell, C. L. (1991). Natural killer (NK)
cell response to virus infections in mice with severe combined immunodeficiency. The
stimulation of NK cells and the NK cell-dependent control of virus infections occur
independently of T and B cell function. J Exp Med, 173(5), 1053-1063.
Wolfe, S. A., Tracey, D. E., & Henney, C. S. (1976). Introduction of "natural" killer' cells by BCG.
Nature, 262(5569), 584-586.
Zeiher, B. G., Eichwald, E., Zabner, J., Smith, J. J., Puga, A. P., McCray, P. B., Jr., Capecchi, M.
R., Welsh, M. J., & Thomas, K. R. (1995). A mouse model for the delta F508 allele of
cystic fibrosis. J Clin Invest, 96(4), 2051-2064. doi:10.1172/JCI118253
Zhou, Z., Duerr, J., Johannesson, B., Schubert, S. C., Treis, D., Harm, M., Graeber, S. Y.,
Dalpke, A., Schultz, C., & Mall, M. A. (2011). The ENaC-overexpressing mouse as a
model of cystic fibrosis lung disease. J Cyst Fibros, 10 Suppl 2, S172-182.
doi:10.1016/S1569-1993(11)60021-0
Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A.
(1999). Pulmonary expression of interleukin-13 causes inflammation, mucus
hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J
Clin Invest, 103(6), 779-788. doi:10.1172/JCI5909

37

CHAPTER II. E ARLY POSTNATAL SECO NDHAND SMOKE (SHS)
ABOLISHES TH2 RESPONSES AND DISRUP TS BACTERI AL
CLE AR ANCE IN A MURIN E MODEL OF MUCO-OBSTRUCTIVE
LUNG DISE ASE
Introduction
Poor indoor air quality is a serious health concern, especially for young children who spend
85-90% of their time indoors (United States. Environmental Protection Agency. et al., 2004).
Secondhand smoke (SHS) is a major contributor to indoor air pollution (Eisner, 2007; Repace et
al., 1980). Early childhood SHS exposure accounts for nearly 300,000 annual cases of lower
respiratory tract infections (United States. Environmental Protection Agency. et al., 2004).

The

majority of these cases reflect SHS-induced exacerbations of existing muco-obstructive airway
diseases (United States. Public Health Service. Office of the Surgeon General., 2006).
Superimposition of SHS exposure onto the muco-obstructive airways in early postnatal life may
trigger complex interactions between various pathophysiological processes, including tobacco
smoke-induced perturbations, muco-obstructive disease-associated inflammatory milieu, and early
postnatal lung development (Gibbs et al., 2016). The existence and the nature of these interactions
remain elusive. Therefore, in-depth understanding of the effect of SHS exposure on normal lung
development and on imminent muco-obstructive lung disease is essential and warrants direct
investigation.
The Scnn1b transgenic (Scnn1b-Tg+) mouse, an experimental model of muco-obstructive
airway disease, has been developed by Tg targeting of the epithelial sodium ion channel subunit β
(βENaC) to airway epithelial cells (Mall et al., 2004).

Overexpression of βENaC-encoding

epithelial sodium channel, non-voltage gated-1, β subunit (Scnn1b) transgene results in sodium ion
This chapter previously appeared as Lewis, B. W., Sultana, R., Sharma, R., Noel, A., Langohr, I., Patial, S., Penn, A. L., &
Saini, Y. (2017). Early Postnatal Secondhand Smoke Exposure Disrupts Bacterial Clearance and Abolishes Immune
Responses in Muco-Obstructive Lung Disease. J Immunol, 199(3), 1170-1183. doi:10.4049/jimmunol.1700144. It is reprinted
by permission of American Association of Immunologists-see the permission in appendix.
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hyperabsorption, airway surface liquid dehydration, mucus hyperconcentration, muco-obstruction,
and airway inflammation (Mall et al., 2004; Mall et al., 2008). As a result, Scnn1b-Tg+ pups exhibit
a mucociliary clearance defect that leads to defective clearance of spontaneously aspirated
bacteria from lung airspaces (Livraghi-Butrico et al., 2012; Saini et al., 2016). The Scnn1b-Tg+
airway inflammation is characterized by macrophage activation and increased immune-cell
recruitment, including macrophages, neutrophils, lymphocytes, and eosinophils (Livraghi-Butrico et
al., 2012; Mall et al., 2004; Mall et al., 2008; Saini et al., 2014; Saini et al., 2016). Early postnatal
initiation of human cystic fibrosis (CF) or chronic bronchitis-like lung disease in this model provides
a unique opportunity to investigate the initiation and progression of pediatric lung diseases.
Studies employing the Scnn1b-Tg+ adult mice have highlighted the effects of exposure to
environmental toxicants including as nanoparticles, fungal spores, and mainstream tobacco smoke
on airway-disease phenotypes in these mice (Geiser et al., 2013; Geiser et al., 2014; Seys et al.,
2015). A recent report investigated the effect of short-term mainstream tobacco smoke exposure
(PND 10-14) on the ongoing airway disease in Scnn1b-Tg+ neonates (Jia et al., 2016). The effects
of early SHS, however, on the initiation and progression of key airway disease-associated
phenotypes,

i.e.,

airspace

inflammation,

spontaneous

bacterial

infection,

and

mucus

hypersecretion, remain unclear. Furthermore, a dearth of studies focused on the effects of SHS
exposure in neonates necessitates further investigation.
To understand the complex interactions between early postnatal SHS exposure and mucoobstructive disease pathogenesis, two separate studies were conducted. The first time-point study,
i.e., a 22-d study, was conducted to test the hypothesis that SHS-exposure from PND 3-PND 21
will perturb normal lung homeostasis in wild-type (WT) pups and exaggerate Scnn1b-Tg+ lung
pathology. Because two major pathological events, i.e., spontaneous bacterial infection and Th2
response-mediated mucus hypersecretion, are initiated and progress during first 21 d of postnatal
lung development in Scnn1b-Tg+ mice; the effect of SHS exposure on bacterial clearance and
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modulation of Th2 responses was examined on PND22. To gain further insights into the long-term
effects of early postnatal SHS exposure, a second time-point study, i.e., a 43-day study was
conducted. In this study, we tested the hypothesis that the cessation of SHS exposure will restore
the Scnn1b-Tg+ pathological responses. A 21-d recovery period (PND 22-42) was allowed
following cessation of SHS exposure on PND21. To accomplish these investigations,
bronchoalveolar lavage fluid (BALF) cell counting, BALF cytokine/IgA measurement, lung
histopathological analyses, and mucous cell metaplasia/Th2 response-related gene expression
analyses were performed on PND43. The results of these studies provided novel insights into the
effects of early postnatal SHS exposure on the manifestation of responses associated with mucoobstructive lung disease.
Methods
Transgenic mice and animal husbandry:

Cryopreserved embryos of Scnn1b-Tg+ mice

[Tg(Scgb1a1-Scnn1b)6608Bouc/J] were recovered from a cryorepository at the Jackson
Laboratory (Bar Harbor, ME). Offspring were shipped to and maintained at a pathogen-free facility
at the Division of Laboratory Animal Medicine at Louisiana State University, Baton Rouge.

The

procured Scnn1b-Tg+ mice were on C57BL/6-congenic background and were maintained on this
background by controlled breeding between wild-type [WT; Scnn1b-Tg-] and Scnn1b-Tg+ breeders.
All the animals used in this study were genotyped by PCR for the presence of the Scnn1b
transgene, as previously reported (Mall et al., 2004).

Mice were maintained in hot-washed,

individually ventilated cages on a 12-hour dark/light cycle and were fed regular diet and water ad
libitum except during the SHS exposure period (5 h/d).

All animal use and inhalation exposure

procedures were approved by the Institutional Animal Care and Use Committee of Louisiana State
University.
Secondhand smoke and filtered air exposure system: SHS is comprised ~85-90% of side-stream
smoke with the remainder being exhaled mainstream smoke. In this study, we used side-stream
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smoke as a surrogate for SHS as previously described (Xiao et al., 2012). SHS exposures were
conducted at the Accreditation of Laboratory Animal Care-accredited Inhalation Facility at
Louisiana State University. We used a TSE Cigarette Smoke Generator (TSE Systems,
Chesterfield, MO) to generate SHS from 3R4F filtered research cigarettes (University of Kentucky,
Lexington, KY). HEPA-filtered air (FA) or SHS in FA was supplied to 1.3m 3 Plexiglas exposure
chambers fitted with stainless steel wire cages (Penn et al., 2007). Throughout the exposures, we
recorded carbon monoxide (by infrared spectroscopy) and total suspended particulate (TSP) levels
with a DustTrak and by gravimetric sampling. Various ambient parameters, including particle
concentration, carbon monoxide content, temperature, and relative humidity (RH) were monitored
daily for FA and SHS chambers during the entire 19 consecutive days (PND3-21) of 5 h/d
exposures (Figure 2.1b).
Tg mice exposure, BALF harvesting, and tissue collection: Our investigation included two separate
time-point studies, i.e., 22 d (Figure 2.1a) and 43 d (Figure 2.13a). The detail on total number of
litters, litter sizes, and genders included for data analyses is provided in Table 2.1. The start of
SHS exposure on PND 3 circumvented the challenge of a pup-rejection response in dams and its
resulting neonatal deaths. For both studies, three-day old litters along with nursing dams were
randomly transferred to SHS or FA chambers. BALF was harvested aseptically for total and
differential cell counting, cytokine/IgA analyses, and microbiological analyses as previously
described (Livraghi-Butrico et al., 2012; Saini et al., 2016). Briefly, mice were anaesthetized via i.p.
injection of 2,2,2-tribromoethanol and were exsanguinated by incising the posterior vena cava. The
thoracic cavity was exposed and the trachea was cannulated with appropriate stub adaptors (23gauge, 22 d; 20-gauge, adults). The stub adaptor was secured in place with silk suture (4.0). The
left main-stem bronchus was ligated with silk suture to prevent lavaging of left lung lobe. The
lavaging was performed with the calculated volume of calcium and magnesium-free phosphate
buffered saline (PBS) following a “twice three-times” rule, as described previously (Livraghi et al.,
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2009). Left lung lobes were stored in 10% neutral buffered formalin and lavaged right lungs were
snap frozen for further analyses.
BALF Cell Counts: Harvested BALF was centrifuged at 300x g for 5 minutes and the supernatant
was stored at -80˚C for further analyses. The pellet was resuspended in 500 l of PBS and total
cell counts were determined with hemocytometer (Bright-line, Horsham, PA). Two hundred
microliters of cell suspension was used for cytospin preparation (CytoSpin 3; Thermo Shandon,
Pittsburgh, PA) followed by differential staining (Modified Giemsa kit; Newcomer Supply, Middleton,
WI).
Analyses of BALF for cytokines and IgA: To estimate IgA concentration in BALF, cell-free BALF
supernatant was analyzed with a Mouse IgA ELISA kit (88-50450), according to the manufacturer’s
instructions (eBioscience, San Diego, CA). Mouse IL-1

IL-4, IL-5, IL-13, keratinocyte

chemoattractant (KC), TNF-α, MCP-1, and Eotaxin levels were assayed in cell-free BALF
supernatant using a Luminex-XMAP-based assay (MCYTOMAG-70K), according to the
manufacturer’s instructions (EMD Millipore Corporation, Billerica, MA).
Lung Histopathology: Lungs were fixed in 10% neutral buffered formalin for subsequent
assessment of lung pathology and intracellular and extracellular muco-polysaccharides. We
adopted a previously reported strategy for semi-quantitative grading of histological changes in
Scnn1b-Tg+ lungs, as explained in previous report (Livraghi et al., 2009). A board-certified
anatomic pathologist and anatomic pathology resident performed the histopathological analyses.
Immunohistochemical analyses for IL-33: Formalin-fixed, paraffin-embedded lung sections were
used for immunohistochemical localization of IL-33. Five-micrometer sections were deparaffinized
with Citrisolv (2 x 5 min each) and were rehydrated with graded ethanol (100, 100, 95, 70, 30%,
distilled water; 3 min each). Ag retrieval was performed using a heat-induced, Ag-retrieval method
(heating slides in 0.1M sodium citrate solution [with 0.05% Tween 20] at 95-100C for 30 min,
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followed by cooling to room temperature). The sections were then rinsed in deionized water (2 x 5
min each) and processed according to illustrated protocol (Immunocruz goat ABC Staining Kit,
catalog number SC2023; Santa Cruz Biotechnology) with the following modifications. Polyclonal
goat IL-33 primary Ab (AF3626; R&D systems, Minneapolis, MN) and isotype control (goat IgG;
Jackson Immuno-Research) were used at 1.25 g/mL concentration with overnight incubation in
the cold room. After the primary incubation, quenching for endogenous peroxidases was performed
with 3% hydrogen peroxide in deionized water for 10 min at room temperature. Coverslip-mounted
slides were imaged by transmitted light microscopy (Nikon Ci-L microscope).
Gene Expression Analyses: Frozen right lung lobes were processed for extraction of total RNA with
a Quick-RNA MicroPrep kit (R1051), according to the manufacturer’s instructions (Zymo Research,
Irvine, CA). Total RNA was analyzed spectrophotometrically for quantity and purity (Nanodrop,
Wilmington, DE). All the samples used for further analyses had A260/A280 ratio of 1.85 or greater.
cDNA generation and RT-PCR were performed as described previously (Saini et al., 2015). Geneexpression primer sequences used in this study are listed in Table 2.2.
BAL microbiology and 16S sequencing: Aseptically harvested BALF from 22-d-old mice was plated
for CFU enumeration as previously described (Livraghi-Butrico et al., 2012; Saini et al., 2016). The
Columbia blood agar plates were incubated at 37˚C in anaerobic candle jar. The CFUs were
counted and morphologically distinguished colonies were restreaked, expanded, and processed
for 16S ribosomal DNA sequencing. Bacterial cultures derived from individual CFUs were
processed for bacterial identification using 16S rRNA gene sequencing. Briefly, frozen bacterial
samples were heat inactivated at 100˚C for 3 minutes. Bacterial genomic DNA was extracted using
Maxwell 16 Cell DNA extraction Kit (Promega, Madison, WI). Hyper variable regions of the 16S
rRNA gene were amplified by using the primer pair 338F (5′-ACTYCTACGGRAGGCWGC-3′) and
1061R (5′-CRRCACGAGCTGACGAC-3′) using  HiFi master mix (Kappa Biosciences, Wilmington,
USA) at 55˚C annealing temperature (Ong et al., 2013). Amplified PCR products were purified using
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RapidTips (Diffinity Genomics, West Chester, PA) and sequenced by both forward and reverse
primers using ABI Prism 3130 Genetic Analyzer (Life Technologies, CA). Obtained sequences were
queried into the 16S rRNA sequence data base at NCBI using the Basic Local Alignment Search
Tool and genus or species of culture isolates were determined based on the sequence homology
to the 16S rRNA gene sequence.
Statistical Analyses: ANOVA followed by Tukey’s post hoc test for multiple comparisons was used
to determine significant differences among groups. Measurements from two groups were compared
using Student t test assuming unequal variance. All data were expressed as mean ± SEM. A p
value <0.05 was considered statistically significant. Statistical analyses were performed using
GraphPad Prism 6.0 (La Jolla, CA). For selected endpoints, the summary of results is provided for
individual genders in Tables 2.3 and 2.4.
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Table 2.1. Total number of animals
Number of Animals: 22 Days Study
Cell Counts

FA-WT

SHS-WT

FA-Tg+

SHS-Tg+

Male

6

15

7

10

Female

5

3

5

4

Mixed-gender

11

18

12

14

FA-WT

SHS-WT

FA-Tg+

SHS-Tg+

Male

4

5

7

10

Female

3

4

5

4

Mixed-gender

7

9

12

14

FA-WT

SHS-WT

FA-Tg+

SHS-Tg+

Male

3

4

4

4

Female

3

4

4

4

Mixed-gender

6

8

8

8

Histopathological Analyses

Cytokines and IgA Analyses

Number of Animals: 43 Days Study
Cell Counts

FA-WT

SHS-WT

FA-Tg+

SHS-Tg+

Male

7

9

3

7

Female

6

7

8

4

Mixed-gender

13

16

11

11

FA-WT

SHS-WT

FA-Tg+

SHS-Tg+

Male

7

9

3

6

Female

6

7

7

4

Mixed-gender

13

16

10

10

FA-WT

SHS-WT

FA-Tg+

SHS-Tg+

Male

3

4

3

4

Female

3

4

5

4

Mixed-gender

6

8

8

8

Histopathological Analyses

Cytokines and IgA Analyses

Total numbers of animals (males and females) used in the study are shown for indicated endpoints.
For 22 days study: a total of 7 litters (litter size: 4,4,2,8,5,5,4) were used for SHS exposure and a
total of 6 litters (litter size: 1,5,4,7,3,3) were used for FA exposures. For 43 days study: a total of 5
litters (litter size: 8,5,2,6,6) were used for SHS exposure and a total of 6 litters (litter size:
4,2,6,3,4,5) were used for FA exposures. FA, Filtered Air; SHS, secondhand smoke; WT, wild-type;
Tg+, Scnn1b-Tg+.
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Table 2.2 Primer sequences for RT-PCR

S.
No
.
1

Gene
Name

Forward Sequence

Reverse Sequence

Il13

TGAGGAGCTGAGCAACATCACACA

TGCGGTTACAGAGGCCATGCAA
T

2

Gata3

GCTCCTTGCTACTCAGGTGAT

GGAGGGAGAGAGGAATCCGA

3

Muc5ac

CCATGCAGAGTCCTCAGAACAA

TTACTGGAAAGGCCCAAGCA

4

GACTGTAAAGACCCTCTTGATCTGA

GGAAGCAAGTCTACGCATGG

5

Slc26a
4
Clca1

AAGCAGTGAGGTGTTCAGCA

CAGTCCCGTTACTCTGTCGAT

6

Retnla

CCTGCTGGGATGACTGCTAC

CAGTGGTCCAGTCAACGAGT

7

Foxa3

GGCTCAGTGAAGATGGAGGCT

TCACTGGAGAATACACCTCGCC

8

Agr2

AGCCCAGATTTGCCATGGAG

CTGAGGTAGTTTGGGCCGAG

9

Tff2

TCCAAACCAAGAATCGGAGCA

TTTCGACTGGCACAGTCCTC

10

Muc5b

CTGCACAGATACGGAGGACA

TGGACACAGGCATCCAAGTA

11

Chi3l4

CCACTTTGAACCACATTCCAAGG

GAGAGACTGAGACAGTTCAGGG

12

Il33

GCGTCATTCCTCTGGAAACC

TGGTCACACGTGGTTTTGAA

13

Actb

GGCTGTATTCCCCTCCATCG

GGGGTACTTCAGGGTCAGGA

14

Ifng

ACAGCAAGGCGAAAAAGGAT

TGAGCTCATTGAATGCTTGG
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a

b
FA Chamber

SHS Chamber

ND
ND

10.21± 2.42
28.39 ± 6.82

23 ± 0.35

23.21 ± 0.28

54.74 ± 6.08

61.15 ± 7.54

Particle conentrations (mg/m 3)
Carbon monoxide (ppm)
Chamber temperature (°C)
Chamber RH (%)

Figure 2.1. SHS exposure methodology. (a) Experimental design depicting exposure regimen and
various outcomes examined. (b) Exposure parameters for 21-d study. Copyright 2017. The
American Association of Immunologists.
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Table 2.3. Comparison between FA-Tg+ and FA-WT mice
Cell Counts

FA-Tg+ (n=12) vs FA-WT (n=11)
Females
(n=5)

Mixed-gender (n=11-12)

Males (n=6-7)

Macrophages

***

***

*

Neutrophils

***

***

***

Eosinophils

***

***

p=0.12

Lymphocytes

***

**

*

Histopathological
Analyses

FA-Tg+ (n=12) vs FA-WT (n=7)
Mixed-gender (n=7-12)

Males (4-7)

Females
(n=3-5)

Mucus Plugging

*

p=0.12

p=0.12

Airway Inflammation

*

*

p=0.4

Epithelial Necrosis

**

*

p=0.12

Mucous Secretory Cells

**

**

*

Consolidation

***

**

p=0.06

Lymphoid Aggregates

**

*

p=0.12

Cytokines and IgA
Analyses

FA-Tg+ (n=8) vs FA-WT (n=6)
Mixed-gender (n=6-8)

Males (3-4)

Females
(n=3-4)

KC

****

**

**

IL4

**

*

*

IL5

**

**

p=0.22

MCP1

**

*

p=0.15

EOTAXIN

*

p=0.09

p=0.19

IL1A

*

p=0.12

p=0.06

TNFA

p=0.10

p=0.26

p=0.37

IL13

p=0.15

p=0.09

p=0.38

IgA

p=0.09

p=0.12

p=0.42

Comparisons between FA-Tg+ and FA-WT mice for indicated endpoints. Summary of statistical
significant differences is presented for mixed-gender, males, and female categories. Statistical
significant differences are represented as * p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001 using
ANOVA followed by Tukey’s multiple comparison post-hoc test. Actual p values are shown where
p>0.05. FA, Filtered Air; SHS, secondhand smoke; WT, wild-type; Tg+, Scnn1b-Tg+.
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Table 2.4. Comparison between FA-Tg+ and SHS-Tg+ mice
Cell Counts

FA-Tg+ (n=12) vs SHS-Tg+ (n=14)
Mixed-gender (n=12-14)

Males (7-10)

Females (n=4-5)

Macrophages

ns

ns

ns

Neutrophils

***

**

**

Eosinophils

***

***

p=0.18

Lymphocytes

**

*

p=0.23

Histopathological
Analyses
Mucus Plugging
Airway
Inflammation
Epithelial Necrosis
Mucous Secretory
Cells
Consolidation
Lymphoid
Aggregates

FA-Tg+ (n=12) vs SHS-Tg+ (n=14)
Mixed-gender (n=12-14)

Males (7-10)

Females (n=4-5)

*

*

p=0.24

ns

ns

ns

ns

ns

ns

*

p=0.09

*

*

p=0.07

p=0.35

**

*

p=0.36

Cytokines and IgA
Analyses

FA-Tg+ (n=8) vs SHS-Tg+ (n=8)
Mixed-gender (n=8)

Males (4)

Females (n=4)

KC

p=0.48

p=0.73

p=0.45

IL4

**

*

*

IL5

**

**

p=0.19

MCP1

*

p=0.09

p=0.22

EOTAXIN

*

*

p=0.18

IL1A

p=0.54

p=0.71

p=0.29

TNFA

p=0.90

p=0.48

p=0.87

IL13

*

*

p=0.08

IgA

**

*

p=0.07

Comparisons between FA-Tg+ and SHS-Tg+ mice for indicated endpoints. Summary of statistical
significant differences is presented for mixed-gender, males, and female categories. Statistical
significant differences are represented as * p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001 using
ANOVA followed by Tukey’s multiple comparison post-hoc test. Actual p values are shown where
p>0.05. FA, Filtered Air; SHS, secondhand smoke; WT, wild-type; Tg+, Scnn1b-Tg+.
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Results
Early postnatal SHS exposure results in altered inflammatory cell composition in WT and
Scnn1b-Tg+ mice: To determine whether SHS exposure can perturb airspace homeostasis, we
exposed neonatal Scnn1b-Tg+ mice, a well-characterized mouse model of muco-obstructive
airway disease, and littermate control WT mice to SHS (TSP=10 mg/m 3) or HEPA-FA and assessed
various BALF signatures of airspace homeostasis, including immune-cell counts and soluble
mediators (Fig. 2.1A), at PND 22. SHS exposure alters immune-cell composition of BALF: To
examine the effect of SHS exposure on BALF immune-cell composition, we first compared FAexposed WT (FA-WT) and SHS-exposed WT (SHS-WT) littermates. Although SHS exposure did
not significantly alter total BAL cell counts in WT mice (Figure 2.2A), differential cell counts revealed
significantly increased numbers of neutrophils in SHS-WT mice as compared to FA-WT (SHS-WT,
3910510; FA-WT, not detected) (Figure 2.2B). The total cell number of BALF cells was
significantly increased in FA-exposed Scnn1b-Tg+ (FA-Tg+) mice (~4.4-fold vs. FA-WT mice,
Figure 2.2A). This was attributable to significantly increased numbers of macrophages (~1.9-fold),
neutrophils (~36-fold), eosinophils (~5-fold), and lymphocytes (~3.5-fold) (Figure 2.2B). A similar
comparison between FA-WT or SHS-WT mice and SHS-exposed Scnn1b-Tg+ (SHS-Tg+) mice
revealed a significant increase in the total cell number (~2.2-fold versus FA-WT or SHS-WT mice,
Figure 2.2B), which was attributable to a significant increase only in macrophages (~1.5-fold) and
neutrophils (~14-fold) (Figure 2.2B). Further comparison of cell counts between FA-Tg+ and SHSTg+ mice revealed a significant reduction in total number of cells (~0.7-fold lower vs. FA-Tg+ mice,
Figure 2.2A) which was accounted for by a significant reduction in neutrophils (~1.4-fold),
eosinophils (~3.5-fold), and lymphocytes (~1.2-fold) (Figure 2.2B). These data suggest that SHS
exposure results in suppressed immune-cell recruitment to muco-obstructive airspaces. Altered
immune-cell recruitment is associated with altered BALF chemokine and IgA levels: Because
chemokines are responsible for recruitment of inflammatory cells into the
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a

b

c

Figure 2.2. SHS exposure alters immune cell composition in lung airspaces. (a) Total cell counts
in harvested BALF from 22-d FA- and SHS-exposed WT and Scnn1b-Tg+ mice (n= 7-14 per group,
overall p value < 0.0001) (b) Differential cell counts (overall p value < 0.001) and (c) their respective
percentages (overall p value < 0.0001) are shown as a stacked bar graph [BALF macrophages
(red), neutrophils (blue), eosinophils (green), lymphocytes (black)]. Error bars represent SEM. **p
< 0.01, ***p < 0.001, ***p < 0.001 using ANOVA followed by Tukey’s multiple comparison post hoc
test. Copyright 2017. The American Association of Immunologists.
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Figure 2.3. Representative photomicrographs BALF cytospins. (a) FA-WT, (b) SHS-WT, (c) FATg+, and (d) SHS-Tg+ mice at PND 22. Macrophages (red arrows), neutrophils (blue arrows),
eosinophils (green arrows), and lymphocytes (black arrows). Cytospins were stained with WrightGiemsa stain (modified Giemsa kit; Newcomber Supply, Middleton, WI). Copyright 2017. The
American Association of Immunologists.
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inflammatory milieu, we next measured the levels of some BALF chemokines that have been
previously demonstrated to be responsible for recruitment of inflammatory monocytes, eosinophils,
and neutrophils. MCP-1, a monocyte and neutrophil chemoattractant, was below detection limits in
FA- and SHS-WT BALF, but was significantly elevated in FA-Tg+ BAL (~26 pg/ml, Figure 2.4A).
Exposure of Scnn1b-Tg+ mice to SHS, however, resulted in significant reduction in BALF MCP-1
levels (~7 pg/ml, i.e., ~2.7-fold lower vs. FA-Tg+ mice, Figure 2.4a). Although macrophage counts
were comparable between FA- and SHS-Tg+ BALF, a reduction in BALF neutrophils in SHS-Tg+
(Figure 2.2b) was consistent with lower BALF MCP-1 levels. Eotaxin (CCL11), a potent eosinophil
chemoattractant, was significantly increased in SHS-WT (~3.8-fold versus FA-WT mice, Figure
2.4b) and, as expected from previous studies (Mall et al., 2008), in FA-Tg+ mice (~7.6-fold vs. FAWT mice, Figure 2.4b). Similarly, IL-5, a priming factor for eosinophil activation and recruitment
was significantly increased in FA-Tg+ mice (~35.0-fold versus FA-WT, Figure 2.4b). Consistent
with the significant decrease in eosinophils, Eotaxin and IL-5 levels were significantly reduced in
SHS-Tg+ mice (Eotaxin, ~3.7-fold lower versus FA-Tg+ mice, Figure 2.4b; and IL-5, ~9.0-fold lower
versus FA-Tg+ mice, Figure 2.4b). As expected from previous studies (Mall et al., 2008), increased
levels of the primary neutrophil chemokine, KC, in FA-Tg+ (~106 pg/ml) mice mirrored a significant
increase in neutrophils in this group compared to FA- or SHS-WT mice (Figure 2.4d).

In

comparison with FA-Tg+ mice, however, the KC levels of SHS-Tg+ mice (~90 pg/ml) were not
decreased significantly (Figure 2.4d). To assess the effect of early postnatal SHS exposure on the
release of soluble mediators of airway inflammation in WT and Scnn1b-Tg+ lungs, we measured
selected pro-inflammatory mediators in the BALF. BALF concentrations for IL-1α, a damage- or
danger-associated molecular pattern (DAMP) molecule, and TNF- α, a pro-inflammatory cytokine,
were not increased in SHS-WT mice. As expected from previous studies (Mall et al., 2008; Saini
et al., 2016), the levels of TNF- α and IL1- α were significantly increased in FA-Tg+ BALF; SHS

53

a

b

d

e

c

f

Figure 2.4. Altered immune-cell recruitment is associated with altered BALF chemokine levels.
BALF cytokine levels (picograms per milliliter) of (a) MCP-1 (overall p value < 0.0001), (b) Eotaxin
(overall p value = 0.0089), (c) IL-5 (overall p value = 0.0002), (d) KC (overall p value < 0.0001), (e)
TNF- (overall p value = 0.2227), and (f) IL-1 (overall p value = 0.0026) in BALF from FA-WT
(white bar), SHS WT (orange bar), FA-Tg+ (red bar), and SHS-Tg+ (green bar) mice (n = 6-8 per
group). The dotted line represents lower limit of detection (LOD) for respective chemokine. Error
bars represent SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ***p < 0.001 using ANOVA followed by
Tukey’s multiple comparison post hoc test. Copyright 2017. The American Association of
Immunologists.
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exposure, however, did not result in significant alteration in their release into the Scnn1bTg+ airspaces (Figure 2.4e and 2.4f).
Because SHS-Tg+ mice have significantly reduced numbers of BALF lymphocytes (Figure
2.2a), we speculated that the suppressive effects of early postnatal SHS exposure would also be
reflected in the suppression of mucosal B-cell humoral immune responses. Therefore, we assessed
BALF IgA levels as a readout of a B cell-specific adaptive immune response. BALF IgA levels were
comparable between FA-WT and FA-Tg+ mice (Figure 2.5). SHS exposure, however, resulted in
significant reduction in the levels of BALF IgA in WT as well as Scnn1b-Tg+ mice (Figure 2.5).
SHS exposure results in defective clearance of spontaneous bacterial infection: Early
postnatal spontaneous bacterial infections, predominately due to the aspiration of normal microflora
of oropharyngeal origin, are a consistent manifestation of defective mucociliary clearance in
Scnn1b-Tg+ mice (Livraghi-Butrico et al., 2012). These spontaneous bacterial infections of
Scnn1b-Tg+ lungs usually clear spontaneously by 3-4 weeks of age (Livraghi-Butrico et al., 2012),
perhaps due to enhanced adaptive immune responses, e.g., formation of lymphoid nodules and
IgA-mediated bacterial clearance. To determine the effect of early postnatal SHS exposure on
spontaneous bacterial clearance, we harvested BALF aseptically and enumerated microaerophilic
CFUs. Whereas only 1 out of 10 FA-WT mice had CFUs (CFU Counts= ~100 counts/ml), 5 out of
16 SHS-WT mice had elevated CFU counts (Average CFU Counts= ~320 counts/ml) (Figure 2.6A).
As expected from previous studies (Livraghi-Butrico et al., 2012), only 3 out of 10 FA-Tg+ lungs
had CFUs (Average CFU Counts= ~4100 counts/ml) (Figure 2.6A).

Following SHS exposure,

however, 11 out of 12 Scnn1b-Tg+ mice lungs had microaerophilic bacterial infections with
significantly higher CFU counts (Average CFU Counts= ~6600 counts/ml) suggesting that SHSTg+ mice failed to clear infection.
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Figure 2.5. SHS exposure is associated with altered BALF IgA levels. IgA levels in cell-free
BALF from FA-WT (white bar), SHS-WT (orange bar), FA-Tg+ (red bar), and SHS-Tg+ (green
bar) (n = 6-8 per group, overall p value = 0.0008). Error bars represent SEM. *p < 0.05, **p <
0.01, ***p < 0.001, ***p < 0.001 using ANOVA followed by Tukey ‘s multiple comparison post hoc
test. Copyright 2017. The American Association of Immunologists.
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Figure 2.6. SHS exposure results in defective clearance of spontaneous bacterial infection. (a)
CFUs in BALF from FA-WT (white bar), SHS-WT (orange bar), FA-Tg+ (red bar), and SHS-Tg+
(green bar) (n = 10-16 per group, overall p value = 0.0130). The CFU values were log10transformed with an offset of +1 (log10+1 transformation). (b)16S ribosomal DNA sequencing-based
species identification of cultured bacteria from BALF. Error bars represent SEM. *p < 0.05, **p <
0.01, ***p < 0.001, ***p < 0.001 using ANOVA followed by Tukey’s multiple comparison post hoc
test. Copyright 2017. The American Association of Immunologists.
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Next, to determine the effect of SHS exposure on the diversity of microaerophilic microflora,
we performed bacterial 16S DNA sequencing. These analyses on CFUs isolated from SHS-Tg+
mice revealed the presence of most of the previously reported bacterial species in Scnn1b-Tg+,
including Pasteurella pneumotropica, Streptococcus sp., Staphylococcus sp., and Enterococcus
sp. (Figure 2.6B). Irrespective of mouse genotype, SHS exposure was associated with increased
incidence of Micrococcus sp. suggesting that the SHS exposure may have resulted in defective
host defense specifically towards this bacterium.
SHS-Tg+ mice exhibit diminished mucous cell metaplasia and airspace Th2 responses: In
agreement with the BALF lymphocyte cell counts (Figure 2.2b), tissue lymphoid aggregates were
not evident in either FA- or SHS-WT mice (Figure 2.7a and Figure 2.7b), although a significant
increase in the number of lymphoid aggregates was observed in FA-Tg+ mice (Figure 2.7c and
2.7e). This was with significantly increased numbers of BALF lymphocytes in these mice (Figure
2.2b). Further, as expected from BALF lymphocyte counts, SHS-Tg+ mice had significantly reduced
numbers of lymphoid aggregates compared with FA-Tg+ mice (Figure 2.7d and 2.7f). Mucus
obstruction or plugging, mucin hypersecretion, and mucous cell metaplasia are the hallmark
pathologic features of Scnn1b-Tg+ lung disease (Mall et al., 2004; Mall et al., 2008). To determine
whether neonatal SHS exposure modulates these features, we compared airway histopathology in
FA-Tg+ mice versus SHS-Tg+ mice. Mucus obstruction or plugging was not evident in FA- and
SHS-WT mice (Figure 2.8a and Figure 2.8b), and the abundance of mucous secretory cells positive
for Alcian Blue-periodic acid-Schiff (AB-PAS) in the first and second generation of airways was
comparable in FA- and SHS- exposed WT mice (Figure 2.8a and Figure 2.8b). As expected from
previous studies (Mall et al., 2004; Mall et al., 2008), mucus obstruction or plugging and abundance
of mucous secretory cells, particularly within the first and the second generation airways was
markedly increased in FA-Tg+ mice, whereas both of these pathologic features were significantly
reduced in SHS-Tg+ mice (Figure 2.8d). To test whether the reduction in the proportion of mucous
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Figure 2.7. SHS exposure alters Scnn1b-Tg+ lung pathology. Representative photomicrographs
from H&E stained, left lung lobe sections from 22-d-old (a) FA-WT, (b) SHS-WT, (c and e) FA-Tg+,
and (d and f) SHS-Tg+ mice. Lymphoid aggregates (black arrow), peribronchiolar neutrophilic
inflammation (green arrow), and lymphocytic infiltration (red arrow). Copyright 2017. The American
Association of Immunologists.
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Figure 2.8. SHS exposure alters Scnn1b-Tg+ lung pathology. Representative photomicrographs
from AB-PAS stained, left lung lobe sections from 22-d-old (a) FA-WT, (b) SHS-WT, (c) FA-Tg+,
and (d) SHS-Tg+ mice. Mucus plugging and mucous cell metaplasia are apparent in FA-Tg+ mice.
AB-PAS-stained mucous secretory cells (blue arrow). Copyright 2017. The American Association
of Immunologists.
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Figure 2.9. SHS exposure alters Scnn1b-Tg+ lung pathology. Semiquantitative histopathology
scores for mucus plugging, airway inflammation, epithelial necrosis, mucous secretory cells,
parenchymal consolidation, and lymphoid hyperplasia. FA-WT (n =7, white bar), SHS-WT (n = 9,
orange bar), FA-Tg+ (n = 12 red bar), and SHS-Tg+ (n= 14, green bar). Error bars represent SEM.
*p < 0.05, **p < 0.01, ***p < 0.001 using ANOVA followed by Tukey’s multiple comparison post hoc
test. Copyright 2017. The American Association of Immunologists.
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secretory cells in SHS-Tg+ airways is a result of increased ciliated cell necrosis or of a diminished
Th2 environment, further analyses of lung sections, cytokine analyses, and gene expression
analyses were carried out. Detailed histopathological analysis of lung sections revealed 1)
abundance of ciliated cells in SHS-Tg+ airways, and 2) similar degree of necrosis between FA- and
SHS-Tg+ airways (Figure 2.9). These results suggest that the reduction in the proportion of mucous
secretory cells is not caused by SHS-induced loss of epithelial cells but may be attributable to the
inhibition of trans-differentiation of ciliated or club cells to mucous cells, i.e., mucous cell
metaplasia.
Because mucous cell metaplasia responses are primarily associated with Th2
environment, we measured three major Th2 cytokines, i.e., IL4 (Figure 2.10a), IL13 (Figure 2.10b)
and IL5 (Figure 2.4c), in the BALF. The levels of IL4 and IL5 were below the detection limits in both
FA- and SHS-WT mice whereas basal levels of IL13 were detected in both FA- and SHS-WT mice.
In agreement with the increased number of mucous secretory cells (Figure 2.9), the BALF analysis
revealed significantly elevated levels of IL5 (Figure 2.4c) and IL4 (Figure 2.10A) in FA-Tg+ BALF
(Figure 2.10a). As expected, SHS-Tg+ mice had significantly reduced levels of IL5 (Figure 2.4C),
IL4 (Figure 2.10a) and IL13 (baseline mean fluorescence intensity) (Figure 2.10b).
To further determine the downstream effect of altered Th2 cytokine levels in BALF, we
carried out RT-PCR-based gene expression analyses on whole lung homogenates with a focus on
selective Th2/mucous cell metaplasia-related genes, including Gata3, Spedf, Foxa3, Tff2, Agr2,
Muc5ac, Muc5b, Clca1 (gob5/Clca3), Slc26a4 (Pds/pendrin), Retnla, and Chi3l4 (Table 2.5). In
comparison with FA-WT mice, SHS-WT mice did not exhibit any significant alterations in the
expression levels of these genes (Table 2.5). However, except for Gata3, Spef, Muc5ac, and
Chi3l4, all the analyzed genes were significantly upregulated in the lungs of FA-Tg+ mice. As
expected from BALF cytokine and histopathological data, the SHS-Tg+ mice exhibited significant
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Figure 2.10. SHS exposure suppresses Th2-associated cytokine release into airspaces. (a) BALF
levels of IL-4 (picograms per milliliter) (n = 6-8 per group, overall p value = 0.0006); the dotted line
represents lower level of detection (LOD). (b) IL-13 (mean fluorescence intensity [MFI]) (n = 6-8
per group, overall p value = 0.0411) in FA-WT (white bar), SHS-WT (orange bar), FA-Tg+ (red bar),
and SHS-Tg+ (green bar). Error bars represent SEM. *p < 0.05, **p < 0.01 using ANOVA followed
by Tukey’s multiple comparison post hoc test. Copyright 2017. The American Association of
Immunologists
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Table 2.5. SHS supresses Th2/ mucous cell metaplasia-associated responses in Scnn1b-Tg+
mice

Absolute quantification of mRNA for selective genes related to mucous cell metaplasia and Th2
inflammation. Two values carrying identical designations (for example, † or ‡) in the same row
represent significant difference. Bold text indicates significantly higher values compared with SHSTg+ group. n = 5 mice per group. The data are presented as  SEM. p < 0.05 using ANOVA followed
by Tukey’s multiple comparison post hoc test. Copyright 2017. The American Association of
Immunologists
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downregulation of gene expression levels in most analyzed genes, i.e., Gata3, Foxa3, Tff2, Agr2,
Muc5ac, Muc5b, Clca1 (gob5/Clca3), Slc26a4 (Pds/pendrin), Retnla, and Chi3l4; Table 2.5).
In addition to the involvement of Th2 cytokines, IFN-, a Th1 mediator, has been implicated
in the mucous cell metaplasia (Cohn et al., 1999; Eichinger et al., 2015). To rule out the contribution
of IFN- in the suppression of mucous cell metaplasia in SHS-Tg+ mice, gene expression levels for
Il13 (Figure 2.11a) and Ifng (Figure 2.11c) and the ratio of Il13/Ifng (Figure 2.11c) were determined.
Although, the expression levels of Ifng were comparable between FA-WT and SHS-WT, and FATg+ mice, significant suppression was observed in SHS-Tg+ mice (Figure 2.11b). The relative levels
of Il13 to Infg expression suggest that the IL-13-dominant environment in FA-Tg + is suppressed in
SHS-Tg+ mice. These data suggest that the SHS exposure-induced suppression in mucous cell
metaplasia is associated with suppression of the Th2 environment. These data, along with the
suppressed IgA secretions (Figure 2.5), demonstrate that SHS exposure results in suppression of
Th2 responses, as well as of B cell-mediated humoral responses in muco-obstructive airspaces.
SHS-induced suppression of IL33 expression results in diminished Th2 responses in the
Scnn1b-Tg+ mice: The histopathological (Figure 2.8 and Figure 2.9), BALF cytokine (Figure 2.10)
and gene expression data (Table 2.5) pointed to the possibility that SHS exposure directly affects
IL-4/-13-secreting cellular populations. IL33 and two other cytokines, i.e., IL25 and thymic stromal
lymphopoietin (TSLP), are known to be released from stressed epithelial cells and stimulate IL4/5/-13-secreting type II innate lymphoid cells (ILC2s). SHS induced suppression of the IL33R, i.e.,
ST2, on ILC2 has been linked to the suppression of Th2 responses (Kearley et al., 2015). Our
preliminary screening (gene expression analyses on pooled cDNA samples [data not shown])
revealed significant suppression of Il33 expression, but not of Il25 and Tslp, in SHS-Tg+ mice.
Therefore, we carried out RT-PCR on whole-lung homogenates to assess Il33 mRNA levels in all
the experimental groups. Early postnatal SHS exposure of WT mice did not alter the expression
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Figure 2.11. SHS exposure results in downregulation of Th2-associated genes. (a) Absolute
quantification of Il13 mRNA expression; FA-WT (white bar), SHS-WT (orange bar), FA-Tg+ (red
bar), and SHS-Tg+ (green bar) (n = 5 per group, overall p value < 0.0001). (b) Absolute
quantification of Infg mRNA expression; FA-WT (white bar), SHS-WT (orange bar), FA-Tg+ (red
bar), and SHS-Tg+ (green bar) (n = 5 per group, overall p value = 0.1326). Absolute quantification
(mRNA copies per 105) copies of Actb mRNA) of gene expression of selective genes in whole-lung
homogenate from FA- or SHS-WT or Scnn1b-Tg+. (c) relative expression levels of Il13 as
compared with Infg. Expression levels were normalized within gene group (by values from all
samples with the lowest value). Normalized Il13 value for each sample was divided by normalized
Infg value. Obtained values indicating Il13/Ifng ratios were plotted (n = 5 per group, overall p value
= 0.0039). Error bars represent SEM. *p < 0.05, **p < 0.01 using ANOVA followed by Tukey’s
multiple comparison post hoc test. Copyright 2017. The American Association of Immunologists.
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Figure 2.12. SHS suppresses Il33 gene transcription and protein expression. (a) Absolute
quantification of Il33 mRNA expression, FA-WT (white bar), SHS-WT (orange bar), FA-Tg+ (red
bar), and SHS-Tg+ (green bar) (n = 5 per group, overall p value = 0.0289). (b) Western blot
analyses for secreted IL33 in BALF (Top panel) Quantification (n = 4-6 per group, overall p value
= 0.0006) (Image J analyses, normalized to the BALF volume yield normalized to body weight) and
(bottom panel) representative blot, a ~33-KDa band was observed; FA-WT (white bar), SHS-WT
(orange bar), FA-Tg+ (red bar), and SHS-Tg+ (green bar). Error bars represent SEM. *p < 0.05,
**p < 0.01, ***p < 0.001 using ANOVA followed by Tukey’s multiple comparison post hoc test.
Copyright 2017. The American Association of Immunologists.
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levels of IL33. In contrast, FA-Tg+ mice had an insignificant increase in Il33 mRNA levels, with a
p value of 0.14, which was significantly reduced in SHS-Tg+ mice (Figure 2.12a).To test whether
these changes in gene expression are also reflected at the protein level, we measured both
secreted as well as intracellular levels of IL33 protein. To determine secreted levels of IL-33 into
the airspaces, Western blot analysis was carried out on BALF (Fig 2.13b). Similar to the mRNA
levels, the secreted IL33 protein levels were significantly upregulated in FA-Tg+ BALF but were
significantly reduced to baseline levels in SHS-Tg+ BALF (Fig 2.13b)
Finally, to identify the cellular source of secreted IL33 protein, we carried out
immunohistochemical staining of lung sections (Figure 2.13). Although both FA-WT and SHS-WT
mice revealed intense nuclear staining in alveolar epithelial cells, the airway epithelial cells and
macrophages remained unstained in these mice. The FA-Tg+ mice had comparable nuclear IL33
staining in alveolar epithelial cells. In addition, airway epithelial cells and macrophages of these
mice revealed cytoplasmic localization of IL33. Because intense IL33 nuclear staining of alveolar
epithelial cells in WT groups was not reflected as secreted IL33 in BALF of these mice, the
increased level of cytoplasmic IL33 in macrophages and airway epithelial cells of FA-Tg+ is the
likely source of secreted IL33 in BALF. In agreement with the gene expression and Western blot
data, the IL33 staining in SHS-Tg+ was not evident in the nuclei of alveolar epithelial cells.
Further, the cytoplasmic staining for IL33 in airway epithelial cells and macrophages of
SHS-Tg+ lungs was remarkably reduced. These data revealed two novel findings: 1) IL33 signaling
is both upregulated in the airway epithelium and alveolar macrophages of Scnn1b-Tg+ lungs and
is secreted into the airspaces, and 2) SHS exposure of neonates inhibits Il33 transcription in
stressed Scnn1b-Tg+ lung macrophages and epithelial cells (Figure 2.13).
Cessation of SHS exposure restores cellular recruitment, adaptive immune responses, and
mucous cell metaplasia, but exaggerates lung pathology: To determine whether the suppressed
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Figure 2.13 Representative images from sections stained for immunolocalization of IL-33 protein
in (a) FA-WT, (b) SHS-WT, (c, e, and g) FA-Tg+, or (d, f, and h) SHS-Tg+. Airway epithelium
enclosed in red box in (c) (FA-Tg+) and green box in (d) (SHS-Tg+) are further enlarged as (e) and
(f) respectively. Nuclear staining of alveolar epithelial cells (red arrow) in WT (FA-WT as well as
SHS-WT) and FA-Tg+ lung sections. Cytoplasmic localization of IL-33 in airway epithelial cells
(blue arrows) and macrophages (green arrow). Immunostaining was performed using 3’,3’diaminobenzidine (DAB) substrate to detect immunolocalized HRP (brown chromogen). Copyright
2017. The American Association of Immunologists.
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immune responses in SHS-exposed mice were irreversible or reversible, and whether there are
lagged responses or consequences of SHS exposure, we next performed a 42-d study whereby 3d-old neonates were exposed to FA or SHS from PND3 onwards until the age of PND21, followed
by maintenance of the weanlings in FA-supplied regular cages until PND43 (Figure 2.14a).
Cessation of early postnatal SHS exposure restores immune cell recruitment into the airspaces: To
determine whether the cessation of SHS exposure restores suppressed immune-cell recruitment
into the lung airspaces, BALF was examined to measure cell counts and chemokines responsible
for immune cell recruitment. Whereas total BALF cell counts were comparable between FA-WT
and SHS-WT (Figure 2.6a), FA-Tg+ mice had significantly higher total cells in BALF (Figure 2.15a).
In contrast with 21-d study (Figure 2.2a), SHS-exposure to Scnn1b-Tg+ mice resulted in
significantly increased total cells (SHS-Tg+, ~408,000; FA-Tg+, ~332,000) in BALF, which were
largely attributable to increased numbers of macrophages, neutrophils, and lymphocytes (Figure
2.15b). In comparison with FA-Tg+ group, however, SHS-Tg+ mice had significantly reduced
numbers of eosinophils in BALF (Figure 2.15b).
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FA Chamber

SHS Chamber

ND
ND

9.68 ± 2.14
25.8 ± 7.30

Chamber temperature (°C)

23.63 ± 0.38

23.87 ± 0.39

Chamber RH (%)

43.53 ± 11.04

48.49 ± 11.84

Particle conentrations (mg/m 3)
Carbon monoxide (ppm)

Figure 2.14. Cessation of SHS exposure. (a) Experimental design for 42-d time point depicting
exposure regimen and various endpoints examined. (b) Exposure parameters for 42-d study.
Copyright 2017. The American Association of Immunologists.
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Figure 2.15. Cessation of SHS exposure restores immune-cell recruitment into the lung airspaces.
(a) Total cell counts in harvested BALF from 43-d FA- and SHS-exposed WT and Scnn1b-Tg+ mice
(n= 11-17 per group, overall p value < 0.0001) (b) Differential cell counts (overall p value < 0.001)
and (c) their respective percentages (overall p value < 0.0001) are shown as a stacked bar graph
[BALF macrophages (red), neutrophils (blue), eosinophils (green), lymphocytes (black)]. Error bars
represent SEM. **p < 0.01, ***p < 0.001, ***p < 0.001 using ANOVA followed by Tukey’s multiple
comparison post hoc test. Copyright 2017. The American Association of Immunologists.

72

Figure 2.16. Representative photomicrographs BALF cytospins. (a) FA-WT, (b) SHS-WT, (c) FATg+, and (d) SHS-Tg+ mice at PND 22. Macrophages (red arrows), neutrophils (blue arrows),
eosinophils (green arrows), and lymphocytes (black arrows). Cytospins were stained with WrightGiemsa stain (modified Giemsa kit; Newcomer Supply, Middleton, WI). Copyright 2017. The
American Association of Immunologists.
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Next, we sought to determine whether the restored BALF cellularity was the result of
reversal of chemokine suppression (Figure 2.17).

BALF chemokine estimation for three major

chemokines revealed a striking correlation between numbers of individual cell types and levels of
respective chemokines that are known to recruit these cells. For example, MCP1, a major monocyte
chemoattractant, was restored in the SHS-Tg+ BALF; suggesting its contribution toward
macrophage and neutrophil recruitment (Figure 2.17a). A similar cell-chemokine correlation was
clearly evident between eosinophils and neutrophils and their respective chemokines, i.e., Eotaxin
(Figure 2.17b) and KC (Figure 2.17b), respectively. Similarly to PND21 age point (Figure 2.4), BALF
levels for TNF- and IL-1 were comparable between FA-Tg+ and SHS-Tg+ mice (Figures 2.17e
and 2.17f).
SHS-exposed neonates exhibit significantly enhanced adaptive immune responses in
adulthood: To determine whether the termination of SHS exposure for 3 wk will allow the reversal
of adaptive immune suppression, we evaluated lung sections and BALF for the presence of
lymphoid aggregates and secreted IgA, respectively. As seen at PND22 (Figure 2.5), the SHS
exposure to WT mice did not increase BALF lymphocytes (Figure 2.15b) and the number of
lymphoid aggregates in lungs (Figure 2.18b). FA-Tg+ mice, however, had significantly increased
BALF lymphocytes (~5-fold versus FA-WT mice, Figure 2.15b) and lymphoid aggregates (Figure
2.18b). However, unlike at PND22, adult SHS-Tg+ mice had significantly increased BALF
lymphocytes (~1-fold versus FA-Tg+ mice, Figure 2.15b) and lymphoid aggregates (Figure 2.18b).
Furthermore, while only 3 out of 9 FA-Tg+ mice had well-defined lymphoid nodules (Figure 2.19b),
8 out of 10 SHS-Tg+ mice had these nodules (Figure 2.18b).
Further, to determine whether the increase in the incidence of lymphoid nodules was
sufficient to restore the suppression of IgA levels that was detected at PND22, BALF IgA levels
were determined at PND43 (Figure 2.19). Although both the WT groups, i.e., FA-WT and SHSWT, had minimal levels of BALF IgA, significantly higher levels were detected in BALF from both
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Figure 2.17. Cessation of SHS exposure restores BALF chemokine levels. BALF cytokine levels
(picograms per milliliter) of (a) MCP-1 (overall p value = 0.0104), (b) Eotaxin (overall p value =
0.3541), (c) IL-5 (overall p value = 0.0016), (d) KC (overall p value < 0.0001), (e) TNF- (all values
were below detection limits), and IL-1 (overall p value < 0.0001) in BALF from FA-WT (white bar),
SHS WT (orange bar), FA-Tg+ (red bar), and SHS-Tg+ (green bar) mice (n = 6-8 per group). The
dotted line represents lower limit of detection (LOD) for respective chemokine. Error bars represent
SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ***p < 0.001 using ANOVA followed by Tukey’s multiple
comparison post hoc test. Copyright 2017. The American Association of Immunologists
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Figure 2.18. Early postnatal SHS exposure followed by cessation leads to exaggerated lung
pathology. Representative photomicrographs from H&E stained, left lung lobe sections from 43-dold (a-a) FA-WT, (a-d) SHS-WT, (a-b and a-c) FA-Tg+, and (a-e and a-f) SHS-Tg+ mice. Lymphoid
aggregates (black arrow), peribronchiolar neutrophilic inflammation (green arrow), and lymphocytic
infiltration (red arrow). (b) Number of BALT nodules in lung sections from FA-WT (white bar), SHSWT (orange bar), FA-Tg+ (red bar), and SHS-Tg+ (green bar). (n = 11-16 per group, overall p value
= 0.0014). Error bars represent SEM. *p<0.05, **p < 0.01 using ANOVA followed by Tukey’s
multiple comparison post hoc test. Copyright 2017. The American Association of Immunologists.
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Figure 2.19. Cessation of SHS exposure restores IgA concentrations in BALF. IgA levels in cellfree BALF from FA-WT (white bar), SHS-WT (orange bar), FA-Tg+ (red bar), and SHS-Tg+ (green
bar). Error bars represent SEM. **p < 0.01 using ANOVA followed by Tukey’s multiple comparison
post hoc test. Copyright 2017. The American Association of Immunologists
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FA-Tg+ mice (~66.35  17.70 ng/ml, Figure 2.19) as well as SHS-Tg+ mice (108.3  14.01 ng/ml,
Figure 2.19).
These data indicate that the IgA levels in the BALF increase with increased incidence of
lymphoid tissue, i.e., loose lymphoid aggregates and organized BALT nodules, and that cessation
of SHS exposure restores lymphocyte homing to the lungs and BALF IgA secretion.
SHS exposed neonates exhibit exaggerated lung pathology: Although the SHS-WT mice
appeared free of mucus plugging, airway inflammation, mucous cell metaplasia, parenchymal
consolidation, and lymphoid hyperplasia responses, a significantly higher degree of epithelial
necrosis was present in SHS-WT mice (Figure 2.21b). As expected from previous studies (Livraghi
et al., 2009; Livraghi-Butrico et al., 2012; Mall et al., 2008), the FA-Tg+ group had significantly
elevated responses including mucus plugging, airway inflammation, epithelial necrosis, mucous
cell metaplasia, parenchymal consolidation, and lymphoid hyperplasia. In contrast, SHS-Tg+ mice
exhibited all the features of Scnn1b-Tg+ lung pathology with exaggerated degree of airway
inflammation, epithelial necrosis, parenchymal consolidation, and lymphoid hyperplasia (Figure
2.20b).
Cessation of SHS exposure restores Th2 responses in Scnn1b-Tg+ adults: Since the mucus
plugging and mucous cell metaplasia features were restored in SHS-Tg+ adult mice, we sought to
test whether the restoration of mucous cell metaplasia was a result of restored levels of Th2
cytokines in BALF. BALF cytokine estimation indicated that levels of IL-5 and IL-4 were below
detection limits in WT mice, regardless of their exposure groups, whereas a significant increase in
their levels were observed in Scnn1b-Tg+ mice (Figure 2.17c and Figure 2.21).

However, the

levels of IL5 and IL4 were not significantly different between FA- and SHS-Tg+ mice (Figure 2.17c
and Figure 2.21) suggesting restoration of previously suppressed secretion of these cytokines.
Next, we examined whether the restoration of IL4 levels was reflected in IL4-IL4Rα signaling-
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Figure 2.20. Cessation of SHS exposure restores pathological features of Scnn1b-Tg+ lung
disease. Representative photomicrographs from AB-PAS stained, left lung lobe sections from 43d-old (a-a) FA-WT, (a-b) SHS-WT, (a-c) FA-Tg+, and (a-d) SHS-Tg+ mice. (B) Semiquantitative
histopathology scores for mucus plugging, airway inflammation, epithelial necrosis, mucous
secretory cells, parenchymal consolidation, and lymphoid hyperplasia. FA-WT (n =13, white bar),
SHS-WT (n = 16, orange bar), FA-Tg+ (n = 11, red bar), and SHS-Tg+ (n= 11, green bar). Error
bars represent SEM. *p < 0.05, **p < 0.01, ***p < 0.001, **** p < 0.0001 using ANOVA followed
by Tukey’s multiple comparison post hoc test. Copyright 2017. The American Association of
Immunologists
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Figure 2.21. Cessation of SHS exposure restores Th2 responses in Scnn1b-Tg+ adults. (A) IL-4
cytokine levels (picograms per milliliter) from FA-WT (white bar), SHS-WT (orange bar), FA-Tg+
(red bar), and SHS-Tg+ (11, green bar). Error bars represent SEM. *p < 0.05 using ANOVA
followed by Tukey’s multiple comparison post hoc test. Copyright 2017. The American Association
of Immunologists
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Table 2.6. Cessation of SHS restores Th2/ mucous cell metaplasia-associated responses in
Scnn1b-Tg+ mice

Cessation of SHS restores Th2/ mucous cell metaplasia-associated responses in Scnn1b-Tg+
mice. mRNA levels for selective genes related to mucous cell metaplasia and Th2 inflammation.
Absolute quantification (mRNA copies per 10 5) copies of Actb mRNA) of gene expression of
selective genes in whole-lung homogenate from FA- or SHS-WT or Scnn1b-Tg+. Two values
carrying identical designations (for example, † or ‡) in the same row represent significant difference.
Bold text indicates significantly higher values compared with SHS-Tg+ group. n = 5 mice per group.
The data are presented as  SEM. p < 0.05 using ANOVA followed by Tukey’s multiple comparison
post hoc test. Copyright 2017. The American Association of Immunologists
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mediated upregulation of Th2/mucous cell metaplasia-associated gene expression levels.
Interestingly, although insignificantly, the mean expression levels of selective genes, i.e., Il33, Infg,
Agr2, and Muc5ac, were increased in SHS-WT mice; suggesting a long-term effect of early
postnatal SHS exposure in WT mice. As speculated, the mRNA levels of all the genes (Il33, Il4,
Il13, Ifng, Gata3, Spdef, Foxa3, Tff2, Agr2, Muc5ac, Muc5b, Clca1 [gob5/Clca3],Slc26a4,
(Pds/Pendrin), Retnla, and Chi3l4) that were suppressed in 22-day old SHS-Tg+ lungs were
returned to the levels similar to FA-Tg+ lungs (Table 2.6) at PND43. Of note, the restoration of
expression level of Th2 response-associated gene signatures showed strong correlation with
restoration of morphological features of mucous cell metaplasia (Figure 2.20a and Figure 2.20b).
Discussion
Mucosal host defense at respiratory surfaces is composed of multiple layers, e.g., physical
epithelial barrier, mucociliary clearance, antimicrobial peptides Igs, and immune cells, including
macrophages and neutrophils (Whitsett et al., 2015). Direct or indirect interactions between
mucosal host defense and airborne pollutants, such as secondhand smoke (SHS), may alter the
normal physiology of the respiratory system, shift the natural history of an ongoing disease, or alter
the manifestation of imminent diseases. Therefore in vivo testing of interactions between mucosal
defense layers and airborne pollutants is critical to our understanding of the initiation and
progression of environmental lung diseases.
Because early childhood SHS exposure is considered as a risk factor for muco-obstructive
lung diseases of pediatric origin, including asthma, cystic fibrosis, and chronic obstructive
pulmonary disease (Eisner et al., 2009; Pattenden et al., 2006); detailed analyses on threedimensional interactions between SHS exposure, normal lung homeostasis, and the natural history
of disease pathogenesis due to intrinsic defects, e.g., due to ion channel defects in CF disease,
are warranted. For this study, we focused on early postnatal exposures of SHS, a primary
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contributor to poor air quality (Repace et al., 1980), to the Scnn1b-Tg+ mouse model, in which
muco-obstructive airway disease evolves during early postnatal lung development.
Due to the early onset of lung disease, i.e., at the age of 2-3 days, the Scnn1b-Tg+ model
provides an excellent tool for studying muco-obstructive disease pathogenesis along with other
variables, e.g., airborne exposure to environmental pollutants. We therefore focused our
investigation on the pre-adult phase, i.e., PND3-21 and investigated the effect of SHS exposure
on: 1) early postnatal airspace homeostasis and 2) the natural history of muco-obstructive airway
disease. In particular, we examined the effects of early postnatal SHS exposure on inflammatory
cell recruitment, mucous cell metaplasia, adaptive immune response, and bacterial clearance.
This study revealed that SHS exposure of Scnn1b-Tg+ mice results in significantly altered
phenotypes, including suppressed immune cell recruitment, delayed bacterial clearance, and
diminished adaptive immune responses. These data reveal that, rather than exaggerating immunecell recruitment and Th2 responses or mucous cell metaplasia, early postnatal SHS exposure
suppresses these responses. These observations highlight the important complex interaction
between variables, including SHS exposure, ongoing muco-obstructive lung disease, and the
developmental stage.
Immune-cell recruitment, a key important component of host defense against inhaled
insults, has been shown to be increased in smoke-exposed adults as well as in neonatal mice
(D'Hulst A et al., 2005; John et al., 2014). In agreement with these studies, as compared with FAWT mice, the SHS-WT mice in our study had significantly increased neutrophil counts. In contrast,
however, perhaps due to a significantly low dose of smoke exposure levels (TSP = 10 mg/m 3)
adopted in our current study as compared with previous reports (D'Hulst A et al., 2005; John et al.,
2014; McGrath-Morrow et al., 2011), macrophage counts were comparable between FA- and SHSWT mice (Figure 2.2b). As previously reported (Mall et al., 2008), the FA-Tg+ mice, in contrast to
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WT mice, had significant increases in total, as well as differential cell numbers and percentages.
Contrary, however, to the expected exaggerated cellular recruitment (Jia et al., 2016), SHS-Tg+
exhibited significantly suppressed immune-cell recruitment responses. This reduction was not due
to a decrease in macrophage counts but rather to reduced numbers of neutrophils, eosinophils,
and lymphocytes (Figure 2.2b). These data show that early postnatal SHS exposure results in
suppressed cellular recruitment in Scnn1b-Tg+ mice.
Based on this suppressed cellular recruitment, we speculated that the reduced total cell
counts in SHS-Tg+ lung airspaces might be a result of reduced chemokine levels in the airspaces
of these mice. KC, a neutrophil chemoattractant (Craig et al., 2009), was found at comparable
levels in FA-Tg+ and SHS-Tg+ BALF (Figure 2.4D), suggesting the possibility that the cognate
chemokine receptor for KC may either be suppredsed due to systemic effects of SHS on blood
cells, or is nonresponsive in neonates. MCP-1 (CCL2), a monocyte (Deshmane et al., 2009) and
neutrophil chemoattractant (Balamayooran et al., 2011), however, was significantly lower in SHSTg+ BALF; suggesting a direct effect of SHS exposure on the synthesis and release of this
chemokine that resulted in inhibition of MCP-1-/CCR2-mediated neutrophil recruitment. These data
indicate that SHS exposure can suppress resident cell functions and early postnatal innate immune
responses. Whether the suppressed populations are epithelial cells or macrophages, or both, is
still unclear and will require comprehensive analyses focused on the effect of SHS exposure on
epithelium- and macrophage-derived chemokine mediators in healthy and diseased neonates.
Mucous cell metaplasia, an epithelial Th2 response, is a hallmark of Scnn1b-Tg+ airway
disease (Mall et al., 2004; Mall et al., 2008), as well as of human muco-obstructive airway disease
(Saetta et al., 2000). Our previous report on gene expression analyses on whole lung tissues from
10- to 42-d-old WT and Scnn1b-Tg+ mice demonstrated significantly upregulated Th2 responses in
the latter group (Saini et al., 2014), which were also confirmed in this study (Table 2.5). In contrast,
the SHS-Tg+ mice exhibited significantly suppressed mRNA levels for Gata3, a gene encoding a
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transcription factor controlling Th2 differentiation (Zheng et al., 1997). These data clearly show a
direct effect of diminished BALF Th2 cytokine (IL-4 and IL-13) levels on Th2 cell developmental
machinery, i.e., Gata3-controlled Th2 responses. Along the same axis, the SHS-Tg+ mice exhibited
downregulated expression of all Th2 response-related genes (Spdef, Foxa3, Tff2, Agr2, Muc5ac,
Muc5b, Clca1 [gob5/clca3], Slc26a4 [pds/pendrin], Retnla, and Chi3l4; Table 2.5). These data
strongly suggest that SHS exposure at the onset of respiratory disease results in suppressed Th2
responses (Figure 2.22).
Based on histopathological (Figure 2.8), cytokine (Figure 2.10), and gene expression data
(Table 2.5), we speculated that the suppressed secretions of Th2-related cytokines, i.e., IL-4 and
IL-13, in SHS-Tg+ BALF might have arisen due to SHS-induced suppression of resident cells, i.e.,
epithelial cell and macrophages. Epithelial cells upon exposures to insults such as allergens
(Bartemes et al., 2012; Divekar et al., 2015) , nematodes (Yasuda et al., 2012), helminths (Hung
et al., 2013), and viral infections (Monticelli et al., 2011), have been reported to release IL33, an
alarmin. IL33, in association with IL-25 and TSLP, stimulates ILC2 to produce Th2 cytokines,
including IL4, IL-5, and IL-13 (Kim et al., 2013). Our data demonstrate that whereas FA-Tg+ mice
had significantly increased levels of IL33 expression (mRNA levels, intracellular IL33 protein, and
secreted BALF IL-33), the SHS-Tg+ mice had significant reductions in these endpoints (Figure
2.12). This reduction in the expression levels of IL33 suggests loss of SHS-induced ILC2
stimulation. Interestingly, a recent study on the role of IL33/ST2 axis demonstrated that although
mainstream smoke exposure of adult mice results in increased IL33 release, these exposures
simultaneously suppress the expression of IL33R, i.e., ST2, which mediates ILC2 stimulation
(Kearley et al., 2015). At present, we cannot determine whether the differences between these two
studies stem from different exposure models (SHS versus mainstream smoke), age-group
differences (neonates versus adults), or a combination of the two. Accordingly, our data suggest
that the IL33-ILC2-IL4/-13-IL-4R axis mediates Th2 responses in Scnn1b-Tg+ neonates and that
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the SHS exposure directly suppresses IL33 expression in epithelial and immune cells (Figure 2.22).
These alterations eventually result in suppression of downstream Th2 immune responses, most
likely, due to disrupted IL4/-13-IL4R signaling.
Mucostasis creates a fertile anaerobic niche for the colonization of bacterial species
(Boucher, 2004). Scnn1b-Tg+ mice exhibit spontaneous infection with microflora of oropharyngeal
origin (Livraghi-Butrico et al., 2012), due to the muco-obstructive airways and resulting defective
mucociliary clearance. These infections have been reported to clear in ~70% of mice by the age of
4 week (Livraghi-Butrico et al., 2012). In agreement with the latter report, only 3 out of 10 FA-Tg+
mice in this study exhibited microaerophilic bacterial infection at PND22 (Figure 2.6). Despite
significant reduction in mucus plugging and Th2-responses (Muc5ac and Muc5b), SHS-Tg+ mice
exhibited defective bacterial clearance, i.e., 11 out of 12 SHS-Tg+ mice had persistent infections at
PND22 (Figure 2.6). These data indicate that SHS exposure results in weakened host defense
against spontaneously acquired microbial infection and that this defect is unrelated to mucostasis.
The roles of IL33 in bacterial infections have also been explored in recent years in various
models. Earlier, Lan et al. (Lan et al., 2016) and, recently, Robinson et al. (Robinson et al., 2018)
demonstrated that IL33 facilitates neutrophil recruitment and improves bacterial clearance in
different bacterial infection models. In line with these reports, reduced IL33 levels in SHS-Tg+ mice
were associated with reduced BALF neutrophil counts and delayed bacterial clearance. Further, in
addition to neutrophils, secretory IgA (SIgA)-mediated neutralization of mucosal microorganisms
(Phalipon et al., 2002) and microbial toxins (Fernandez et al., 2003) is a major component of
mucosal host defense (Corthesy, 2013). In our study, SHS exposure resulted in a significant
reduction in BALF SIgA levels both in WT and Scnn1b-Tg+ mice (Figure 2.5). Malik et al. (Malik et
al., 2016) has recently established a link between IL33 and SIgA levels in gut homeostasis and
colitis. In line with this report, suppression in IL33 levels in SHS-Tg+ mice may have resulted in
suppressed SIgA levels, thus introducing an additional defect in antibacterial host defense (Lugade
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et al., 2014). Accordingly, we speculate that the beneficial effect of IL33 downregulation toward
bacterial clearance, i.e., through the reduction in mucostasis or mucus production, was
counterbalanced or overpowered by the detrimental effects of IL33 downregulation, i.e., through
reduction in neutrophil counts (Figure 2.2B) and SIgA levels (Figure 2.5).
Although the effect of SHS exposure on WT mice was milder, as previously reported (Mall
et al., 2004; Mall et al., 2008), the presence of the Scnn1b transgene resulted in marked mucoobstructive lung disease. However, the simultaneous presence of these two challenges revealed
significant alterations in the manifestation of imminent lung disease of Scnn1b-Tg+ neonates.
Whether the presence of the SHS insult suppresses the immune responses associated with
Scnn1b expression, or whether the presence of a Scnn1b-expression-induced ion channel defect
exposes neonates to SHS-induced suppression, is still unclear and requires further investigation.
The gender-specific responses to SHS have been reported previously. In comparison with
tobacco smoke-exposed adult males, the females exhibit exaggerated allergic responses
(Seymour et al., 2002), alveolar airspace enlargement (Awji et al., 2015), and increased airway
remodeling (Tam et al., 2016; Tam et al., 2016). Interestingly, our key findings, in particular
neutrophil counts, cytokine levels, mucous cell metaplasia, which form the basis of our study,
followed similar trends in both genders (Tables 2.3. and 2.4); This was not very surprising as the
study was concluded at a juvenile age (PND22), well before the age of sexual maturity (PND4256).
In the latter half of the study, we investigated whether the SHS-induced suppression of
immune responses and Th2 inflammation in Scnn1b-Tg+ lungs would sustain or reverse upon
cessation of SHS exposure. As expected, a majority of suppressed responses, including immune
cell recruitment, gene expression signatures, chemokines, and mucous cell metaplasia, were
restored at day 42 after cessation of SHS on day 21. In fact, some of these responses, including
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cell counts, mucous cell metaplasia, epithelial necrosis, and lymphoid hyperplasia, were
exaggerated in SHS-Tg+ mice as compared with FA-Tg+ at day 42. These data suggest that the
suppression of immune responses in SHS-Tg+ mice at PND22 were temporary and the cessation
of SHS allows the restoration of immune responses. Early postnatal SHS exposure, however,
results in lagged effects after cessation of SHS exposure, including structural alterations,
particularly pulmonary consolidation, epithelial necrosis, and airway inflammation, which may have
long-term consequences in adult life.
Although a number of studies have investigated the long-term effects of in utero SHS
exposure (Penn et al., 2007; Xiao et al., 2016; Xiao et al., 2012; Xiao et al., 2013), a limited number
of studies have explored the short-term effects of neonatal SHS exposure. Given the highly
sensitive stage of ongoing lung development, the superimposition of exposure to SHS or any other
airborne environmental pollutant upon early postnatal life makes interpretation of these studies
challenging. One limitation to this study was our inability to further explore the effect of SHS on
individual cell types resident in macrophages, i.e., macrophages and epithelial cells. For example,
although FA-Tg+ macrophages revealed intense IL-33 staining (Figure 2.13), we cannot determine
whether increased IL-33 in macrophages indicates elevated endogenous IL-33 expression levels
or phagocytosed IL-33 of epithelial origin. We therefore propose that further studies should be
conducted to understand the effects of SHS exposures on cell-specific pathological responses of
different neonatal age groups.
In conclusion, this study reveals previously underappreciated multidimensional interactions
between SHS, early postnatal lung development, and muco-obstructive lung disease. has begun
to address a critical area of investigation, i.e., effect of SHS-exposure on lung homeostasis in
newborn WT mice and lung pathogenesis of CF-like diseases. Our data suggest that SHS exposure
during early postnatal stage of muco-obstructive lung disease results in suppressed host
responses, including: 1) suppressed cellular recruitment responses; 2) defective bacterial
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clearance; 3) suppressed mucous cell metaplasia; 4) diminished Th2 responses; and 5)
suppressed adaptive immune response, i.e., IgA secretions. Whereas most of these responses are
reversed upon cessation of SHS exposure, histologically, SHS-exposed lungs exhibit exaggerated
pathological alterations indicating lagged effects of early postnatal SHS exposure that may have
long-term effects of early postnatal SHS exposure that may have long-term consequences in adult
life.
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Figure 2.22. Hypothetical model for SHS exposure-induced suppression of Th2 immune responses.
Airway surface liquid dehydration-induced stress in lung epithelium and macrophages of Scnn1bTg+ mice induces IL-33 secretion. Increased levels of IL-33 stimulate ILC2, which releases Th2
cytokines (IL-4, IL-13) into the airspaces. Th2 cytokines trigger GATA3-transcription factorregulated development of Th2 cells and eventually, IL4R-mediated gene expression changes
(Spdef, Foxa3, Tff2, Agr2, Muc5ac, Muc5b, Clca1 [gob5/Clca3], Slc26a4 [Pds/pendrin], Retnla, and
Chi3l4) leading to epithelial Th2 responses. SHS exposures superimpose additional stress onto
the Scnn1b-Tg+ airspaces, resulting in suppression of IL-33 synthesis and release, thus leading to
suppressed Th2 responses.
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CHAPTER III. AIRWAY MUCOUS CELL METAPLASI A, NOT MUCO OBSTRUCTION, IS MEDI ATED THROUGH INTERLE UKIN 33 (IL33)
Introduction

Airway mucosal surfaces are lined by a thin layer of liquid, i.e., the airway surface liquid
(ASL) layer, consisting of water, ions, proteins, and macromolecules, including mucin
glycoproteins (Knowles et al., 2002). Normal height and solid contents of the ASL layer are
essential for the proper functioning of mucociliary defense system, which propels the ASL layer
and its trapped airborne insults towards the epiglottis (Knowles et al., 2002). Both ASL layer
height and solid contents are severely altered in the airways of patients with cystic fibrosis
(CF), a muco-obstructive lung disease. These alterations likely compromise the ciliary beating
that results in airway muco-obstruction, a consistent feature of CF airways.

While it is well

established that the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
dysfunction induces ionic imbalance as a result of which the ASL layer height is significantly
reduced in the CF airways, the exact cause of ~3 times increase in solid contents is yet to be
identified (Boucher, 2007).
The increase in solid contents may occur due to various factors including ASL layer
dehydration, excessive mucin production, increased inflammatory cell density, and
accumulation of cellular debris. Among these, elevated mucin contents are thought to be the
major contributors of increased percent solids (Boucher, 2007).

On the other hand, the

increase in solid contents may just be caused by the hyperconcentration of normally produced
solid contents of ASL layer. Whether muco-obstructive response is a result of defective ciliary
beating due to dehydrated/thickened ASL layer or mucin hypersecretion or a combination of
both is unclear. While testing of these scenarios is challenging in CF patients, the Scnn1bTransgenic (Tg+) mouse, a model of CF-like lung disease, is an ideal model for experimental
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testing.
The Scnn1b-Tg+ mouse model of muco-obstructive lung disease was developed by
airway epithelium-specific overexpression of epithelial sodium (Na+) ion channel, non-voltage
gated 1  subunit (Scnn1b) transgene (Mall et al., 2004).

The overexpression of Na+ ion

channels induces defective ion transport, similar to the CFTR dysfunction (Tarran, 2004). The
increase in airway epithelial Na+ absorption leads to dehydration of the ASL layer, impaired
mucociliary clearance (MCC), and spontaneous bacterial infections (Mall et al., 2004). The
Scnn1b-Tg+ mice exhibit a robust T-helper 2 (Th2) muco-inflammatory airway pathology, i.e.,
marked mucous cell metaplasia (MCM), increased mucin expression, and muco-obstruction
(Dabbagh et al., 1999; Zhu et al., 1999). Interleukin 33 (IL33) has been shown to be a potent
stimulator of Th2-associated inflammation(Schmitz et al., 2005). Our recent report identified
an intriguing association between reduced IL33 expression and diminished Th2 mucoinflammatory responses, i.e., mucous cell metaplasia (MCM) and muco-obstruction (Lewis et
al., 2017). However, it remains to be tested whether the genetic ablation of IL33 abolishes
MCM and muco-obstruction in Scnn1b-Tg+ mice.
In this study, we hypothesized that IL33 is essential for MCM responses that, in turn,
contributes to the muco-obstruction in the airways of Scnn1b-Tg+ mice. Further, we
hypothesized that the genetic deletion of IL33 will abolish MCM responses and airway mucoobstruction. In order to test these hypotheses, IL33-deficient Scnn1b-Tg+ (Il33-/Scnn1b-Tg+)
mice were generated and observed at two age points, i.e., postnatal day (PND) 7 and PND
21. First, the effect of IL33 deletion on mucous cell metaplasia was determined histologically
and via cytokine analyses.

Second, the effect of IL33 deletion on airway inflammation,

bronchoalveolar lavage fluid (BALF) chemokine levels, and muco-obstruction was determined.
Finally, we determined the effect of IL33 deletion on the clearance of spontaneous bacterial
97

infection. The results from this study provide novel insights into the contribution of IL33 in the
development of MCM in the airways with dehydrated ASL layer.
Methods
Generation of Transgenic mice and animal husbandry: Scnn1b-Tg+ mice (Tg(Scgb1a1Scnn1b)6608Bouc/J) were procured from Jackson Laboratory (Bar Harbor, ME) and Il33-/- mice
were generously provided by Dr. Hëth R. Turnquist (University of Pittsburgh) (Oboki et al., 2010).
These two strains were crossbred to generate IL33-deficient Scnn1b-Tg+ (Il33-/-\Scnn1b-Tg+)
mice. Various genetic combinations were generated by breeding heterozygous (Il33+/-) Scnn1bTg+ females and IL33-deficient (ll33-/-) WT males.

In reciprocal crosses, heterozygous (Il33+/-)

Scnn1b-Tg+ males were mated with IL33-deficient (Il33-/-) WT females.

Genotyping for all mice

was performed by polymerase chain reaction (PCR) as previously described for the presence of
Scnn1b-Tg and Il33 (Figure 3.3a) (Mall et al., 2004; Oboki et al., 2010). Mice were maintained in
individually ventilated, hot-washed cages at the Division of Laboratory Animal Medicine (DLAM;
Louisiana State University, Baton Rouge) on a 12-hour dark/light cycle. Mice were fed regular diet
and water ad libitum. All animal use procedures were approved by the Institutional Animal Care
and Use Committee (IACUC) of Louisiana State University.
Bronchoalveolar lavage fluid (BALF) Analyses: Aseptically harvested BALF was serially diluted
onto Columbia Blood Agar (CBA) plates (Hardy Diagnostics, Santa Maria, CA) as previously
described (Lewis et al., 2017; Livraghi-Butrico et al., 2012; Saini et al., 2016).

The CBA plates

were incubated in an anaerobic candle jar for 48 hours at 37°C. Bacterial burden was determined
by enumerating colony-forming units (CFUs). Remaining BALF was centrifuged at 300 x g for 5
minutes. The supernatant was removed and stored at -80C for cytokine analyses. The cellular
pellet was resuspended in 500 l of PBS.

Total cell counts were determined using a

hemocytometer (Brightline, Horsham, PA). Cytospins (Cytospin 3; Thermo Shandon, Pittsburgh,
PA) were prepared with 200 l cell suspension and differentially stained (Modified Giemsa kit;
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Newcomer Supply, Middleton, WI). Cell-free BALF was assayed for contents of various cytokines
(Table 1) using a Luminex XMAP-based assay (MCYTOMAG-70K), according to manufacturer’s
instructions (EMD Millipore, Billerica, MA).
Histopathological Analyses: Left lung lobes were formalin fixed, paraffin-embedded, sectioned,
and stained for histopathological analyses. Histopathological parameters were compared by
blinded pathologists (SP) using a previously described semi-quantitative grading strategy (Livraghi
et al., 2009). Briefly, histological sections stained with hematoxylin and eosin (H&E) were used to
evaluate histopathological changes. To determine muco-obstruction and MCM, histological slides
were stained with Alcian Blue-Periodic Acid Schiff (AB-PAS).

Mucous cell count per millimeter

(mm) of basement membrane was used as a quantitative parameter to evaluate Mucous Cell
Metaplasia, using 40X objective of Nikon Eclipse Ci-L microscope (Nikon, Japan) with camera
attachment (Nikon Digital Sight DSFi-2).

Airway epithelial cells (at least 50 cells) and mucous

cells, distinguished by presence of AB-PAS staining, were counted.
Mean Linear Intercept Measurements: Briefly, two different lung sections per mouse were imaged
at 10X magnification using Nikon scope (Nikon, Japan) with camera attachment (Nikon Digital Sight
DSFi-2). Images were loaded onto image J software and converted to binary. Horizontal grid lines
were superimposed on each lung section image. Using line drawing software, lines were drawn
along gridlines and measured. Intercepts were considered as points of contact between drawn line
and alveolar septi. Mean Linear Intercepts (MLI) were determined by dividing the sum of the length
of all drawn lines (m) by the sum of the total intercepts between alveolar septi and drawn lines
(Mall et al., 2008).
Analyses of BALF for IL33: To estimate IL33 concentration in BALF, cell-free BALF supernatant
was assayed for various cytokines (Table 3.1) with a Mouse/Rat IL33 ELISA Kit (M3300) according
to manufacturer’s instructions (R&D Systems, Minneapolis, MN).
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Immunohistochemical analyses: Formalin-fixed, paraffin-embedded lung sections were used for
immunohistochemical localization of IL-33 as previously described (Lewis et al., 2017). Rabbit
polyclonal antibodies against MUC5AC (UNC294), MUC5B (UNC223), anti-histone H3 CIT H3
(ab5103; ABCAM) were used to immunostain mucus plugs.
Statistical analyses: One-way Analysis of Variance (ANOVA) followed by Tukey’s post hoc test for
multiple comparisons was used to determine significant differences among groups. Measurements
from two groups were compared using Student’s t test assuming unequal variance. All data were
expressed as mean  standard error of the mean (SEM). A p value <0.05 was considered
statistically significant. Statistical analyses were performed using GraphPad Prism 7.0 (GraphPad
Software, La Jolla, CA).
Results
IL33 contents were elevated in the BALF and lung tissue of muco-obstructive lungs: To
identify the age at which IL33 is released into the airspaces of Scnn1b-Tg+ (Tg+) mice, we
performed ELISA to determine IL33 contents in WT and Tg+ BALF from neonates (PND 7) and
juveniles (PND 21). The IL33 contents were undetectable in the BALF from Wild-type (WT) as well
as Tg+ neonates (Figure 3.1a). While IL33 contents were undetectable in WT BALF from juveniles,
the BALF from Tg+ mice at this age had significantly elevated levels of IL33 (Figure 3.1b).
The IL33 protein contents in the lung tissues were elevated in Tg+ neonates (Figure 3.1c;
p<0.05) as well as juveniles (Figure 3.1d; p=0.078). To identify the cellular source of IL33 in Tg+
lungs, we performed immuno-histochemical localization of this protein in lung sections from WT
and Tg+ mice at both age points. While IL33 contents were below detection limits in the nuclei of
airway epithelial cells of WT and Tg+ mice (data not shown), alveolar epithelial cells were intensely
stained positive for IL33 in Tg+ neonates (Figure 3.2a) as well as juveniles (Figure 3.2b).
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Figure 3.1. IL33 contents are elevated in the Scnn1b-Tg+ lungs. IL33 content in cell-free BALF
from WT (white bar) and Scnn1b-Tg+ (green bar) (a) neonates and (b) juveniles (n=5-6 per group).
IL33 content in lung homogenates from WT (white bar) and Scnn1b-Tg+ (green bar) (c) neonates
and (c) juveniles (n=8-11 per group). Error bars represent SEM. *p<0.05, using Student’s t test. IL33, Interleukin-33; WT, Wild-type.
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Figure 3.2. IL33 contents are elevated in the Scnn1b-Tg+ lungs. Representative images from lung
sections showing immunolocalization for IL-33 protein (blue arrows) in WT (top) and Scnn1b-Tg+
(bottom) (a) neonates and (b) juveniles. IL-33, Interleukin-33; WT, Wild-type.
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Figure 3.3. Generation of IL33-deficient mice. (a) Gel image showing genomic DNA bands
corresponding to a segment of WT and mutated alleles of Il33 gene (top image). Gel image
showing genomic DNA bands corresponding to a segment of WT and transgenic alleles of Scnn1b
gene (bottom image). (b) IL33 contents from lung homogenates in IL33+/WT (white bar), IL33-/WT
(blue bar), IL33+/Scnn1b-Tg+ (green bar), and IL33-/Scnn1b-Tg+ neonates (red bar) (n=8-11 per
group). (c) IL33 contents from lung homogenates in IL33+/WT (white bar), IL33-/WT (blue bar),
IL33+/Scnn1b-Tg+ (green bar), and IL33-/Scnn1b-Tg+ juveniles (red bar) (n=8-9 per group). Note:
White and green bars in b and c were redrawn using dataset used in figure 1c and 1d, respectively.
Error bars represent SEM. *p<0.05, **p<0.01, ****p<0.0001 using ANOVA followed by Tukey’s
multiple comparison post hoc test. ND, not detected; IL-33, Interleukin-33; WT, Wild-type.
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Figure 3.4. Generation of IL33-deficient mice. Representative images from lung sections showing
immunolocalization for IL33 protein in IL33-/WT (top micrograph) and IL33-/Scnn1b-Tg+ juveniles
(bottom micrograph).
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IL33 deletion modulates airspace inflammation in Scnn1b-Tg airways: The IL33-/- (IL33-)
and IL33+/- (IL33+) mice were generated on WT or Tg+ backgrounds (Figure 2a) and tested for the
deletion of IL33 (Figure 3.3b-d). The IL33-/WT and IL33-/Tg+ neonates (Figure 3.3b) and juveniles
(Figure 3.3c) were completely devoid of IL33. The IL33 immuno-staining of lung sections from IL33/WT and IL33-/Tg+ mice confirmed deletion of IL33 in epithelial cells (Figure 3.4).
To determine the effect of IL33 deletion on inflammatory response in Tg+ airways, BALF
was analyzed for alterations in the inflammatory cell counts and soluble inflammatory mediators. In
the absence of Scnn1b transgene, the IL33- and IL33+ mice had comparable number of total
immune cells in the BALF (Figure 3.5a). The proportion of individual immune cells including
macrophages, neutrophils, eosinophils, and lymphocytes were also comparable among IL33 -/WT
and IL33+/WT mice (Figure 3.5b-d). The IL33+/Tg+ mice had significantly increased number of total
BALF cells that was contributed by increase in three cell types, i.e., neutrophils, eosinophils, and
lymphocytes (Figure 3.5a). The total cell, macrophage, neutrophil, and lymphocytes counts in IL33 /Tg+ BALF were comparable to their respective counts in IL33 +/Tg+ BALF (Figure 3.5). The
eosinophilic counts were significantly lower in the IL33-/Tg+ BALF as compared to IL33+/Tg+ BALF
(Figure 3.5).
To determine the effect of IL33 deletion on chemokine levels in Tg+ airspaces, BALF was
assayed for the presence of cell-specific chemokines. Neutrophil chemoattractants including
keratinocyte chemoattractant (KC), Macrophage inflammatory protein-2 (MIP2), Granulocytecolony stimulating factor (G-CSF), Macrophage inflammatory protein-1 alpha (MIP1), and
Monocyte chemoattractant protein-1 (MCP-1) were below detection levels in IL33 +/WT and IL33/WT mice (Figure 3.6; Table 3.1). All of these cytokines were significantly elevated, but comparable
among each other, in BALF from IL33+/Tg+ and IL33-/Tg+ mice (Figure 3.6; Table 3.1). Eosinophil
chemoattractants
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Figure 3.5. IL33 deficiency alters immune cell recruitment. (a) Total cell counts in the harvested
BALF from IL33+/WT (white bar), IL33-/WT (blue bar), IL33+/Scnn1b-Tg+ (green bar), and IL33/Scnn1b-Tg+ (red bar) (n=15-26 per group). (b) Differential cell counts and (c) relative percentages
are shown as stacked bar graph [macrophages (red), neutrophils (blue), eosinophils (green), and
lymphocytes (black). (d) Representative photomicrographs of BALF cytospins. (d-i) IL33+/WT, (dii) IL33-/WT, (d-iii) IL33+/Scnn1b-Tg+ (d-iv) IL33-/Scnn1b-Tg+. Macrophages (red arrow),
neutrophils (blue arrow), eosinophils (green arrow), and lymphocytes (black arrow). Error bars
represent SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 using ANOVA followed by Tukey’s
multiple comparison post hoc test.
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Figure 3.6. IL33 deficiency alters immune cell recruitment. BALF cytokine levels (picograms per
milliliter) of Keratinocyte (a) KC, (b) MIP2, G-CSF (c) G-CSF, and (d) IL5. Error bars represent
SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 using ANOVA followed by Tukey’s multiple
comparison post hoc test. NS, non-significant; IL33, Interleukin 33; KC, Keratinocyte
chemoattractant; MIP2, Macrophage inflammatory protein-2; G-CSF, Granulocyte-colony
stimulating factor; IL5, Interleukin 5.
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Table 3.1. Cytokine Levels (pg/ml) in BALF
Cytokine

IL33+/WT

IL33-/WT

IL33+/Tg+

IL33-/Tg+

IL4

10.4 ± 0.18 #

10.5 ± 0.46 π

22.17 ± 4.96 # π

11.56 ± 0.50

IL5

13.88 ± 0.2#

14.1 ± 0.4 π

42.4 ± 16.0 # π

14.4 ± 0.3

3.2

Rantes

26.3 ± 0.5#

24.9 ± 0.7 π

30.1 ± 1.1# π

26.6 ± 0.8

3.2

MIP1

9.25 ± 0.3 # Φ

10.1 ± 0.3 π θ

46.9 ± 8.9 # π

26.7 ± 2.7 Φ θ

3.2

IP10

34.6 ± 1.9 # Φ

38.1 ± 2.1 π θ

86.4 ± 15.2 # π

52.5 ± 5.4 Φ θ

3.2

MIP1α

31.0 ± 0.9 # Φ

31.2 ± 0.8 π θ

85.0 ± 13.6 # π

64.6 ± 6.5 Φ θ

3.2

IL12 (P70)

26.6 ± 1.0 #

23.3 ± 0.9 π

25.4 ± 1.0 # π

23.3 ± 0.9

3.2

KC

16.6 ± 0.8 # Φ

18.3 ± 0.9 π θ

844.7 ± 148.0 # π

623.6 ± 170.1 Φ θ

3.2

IL6

11.8 ± 0.4 #

12.1 ± 0.5 π θ

53.8 ± 32.6 # π

29.1 ± 8.7 θ

3.2

TNFα

15.3 ± 0.4# Φ

15.3 ± 0.3 π θ

28.1 ± 2.4# π

23.6 ± 1.4 Φ θ

3.2

MIP2

14.6 ± 0.4# Φ

14.8 ± 0.2 π θ

1282.0 ± 665.8# π

893.3 ± 495.3 Φ θ

3.2

G-CSF

16.9 ± 0.5 # Φ

14.6 ± 0.5 π θ

1166.0 ± 507.6 # π

727.1 ± 171.1 Φ θ

3.2

IL17

16.4 ± 0.3 # Φ

15.3 ± 0.5 π θ

22.4 ± 2.8 # π

18.0 ± 0.6 Φ θ

3.2

IL10

16.4 ± 0.8 #

15.5 ± 0.5

15.1 ± 0.5

14.0 ± 0.6 #

3.2

MCP1

10.2 ± 0.4 #

10.2 ± 0.3 π

11.61 ± 0.5 # π

11.4 ± 0.3

3.2

IL2

18.9 ± 1.1 # Φ

20.2 ± 1.9 π θ

14.3 ± 1.1 # π

13.2 ± 0.9 Φ θ

3.2

IL9

19.5 ± 1.0 # Φ

20.5 ± 1.6 π θ

16.4 ± 1.2 # π

15.2 ± 0.5 Φ θ

3.2

IL1α

24.9 ± 2.3

26.5 ± 2.8

34.2 ± 4.4

27.5 ± 2.6

3.2

IL1β

9.4 ± 0.3

9.5 ± 0.3

10.8 ± 0.6

9.8 ± 0.2

3.2

IFN

24.3 ± 0.5

22.6 ± 0.6

25.0 ± 1.4

22.7 ± 0.8

3.2

IL7

21.3 ± 0.7

18.9 ± 0.6

20.0 ± 0.8

20.2 ± 1.1

3.2

IL12 (P40)

26.6 ± 1.0

23.3 ± 0.9

25.4 ± 1.0

23.3 ± 0.9

3.2

LOD
3.2

Values bearing identical designations (# or π or Φ or θ) within a row represent significant
difference. Yellow Background: Significantly lower compared to IL33-sufficient Scnn1b-Tg
(IL33+/Tg+) group. LOD: Lowest Limit of Detection; n=8-10; p value for statistical difference
between groups is less than or equal to 0.05.
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[Interleukin 5 (IL5), Regulated on Activation, Normal T cell Expressed and Secreted (Rantes)] were
below detection levels in IL33+/WT and IL33-/WT mice (Figure 3.6d; Table 3.1). These cytokines
were significantly elevated in BALF from IL33+/Tg+ mice. The levels of these cytokines were
significantly reduced to the basal level in IL33-/Tg+ mice (Figure 3.6d; Table 3.1).
Deletion of IL33 does not alter prevalence of spontaneous bacterial infections in Scnn1bTg mice: To determine the effect of IL33-deletion on bacterial clearance, we analyzed bacterial
burden in aseptically collected BALF from neonates (PND7) and juveniles (PND21). In the absence
of Scnn1b transgene, only 1 (CFU ~3500) out of 10 IL33+ and 3 out of 16 IL33- (mean CFU ~125.9
± 85.3) neonates had bacterial infection (Figure 3.7a). Mean CFU counts were comparable
between in IL33+/Tg+ (mean CFU ~6.9 x104 ± 3.7 x104) and in IL33-/Tg+ (mean CFU ~6.1 x104 ±
2.9 x104) neonates. While only 1 out of 12 IL33+/Tg+ neonates was free of bacterial infection, 4 out
of 14 IL33-/Tg+ neonates had no sign of bacterial infection (Figure 3.7a).
Scnn1b-Tg+ mice are known to clear airspace infection by the age of three weeks(LivraghiButrico et al., 2012). In the absence of Scnn1b, few IL33+ (mean CFU ~16.6 ± 8.5) and IL33- (mean
CFU ~11.2 ± 3.8) juveniles had mild bacterial infection (Figure 3.7b).

The bacterial burden was

significantly elevated in both IL33+/Tg+ (mean CFU ~443.2 ± 231.4) and IL33-/Tg+ (mean CFU
~59.4 ± 24.9) juveniles (Figure 3.7b). While mean CFU counts were trending lower in IL33 -/Tg+
(mean CFU ~59.4 ± 24.9) juveniles, the difference between IL33-/Tg+ and IL33+/Tg+ juveniles was
statistically non-significant (p=0.12) (Figure 3.7b).
IL33 deletion modulates pulmonary pathology in Scnn1b-Tg airways: The effects of IL33
deletion on Scnn1b-Tg pulmonary pathology including airway inflammation, alveolar space
enlargement, and lymphoid hyperplasia, were examined. Sub-epithelial/peri-bronchiolar airway
inflammation with marked leukocytic infiltration is associated with the Scnn1b-Tg+ lung
pathology(Mall et al., 2008).
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Figure 3.7. IL33 deficiency does not improve bacterial clearance. (a) BALF CFU counts from
IL33+/WT (black triangle), IL33-/WT (blue triangle), IL33+/Scnn1b-Tg+ (green triangle), and IL33/Scnn1b-Tg+ neonates (red triangle) (n=11-16 per group). (b) BALF CFU counts from IL33+/WT
(black triangle), IL33-/WT (blue triangle), IL33+/Scnn1b-Tg+ (green triangle), and IL33-/Scnn1b-Tg+
juveniles (red triangle) (bar color) (n=15-29 per group). The CFU values were log10-transformed
with an offset of +1 (log10+1). Error bars represent SEM. *p<0.05, **p<0.01 using ANOVA followed
by Tukey’s multiple comparison post hoc test. NS, non-significant; IL33, Interleukin 33; CFU,
Colony forming unit; BALF, Bronchoalveolar lavage fluid.
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The airway inflammation was not evident in IL33+/WT as well as IL33-/WT groups. As previously
reported (Mall et al., 2008), the peri-bronchiolar inflammation was present in IL33+/Tg+ lungs
(Figure 3.8).
The inflammatory cellular infiltrates were an admixture of neutrophils, eosinophils and lymphocytes
(Figure 3.8). In contrast, the degree of neutrophilic and lymphocytic infiltration was significantly
higher in IL33-/Tg+ lungs (Figure 3.8). As reflected by the absence of eosinophils in IL33 -/Tg+
BALF, the peri-bronchiolar inflammation had negligible presence of eosinophils (Figure 3.9).
Alveolar space enlargement is a consistent feature of Scnn1b-Tg lung disease (Mall et al.,
2008). We performed semi-quantitative (Figure 3.9a) as well as quantitative (mean linear
intercepts) analyses (Figure 3.9b) on lung sections. Both IL33+/WT as well as IL33-/WT had
comparable alveolar space sizes (Figure 3.9). As expected, the IL33+/Tg+ lungs had significant
alveolar space enlargement (Figure 3.9). The alveolar space enlargement was widespread and
significantly greater in IL33-/Tg+ lungs (Figure 3.9).
Lymphoid hyperplasia, i.e., appearance of lymphoid aggregates/nodules, is another
pathological response that is present in Scnn1b-Tg lungs (Livraghi-Butrico et al., 2012; Saini et al.,
2018). Both IL33+/WT as well as IL33-/WT were completely devoid of lymphoid aggregates (Figure
3.10). 5 out of 12 IL33+/Tg+ lungs had lymphoid aggregates. In contrast, greater proportion (9 out
of 14) of IL33-/Tg+ mice had lymphoid aggregates. Further, although not significant, the numbers
of lymphoid aggregates per lung section were also trending higher in IL33-/Tg+ mice (Figure 3.10).
IL33 is essential for mucous cell metaplasia (MCM) in Scnn1b-Tg airways: Mucous cell
metaplasia is a hallmark feature of Scnn1b-Tg+ lung disease (Mall et al., 2008). To determine the
effect of IL33 deficiency on MCM, AB-PAS stained lung sections were examined for intracellular
muco-polysaccharide contents. AB-PAS positive airway epithelial cells were occasionally present
in the airways of IL33+/WT but not in IL33-/WT mice (Figure 3.11a, Figure 3.11d; red arrow). While
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Figure 3.8. IL33 deficiency increases airway inflammation in Scnn1b-Tg+ airways. Semiquantitative
histological scoring for airway inflammation IL33 +/WT (white bar), IL33-/WT (blue bar),
IL33+/Scnn1b-Tg+ (green bar), IL33-/Scnn1b-Tg+ (red bar). Error bars represent SEM. *p<0.05,
**p<0.01, ***p<0.001, ****p<0.0001 using ANOVA followed by Tukey’s multiple comparison post
hoc test. IL33, Interleukin 33; WT, Wild type.
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Figure 3.9. IL33 deficiency increases distal airspace enlargement in Scnn1b-Tg+ airways. (a)
Semiquantitative histological scoring for alveolar space enlargement IL33+/WT (white bar), IL33/WT (blue bar), IL33+/Scnn1b-Tg+ (green bar), IL33-/Scnn1b-Tg+ (red bar). (b) Quantitative
histological scoring for mean linear intercepts IL33+/WT (white bar), IL33-/WT (blue bar),
IL33+/Scnn1b-Tg+ (green bar), IL33-/Scnn1b-Tg+ (red bar). (c) Representative photomicrographs
from H&E-stained left lung lobe sections for IL33+/WT (black box), IL33-/WT (blue box),
IL33+/Scnn1b-Tg+ (green box) and IL33-/Scnn1b-Tg+ (red box). Error bars represent SEM.
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 using ANOVA followed by Tukey’s multiple
comparison post hoc test. IL33, Interleukin 33; WT, Wild type.
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Figure 3.10. IL33 deficiency modulates pulmonary pathology in Scnn1b-Tg+ airways. (a)
Semiquantitative histological scoring for lymphoid hyperplasia IL33 +/WT (white bar), IL33-/WT (blue
bar), IL33+/Scnn1b-Tg+ (green bar), IL33-/Scnn1b-Tg+ (red bar). (b) Representative
photomicrographs from H&E-stained left lung lobe sections showing lymphoid hyperplasia (black
arrow) in IL33+/Scnn1b-Tg+ (green box) and IL33-/Scnn1b-Tg+ (red box). Error bars represent
SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 using ANOVA followed by Tukey’s multiple
comparison post hoc test. IL33, Interleukin 33; WT, Wild type.
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the IL33+/Tg+ mice had widespread AB-PAS staining indicating robust MCM, this response was
completely abolished in IL33-/Tg+ mice (Figure 3.11a, Figure 3.11d; red arrow). The morphometric
comparison of mucous cell density in the large airways revealed a significant decrease in the
proportion of these cells in IL33-/Tg+ mice as compared to IL33+/Tg+ mice (Figure 3.11a, Figure
3.11d).
Levels of Interleukin 4 (IL4), a key mediator in Th2 responses, were assessed in the BALF.
IL4 was present at the basal levels in BALF from IL33+/WT as well as IL33-/WT mice (Figure 3.11b).
The BALF IL4 levels were significantly elevated in IL33+/Tg+ mice. In contrast, the BALF IL4 levels
were significantly reduced to basal levels in IL33-/Tg+ mice (Figure 3.11b).
Abolition of mucous cell metaplasia (MCM) responses does not affect muco-obstruction in
Scnn1b-Tg airways: To determine the effect of abolition of MCM on muco-obstruction, we observed
the lung sections from IL33+ and the IL33- mice for airway obstruction. As expected, while there
was no sign of muco-obstruction in IL33+/WT as well as IL33-/WT mice, the IL33+/Tg+ mice had
marked muco-obstruction (Figure 3.11c-d). Instead of expected reduction, the degree of mucoobstruction in IL33-/Tg+ mice was significantly increased as compared to IL33 +/Tg+ mice (Figure
3.11c-d). This evaluation was consistent with our visual observation that BALF from IL33-/Tg+ mice
had relatively larger mucus plugs.
To determine whether mucus plugs in the IL33-/Tg+ as well as IL33+/Tg+ mice contained
comparable mucins, the lung sections were immuno-stained for Muc5b and Muc5ac. Both of these
proteins were significantly more abundant in the IL33+/Tg+ mucus plugs as compared to IL33-/Tg+
(Figure 3.12). Since muco-obstruction was evident in the absence of MCM, our data indicate that
the formation of mucus plugs in ASL-dehydrated airways might be a result of hyper-concentration
of basally produced mucins, rather than MCM-associated mucins overproduction.
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Figure 3.11. IL33 is essential for mucous cell metaplasia (MCM) in Scnn1b-Tg+ airways. (a) Total
mucous cells per mm of basement membrane, IL33+/WT (white bar), IL33-/WT (blue bar),
IL33+/Scnn1b-Tg+ (green bar), IL33-/Scnn1b-Tg+ (red bar). (b) IL4 cytokine levels in cell-free BALF
(picograms per milliliter) IL33+/WT (white bar), IL33-/WT (blue bar), IL33+/Scnn1b-Tg+ (green bar),
IL33-/Scnn1b-Tg+ (red bar). (c) Semiquantitative histological scoring for airway mucus obstruction
IL33+/WT (white bar), IL33-/WT (blue bar), IL33+/Scnn1b-Tg+ (green bar), IL33-/Scnn1b-Tg+ (red
bar). (d) Representative photomicrographs from AB-PAS-stained left lung sections from IL33+/WT,
IL33-/WT, IL33+/Scnn1b-Tg+, IL33-/Scnn1b-Tg+. AB-PAS-stained mucous secretory cells are
indicated as red arrows. Error bars represent SEM. *p<0.05, **p<0.01, ****p<0.0001 using ANOVA
followed by Tukey’s multiple comparison post hoc test. IL33, Interleukin 33; WT, Wild-type; IL4,
Interleukin 4; BALF, Bronchoalveolar lavage fluid; AB-PAS, Alcian Blue- Periodic Acid Schiff.
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As compared to IL33-/Tg+ mice, the muco-obstructive airways in IL33-/Tg+ had greater number of
inflammatory cells including neutrophils and macrophages (Figure 3.12b). Since, Neutrophil
Extracellular Traps (NETs) have been shown to cause airway obstruction (Cortjens et al., 2016),
we immunostained lung sections for histone H3. Our analyses revealed greater extent of
histones/DNA contents which is likely contributed by neutrophils (neutrophil extracellular traps
(NETs) in IL33-/Tg+ plugs as compared to IL33+/Tg+ plugs.
Discussion
Our recent report demonstrated a positive correlation between increased levels of IL33 in
the muco-obstructive airspaces of Scnn1b-Tg+ mice and robust mucous cell metaplasia (MCM)
(Lewis et al., 2017). Both responses were found remarkably diminished in the second hand smoke
(SHS) exposed Scnn1b-Tg+ juveniles (Lewis et al., 2017). Accordingly, we had proposed our
conceptual model that the ASL-dehydration stress triggers IL33 release from airway epithelial cells
that, via downstream effector cells, orchestrates MCM in Scnn1b-Tg+ airways (Lewis et al., 2017).
Further, we proposed that the SHS exposure results in the suppression of IL33 expression in airway
epithelial cells that, eventually, leads to the suppression of MCM. This model led us to the next
logical step of investigating the effect of germ-line deletion of IL33 on the MCM and MCMassociated pathological features such as muco-obstruction, airway inflammation, and bacterial
infection. In the current study, employing IL33-deficient Scnn1b-Tg+ (IL33-/Tg+) mice, we have
mechanistically tested our central hypothesis that the ablation of IL33 inhibits MCM, which restores
mucociliary clearance, to reduce muco-obstruction and improve bacterial clearance.
The Scnn1b-Tg+ lung disease follows a typical age-associated shift in inflammatory milieu in the
airspaces that alters activation patterns of macrophages (Saini et al., 2014).

While the M1

activation, a T-helper 1 (Th1)-associated classical macrophage activation pattern, predominates in
Scnn1b-Tg+ at PND3, the M2 activation, Th2-associated alternative macrophage activation, is
robust at PND10 and PND42 (Saini et al., 2014).
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Figure 3.12. Mucus plugs from IL33-deficient mice have reduced mucins. (a) Representative
micrograph from IL33+/Scnn1b-Tg+ and (b) IL33+/Scnn1b-Tg+ sections stained for the
immunolocalization of isotype (IgG) control, Cit-H3 (red arrow), Muc5ac (blue arrow), and Muc5b
(green arrow). IgG, Immunoglobulin G; Cit-H3, Citrullinated-H3; IL33, Interleukin 33.
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This trend likely suggests that Th1 response that coincides with the onset of spontaneous bacterial
infection is switched to Th2 responses during second week of age. The estimation of IL33 contents
in Scnn1b-Tg+ BALF confirms this correlation, i.e., undetected IL33 in BALF at PND7 and robust
IL33 signals at PND 21. These data suggest that release of IL33 into the airspaces, which occurs
after PND7, parallels Th2 responses in Scnn1b-Tg+ mice.
In allergen exposed airways, stressed epithelial cells release IL33 that, along with IL25 and
TSLP, initiates Th2-predominated responses (Hammad et al., 2009). The identity of the trigger for
the release of IL33 in Scnn1b-Tg+ airspaces remains unclear. Although ASL dehydration along
with epithelial necrosis is evident well before PND5 (Mall et al., 2008), the BALF from 7 days old
Scnn1b-Tg+ did not show any evidence of IL33. It is likely that epithelial necrosis, a response seen
during the early neonatal stage, initiates IL33 release from necrotic cells that achieve measurable
concentration somewhere between PND7 and PND10. On the other hand, since alveolar epithelial
cells in Scnn1b-Tg+ mice stain intensely for nuclear IL33, the possibility exists that alveolar
epithelial cells are the primary source of BALF IL33. Further studies using Scnn1b-Tg+ mice with
cell-specific, i.e., airway epithelium vs alveolar epithelium, deletions of IL33 are required to identify
the cellular source of IL33 in Scnn1b-Tg+ mice.
IL33 mediate type 2 innate lymphoid cells (ILC2) generation via its binding to its receptor
interleukin 1 receptor-like 1 (IL1RL1; suppressor of tumorigenicity 2 (ST2)) on naïve ILCs (Spooner
et al., 2013). IL13 and amphiregulin (AREG), ligands for Interleukin 4 receptor alpha (IL4R) and
Epidermal Growth Factor Receptor (EGFR) pathways, respectively, are produced by ILC2s
(Monticelli et al., 2011; Moro et al., 2010). Both of these pathways have been implicated in the
initiation of MCM responses (Grunig et al., 1998; Tyner et al., 2006). While IL4R-deficient Tg+
mice have significant age-associated presence of AB-PAS+ mucous producing cells (Livraghi et
al., 2009), the involvement of EGFR pathways in Tg+ MCM responses remains untested. The IL33 /Tg+ lungs did not show any sign of MCM suggesting complete inhibition of IL4R and EGFR
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pathways. While AREG gene expression is upregulated in IL33+/Tg+ lungs, we observed significant
reduction of its expression in IL33-/Tg+ lungs. These data suggest that IL33-induced ILC2s
contribute to MCM responses in Tg+ lungs via activation of IL4R as well as EGFR pathway.
Whether the genetic ablation of EGFR pathway, in the presence of intact IL4R pathway, would
abolish MCM still remain unanswered.
Muco-obstruction was significantly reduced in the SHS-exposed Tg+ mice (Lewis et al.,
2017). Strong association of this outcome with suppressed IL33 expression and diminished MCM
in the SHS-exposed Tg+ mice led to our hypothesis that the muco-obstruction will be significantly
reduced in the absence of MCM in IL33-/Tg+ lungs. Counter-intuitively, our data reveal that the
complete absence of MCM was not sufficient to eliminate/reduce muco-obstruction from Tg+
airways. In other words, retention of ciliated cell density does not restore normal ciliary clearance
function as well. It is, therefore, most likely that the muco-obstruction in Tg+ mice is caused due to
ASL-dehydration.
Livraghi-Butrico et al. demonstrated that the complete loss of Muc5b (Muc5b-/-/Tg+) results
in significant reduction in the degree of muco-obstruction in Tg+ mice (Livraghi-Butrico et al., 2017).
While the contents of Muc5b proteins were significantly reduced in the BALF from monoallelic loss
(Muc5b+/-/Tg+) as compared to Muc5b+/+/Tg+ mice, monoallelic status of Muc5b had no effect/no
improvement on the degree of muco-obstruction. Along these lines, while the lung sections
immunostained for Muc5b and Muc5ac revealed reduced level of these proteins in IL33 -/Tg+ plugs
as compared to IL33+/Tg+ mice, there was no effect/no improvement in the degree of mucoobstruction in our study.
Neutrophil Extracellular Traps (NETs) have been shown to cause airway obstruction
(Cortjens et al., 2016). IL33-/Tg+ mice had significantly increased airway inflammation and the
mucus plugs were infiltrated with greater number of neutrophils as compared to IL33 +/Tg+ mice.
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Our analyses of lung sections immunostained for citrullinated histone H3, a protein marker for
extracellular DNA, revealed higher intensity of staining in IL33-/Tg+ plugs as compared to IL33+/Tg+
mice suggesting the possibility of increased inflammatory cells and NETs as possible contributors
towards mucus plugs in the absence of IL33 and associated MCM.
Based on mean CFU data at two age points, IL33 deletion did not appear to significantly
improve bacterial clearance in Scnn1b-Tg+ mice. However, at PND7, ~28% of IL33-/Tg+ neonates
were free of infection in contrast to ~8% of infection-free IL33+/Tg+ neonates. Further, at PND21,
only ~7% of IL33-/Tg+ juveniles were significantly infected in contrast to ~21% of IL33 +/Tg+
juveniles that had significant CFU counts. These data point to a possible advantage of IL33 deletion
in bacterial clearance.
IL33 has been shown to increase neutrophil recruitment in response to bacterial infections
(Lan et al., 2016; Robinson et al., 2018). Here, we report that neutrophil counts and the level for
key neutrophil chemoattractants, i.e., KC, G-CSF and MIP2, remain comparable between in IL33/Tg+ and IL33+/Tg+ BALF. These data suggest that IL33-independent mechanisms are selfsufficient in neutrophil recruitment in response to spontaneous bacterial infections in Tg+ mice.
It has been shown that ILC2-derived IL5 and IL13 are essential for eosinophil recruitment,
however, the deletion of IL33 receptor (ST2) does not completely inhibit eosinophil recruitment
(Iijima et al., 2014). In a recent report, Verma et al. recently reported the existence of IL13expressing ILC2 in mice lacking ST2 (Verma et al., 2018). These findings suggest the possible
existence of IL33-independent mechanisms for eosinophil recruitment whereby ILC2-derived IL13
may induce eosinophil recruitment. However, eosinophil recruitment into Scnn1b-Tg+ airways was
abolished in the absence of IL33, i.e., scarce eosinophils were found only in 3 out of 14 IL33 -/Tg+
mice. These data suggest that the eosinophil recruitment to the Scnn1b-Tg+ airways occurs via
IL33-responsive ILC2s.
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The ASL-dehydration in Scnn1b-Tg+ is strongly associated with the alveolar space
enlargement (Mall et al., 2008). Two distinct cell-specific proteases, i.e., macrophage-specific
matrix metalloproteinase 12 (MMP12) and neutrophil-specific neutrophil elastase (NE) have been
implicated in the alveolar space enlargement response (Gehrig et al., 2014; Trojanek et al., 2014).
The IL33-/Tg+ mice had significantly greater alveolar space enlargement suggesting a protective
role for IL33 in this outcome. Our analyses revealed comparable MMP12 gene expression and
neutrophil counts in IL33+/Tg+ and IL33-/Tg+ mice. Further studies are required to elucidate the
mechanism by which IL33 provides protection against excessive alveolar space enlargement.
In conclusion, our study mechanistically demonstrates that IL33 plays crucial roles in the
pathogenesis of CF-like lung disease in mice. First, IL33 provides protection against exaggerated
airway inflammation, lymphoid hyperplasia, and alveolar space enlargement. The genetic ablation
of IL33, however, did not provide a significant advantage in the clearance of bacterial burden from
Tg+ airways. Second, IL33 is essential for the mucous cell metaplasia responses. This outcome,
however, did not confer any reduction in the severity of muco-obstruction. These results indicate
that ASL dehydration alone is sufficient to trigger muco-stasis and airway muco-obstruction. These
results indicate that IL33 inhibitors, in association with mucolytic or rehydration agents, may provide
an effective line of treatment against airway inflammation, parenchymal structural damage, and
muco-obstruction.
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CHAPTER IV. CONCLUSION
In conclusion, these interconnected studies revealed novel insights into the role of IL33 in
the pathogenesis of muco-obstructive lung disease. Our finding that SHS suppresses Th2associated responses by suppression of IL33 gene expression and release into the BALF led to a
full scale study using germ-line ablation of IL33 superimposed onto the development of mucoobstructive lung disease.
Separately, these studies revealed various aspects influencing muco-obstructive lung
disease. Early postnatal exposure to SHS resulted in suppression of both innate and adaptive
immune systems. Through the suppression of immune cell chemoattractants and IgA
concentrations, Scnn1b-Tg+ mice exposed to SHS exhibited enhanced susceptibility to
pulmonary bacterial infections. These data indicate that children with muco-obstructive lung
disease reared in smoking homes may be more susceptible to bacterial infections.
Germ-line ablation of IL33 revealed that IL33 is essential for mucous cell metaplasia, but
dehydration of the ASL layer was sufficient to result in muco-obstruction. Further, our data
indicate that IL33 provides a protective role against the development of distal airspace
enlargement and lymphoid hyperplasia.
Collectively, these studies provide a foundation for further analyses into 1) the effect of
SHS exposure on muco-obstructive lung disease in patients and 2) role of specific cell types in
the pathogenesis in muco-obstructive lung disease.
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CHAPTER V.TRANSLATIONAL APPLICATION AND FUTURE
DIRECTIONS
The collective results from described studies provide novel insight into: 1) the effect of a
common environmental pollutant, i.e. SHS, in the pathogenesis of muco-obstructive lung disease,
and 2) the relationship between ASL layer dehydration and airway mucus obstruction in the
absence of mucous cell metaplasia. The results from these studies also laid foundation for future
research into the effects of other environmental pollutants and possible combination therapies to
alleviate the muco-obstructive phenotype.
Results from study presented in chapter 2 reveal both seemingly advantageous effects of
the attenuation of airway muco-obstruction and obvious deleterious effects of pulmonary bacterial
exacerbations. Although SHS is a common indoor pollutant, future exposure studies should
investigate the effects of other common pollutants on the pathogenesis of muco-obstructive lung
disease using the Scnn1b-Tg+ mouse model. Ozone, for example, is a common environmental
pollutant that is linked to the development of Th2-associated responses. It is critical to determine
if ozone exacerbates the muco-obstructive phenotype in the Scnn1b-Tg+ mouse, contrary to the
SHS findings. Further, exposing the Scnn1b-Tg+ mouse model to a similar exposure schedule
(PND 3-21) would reveal the effects of ozone on the pathogenesis of the disease.
Results from the study utilizing the IL33-deficient Scnn1b-Tg+ mice reveal that airway
muco-obstruction persists in the absence of mucous cell metaplasia. These results proved to be
quite astonishing, leading to further investigation in to the cause of airway muco-obstruction in the
absence of MCM. At the conclusion of this study, intense DNA staining, rather than secreted
mucins, within mucus plugs were attributed to the presence of immune cell infiltration and
Neutrophilic Extracellular Traps (NETs). Investigation into immune cell recruitment and the
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release of NETs would lend more insight into combination therapy featuring IL33 inhibitors,
rehydration therapy, mucolytic, DNAses, and inhibitors of immune cell recruitment.
To expand upon IL33 inhibitors, IL33 deficiency in the Scnn1b-Tg+ mice revealed a
protective role of IL33 against the development of alveolar space enlargement, indicating a
possible obstacle into the use of IL33 inhibitors in the treatment of muco-obstructive lung disease.
Perhaps the immune cell recruitment inhibitors, specifically neutrophils and formation of NETs,
would alleviate the alveolar space enlargement associated with IL33 deficiency.
Lastly, the collective results from this dissertation reveal insight into the aforementioned
advantages and possible disadvantages of combination therapy. The SHS study indicated that
immune suppression, i.e., immune cell recruitment, Th2-associated responses, and IgA
secretions, resulted in a decrease in MCM and airway muco-obstruction but an increase in
bacterial burden. In other words, the seemingly advantageous effects of SHS, i.e., decreased
airway mucus obstruction, MCM, and immune cell recruitment, were, indeed led to more serious
outcome, i.e., increased bacterial burden of the airspaces. These results suggest possible sideeffects into treatment with therapies focusing on a broad range of immune function suppression.
While a suppression of a multitude of immune responses may prove beneficial in the mucoobstructive phenotype, it may also facilitate consequences such as increased pulmonary bacterial
exacerbations. Utilizing the Scnn1b-Tg+ mouse model, one could investigate many aspects
related to this proposed combination therapy, e.g., efficiency of treatment, dosing regimen,
advantages, and side-effects, with a translational application to the development to human CF.
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